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i 
Abstract 
Infertile couples worldwide use assisted reproductive technologies (ARTs) to help conceive 
their own biological child. Due to the rising use of ARTs, there is continual emergence of 
new techniques implemented in human fertility clinics. When treatment is successful, there is 
an increased risk even within singletons for perinatal complications including preterm birth, 
intrauterine growth restriction, low and high birth weight and genomic imprinting disorders 
Beckwith Wiedemann Syndrome, Angelman Syndrome, and Silver-Russel Syndrome.  
Consequently, there is a need to investigate the effects of these treatments on the manipulated 
oocyte and preimplantation embryo.  To address this, I first analyzed the combined effects of 
multiple ARTs on imprinted DNA methylation in human day 3 (6 to 8 cells) and blastocyst-
stage embryos.  As imprinted DNA methylation is acquired during gametogenesis and 
maintained throughout preimplantation development, I hypothesized that ARTs disrupt this 
regulation in donated, good quality, human preimplantation embryos.  I observed that 
seventy-six percent of day 3 embryos and fifty percent of blastocysts exhibited perturbed 
imprinted methylation at the SNRPN, KCNQ1OT1 and/or H19 domains.  This frequency was 
similar to that previously observed in the mouse, and importantly demonstrated that extended 
culture did not pose a greater risk for imprinting errors.  Overall, human preimplantation 
embryos generated with ARTs possessed a high frequency of imprinted methylation errors.  
Next, I hypothesized that a single, indispensible ART treatment, ovarian stimulation, disrupts 
mitochondria in mouse oocytes and preimplantation embryos.  Ovarian stimulation led to a 
decreased total and active mitochondrial pool in high hormone-treated oocytes, and an 
increase in the percentage of oocytes displaying mislocalization of active mitochondria.  
Although the total mitochondrial pool was unchanged in hormone-treated preimplantation 
embryos compared to controls, the active mitochondrial pool was decreased in hormone-
treated 1-cell, 2-cell, morula and blastocysts.  Ultimately, the lower active mitochondrial pool 
in treated embryos was associated with a decreased percentage of outer blastomeres 
containing high amounts of active mitochondria in morula and blastocysts.  In blastocysts, 
this was associated with increased superoxide levels.  Overall, my results provide novel 
insight onto ARTs-induced disruption of imprinted DNA methylation and mitochondria in 
human and mouse preimplantation embryos, respectively.  
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Chapter 1  
1 Introduction 
1.1 Epigenetics 
1.1.1 General Introduction 
The term epigenotype was originally proposed by CH Waddington (1905-1975) to 
represent the whole complex of developmental processes that form the connection between 
genotype and phenotype (Waddington, 2012).  Waddington also suggested that the name 
‘epigenetics’ be used for the studies aimed at discovering the mechanisms behind the 
epigenotype. In this context, epigenetics governs numerous developmental processes, 
including cellular differentiation, where cells with identical genotypes exhibit distinct 
patterns of gene expression and consequently, cellular function (Goldberg et al., 2007). 
The modern definition of epigenetics is a heritable mechanism of transcriptional control 
that does not involve a change to the DNA sequence (Rodenhiser and Mann, 2006).  
Epigenetic changes that influence gene expression act by modifying overall chromatin 
structure.  This is accomplished by the addition of covalent and/or non-covalent 
modifications to the histone proteins (1.1.2) and DNA sequence (1.1.3) contained within the 
nucleosome.  Such modifications act to change the local microenvironment by modifying 
charge or affecting binding of regulatory proteins. Additionally, long non-coding RNAs have 
also been identified to play an epigenetic role in mediating gene expression (1.1.4). 
Epigenetic changes to the chromatin that lead to condensation will render a gene as silent or 
inactivated, whereas activating modifications generating open (decondensed) chromatin will 
lead to gene activation or render a gene poised for expression (Goldberg et al., 2007; 
Rodenhiser and Mann, 2006).  Overall, it is only fitting that the study of these modifications 
be referred to as epi- (translating to “above”) genetics. 
1.1.2 Histone Modification 
Chromatin is composed of DNA (147 base pairs) wrapped around a core octamer of 
histone proteins to generate a nucleosome structure.  The histone protein octamer is 
comprised of 2 molecules each of histone 2A (H2A), histone 2B (H2B), histone 3 (H3) and 
2 
 
histone 4 (H4).  Linker DNA connects nucleosomes together to form chromatin, which can 
be further compacted by incorporation into polynucleosome fibers that are stabilized by 
histone 1 (H1) binding (Quina et al., 2006). 
Chromatin can be modified to form heterochromatin, which is highly condensed and 
contains transcriptionally inactive genes, or euchromatin, which is decondensed and contains 
actively transcribed genes (Quina et al., 2006; Rodenhiser and Mann, 2006).  Chromatin 
compaction and decompaction is controlled through post-translational modification to 
histone tails.  Specifically amino (N)-terminal tails protrude from the nucleosome and are 
modified to affect inter-nucleosomal interactions in addition to recruiting chromatin-
remodeling enzymes that are involved in nucleosome repositioning (Bannister and 
Kouzarides, 2011). Different classes of modifications identified on histone tails include but 
are not limited to acetylation, phosphorylation, lysine and arginine methylation, 
ubiquitylation, sumoylation and deimination (Kouzarides, 2007).  Among these 
modifications, acetylation, phosphorylation and methylation are the most commonly studied.  
Histone acetylation neutralizes positive charges, disrupting the stabilizing interactions 
between DNA and histone proteins, which leads to open chromatin conformation (Bannister 
and Kouzarides, 2011; Campos and Reinberg, 2009). This functions similarly to serine, 
threonine and tyrosine phosphorylation, which adds negative charge to the histone structure 
and leads to gene activation (Bannister and Kouzarides, 2011).  In contrast, the covalent 
addition of methyl groups to amino acids does not alter histone charge, and lysine residues 
subjected to methylation can be mono-, di-, or tri-methylated while arginine residues can be 
mono- or di-methylated (Bannister and Kouzarides, 2011). Histone methylation can be 
activating or repressive depending on the residue onto which it is deposited on the histone 
tail.  
In general, active modifications to histone tails include histone acetylation (Bernstein et 
al., 2005; Kim et al., 2005; Roh et al., 2005), H3K4 di- and tri-methylation (H3K4me2 and 
H3K4me3) (Barski et al., 2007; Bernstein et al., 2002; Lauberth et al., 2013; Ruthenburg et 
al., 2007), H3K36me3 (Bannister et al., 2005; Barski et al., 2007), H2BK120 ubiquitylation 
(Thorne et al., 1987; Zhu et al., 2005) and H3S10 phosphorylation (Anest et al., 2003; 
Sassone-Corsi, 1999).  In contrast, transcriptional repression is generally accompanied by 
lack of histone acetylation (Bannister and Kouzarides, 2011), H3K9me2 and H3K9me3 
3 
 
(Bannister et al., 2001; Barski et al., 2007), H3K27me3 (Barski et al., 2007; Boyer et al., 
2006; Lee et al., 2006; Roh et al., 2006), H4K20me3 (Kalakonda et al., 2008; Kourmouli et 
al., 2004), H2AK119 ubiquitylation (Wang et al., 2004a), deimination of H3 and H4 arginine 
to citrulline (Cuthbert et al., 2004; Wang et al., 2004b), and sumoylation (Nathan et al., 2006; 
Shiio and Eisenman, 2003).  Overall, the combined effects of multiple active or repressive 
histone modifications will partition the genome into areas of euchromatin and 
heterochromatin, respectively (Figure 1-1). 
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Figure 1-1: Activating and repressive histone modifications 
Each nucleosome is composed of 147 bp of DNA (blue lines) wrapped around a protein 
octamer containing 2 molecules of histone 2A (H2A), H2B, H3 and H4 (grey circles).  
Linker DNA is shown as a blue line.  Active chromatin modifications (A) to N-terminal 
histone tails (wavy black lines) include H3K4 methylation (H3K4me2, H3K4me3), 
H3K36me3 (red circles), H3 and H4 acetylation (H3Ac, green squares), H3S10 
phosphorylation (orange triangles), ubiquitinated H2BK120 (purple octagons) and 
unmethylated CpGs (small white dots).  Repressive modifications (B) include H3K9me2/3, 
H3K27me3, H4K20me3 (red circles), ubiquitinated H2AK119 (purple octagons) and 
methylated CpGs (black dots).  Each nucleosome in repressive chromatin is linked by histone 
H1 (grey oval) and linker DNA (blue line). 
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1.1.3 DNA Methylation 
DNA methylation is the most widely studied epigenetic modification that controls gene 
expression.  DNA methylation occurs at cytosine residues primarily within CpG 
dinucleotides.  DNA methyltransferase (DNMT) enzymes regulate the acquisition and 
maintenance of 5-methylcytosine (5mC).  Specifically, the de novo DNMTs, DNMT3A and 
DNMT3B (Okano et al., 1999), catalyze the establishment of 5mC at unmethylated cytosines 
along with cofactor DNMT3L (Hata et al., 2002), whereas DNMT1 is the maintenance 
methyltransferases that binds to hemi-methylated DNA during replication to maintain 5mC 
on daughter strands (Figure 1-2).  The cofactor UHRF1 (ubiquitin-like with PHD and ring 
finger domain 1; NP95) recognizes hemi-methylated DNA at the replication fork and recruits 
DNMT1 to these sites (Arita et al., 2008; Rottach et al., 2010; Sharif and Koseki, 2011; 
Sharif et al., 2007).  Mutations in DNMTs lead to early embryonic lethality (Li et al., 1992; 
Okano et al., 1999).  CpG methylation controls gene expression by altering association with 
chromatin binding proteins and transcriptional regulatory factors. 
In general, CpG dinucleotides are infrequent within the genome (roughly 28 million 
CpGs exist within the human genome), and less than 10% occur in dense regions identified 
as CpG islands (Smith and Meissner, 2013).  CpG islands generally occur at transcriptional 
start sites of housekeeping and developmental regulatory genes and are largely unmethylated.  
However, CpG island methylation is essential for processes including chromosome 
alignment, stabilization and integrity, silencing of repetitive elements, X-chromosome 
inactivation and acquisition and maintenance of genomic imprinting (Smith and Meissner, 
2013).  It is important to note that the number of CpG islands per haploid genome and their 
genomic positions (intergenic, intragenic, transcriptional start sites) are conserved between 
mouse and human, indicating functional significance (Deaton and Bird, 2011; Illingworth et 
al., 2010). 
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Figure 1-2: DNA methylation 
Unmethylated CpG dinucleotides (white circles) within active euchromatic regions can be de 
novo methylated by DNMT3A/DNMT3B and cofactor DNMT3L to generate a repressive 
chromatin structure composed of methylated CpGs (black circles).  DNA methylation is 
maintained during replication by DNMT1 and UHRF1.   The difference between cytosine 
and methylated cytosine, circled in red, is the addition of a methyl (CH3) group to the 5th 
carbon in the pyrimidine ring. 
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While DNMTs establish DNA methylation at CpG dinucleotides, counteracting 
mechanisms of DNA demethylation exist to remove methylation marks.  DNA demethylation 
can occur passively in a replication-dependent manner via loss of DNMT1 maintenance, or 
through active DNA demethylation catalyzed by the ten eleven translocation (TET) family of 
dioxygenases.  TET proteins specifically catalyze oxidation of 5mC to 5-
hydroxymethylcysosine (5hmC) and subsequently generate 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC) (Gu et al., 2011; Inoue and Zhang, 2011; Inoue et al., 2011).  This is 
then followed by replication-dependent loss to unmethylated cytosine (Inoue and Zhang, 
2011), although it has also been shown that 5caC can be excised via the thymine-DNA 
glycosylase (TDG)-mediated base excision repair (BER) pathway (He et al., 2011). 
1.1.4 Non-coding RNA 
Approximately 70-90% of the genome is transcribed into non-coding RNA (ncRNA) 
molecules greater than 100 nucleotides in length (Lee, 2012). These ncRNAs have recently 
been shown to play a role in epigenetic regulation.   RNA-mediated epigenetic control has 
primarily been observed during X-inactivation (mediated by X-inactive specific transcript 
(XIST) ncRNA), genomic imprinting (imprinted ncRNAs) and gene silencing by RNA 
interference (RNAi) (Bernstein, 2005; Goldberg et al., 2007).  Evidence suggests that 
ncRNAs function by providing a scaffold to recruit protein complexes that catalyze the 
addition of DNA and histone modifications to a specific genomic location (Khalil et al., 
2009; Koziol and Rinn, 2010; Mercer and Mattick, 2013).  This recruitment can occur in 
trans, whereby chromatin proteins are guided to multiple sites spread across the genome 
(Rinn et al., 2007), or in cis, such as at imprinted domains (Mohammad et al., 2009; Nagano 
et al., 2008; Zhang et al., 2014) and the inactive X-chromosome (Pinter et al., 2012; Wutz, 
2011), where chromatin-modifying enzymes are thought to be recruited to modify their 
surrounding epigenetic neighborhood. In addition to protein recruitment, ncRNAs can 
regulate expression by mediating intrachromosomal loop formation (Zhang et al., 2014).  
Finally, studies at imprinted domains suggest that transcription of long ncRNAs (lncRNA) 
though antisense promoters, rather than the lncRNA itself, mediates gene expression through 
transcriptional interference mechanisms (Golding et al., 2011; Latos et al., 2012; Pauler et 
al., 2007; Santoro and Pauler, 2013).  Overall, the ability for ncRNAs to mediate gene 
expression provides an additional layer of targeting specificity to epigenetic gene regulation. 
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1.2 Genomic Imprinting 
1.2.1 General Introduction 
Genomic imprinting is a consequence of epigenetic gene regulation whereby 
expression of a gene is restricted to one parental allele (Bartolomei and Ferguson-Smith, 
2011).  Imprinting was originally discovered through experimental work aimed at 
understanding failed mammalian parthenogenesis (Kaufman et al., 1977).  Elegant 
pronuclear transplantation studies demonstrated that gynogenetic diploid embryos derived 
from two maternal pronuclei can develop up to 10 days post coitus (dpc). However, these 
embryos exhibit extremely poor development of extraembryonic lineages with relatively 
normal embryonic development (Barton et al., 1984; McGrath and Solter, 1983; 1984; Surani 
et al., 1984).  In contrast, androgenetic embryos with two paternal genomes have well-
developed extraembryonic tissues but exhibit poor embryonic development, dying shortly 
after implantation (Barton et al., 1984; McGrath and Solter, 1983; 1984; Surani et al., 1984).  
Both genetic conditions are lethal.  Consequently, it was established that maternal and 
paternal contributions to embryo development are functionally non-equivalent, as both 
parental genomes are required for complete embryogenesis.  This developmental failure has 
been attributed to the absence or overexpression of imprinted genes.   
To identify and map the specific chromosomal regions that are subjected to parental-
specific regulation, reciprocal translocation experimentation was used to produce mice with 
uniparental disomies (UPDs) (Cattanach, 1986; Cattanach and Kirk, 1985; Searle and 
Beechey, 1978; 1990).  For example, mice with maternal UPD for the central region of 
chromosome 7 (7qB5) exhibit hypotonia, poor suckling response and postnatal lethality 
between days 3-8, while paternal UPD for the same region produces postnatal growth 
restriction, hyperactivity and brain pathologies (Gabriel et al., 1999; Leff et al., 1992; Tsai et 
al., 1999).  In humans, regions syntenic to those in mouse produce pathological disorders 
known as imprinting syndromes. Maternal and paternal deletions and UPD for 15q11-13 
result in Prader-Willi Syndrome and Angelman Syndrome, respectively, producing similar 
pathologies to that seen for mouse 7qB5 (Knoll et al., 1989; Nicholls et al., 1989). These and 
other UPDs further demonstrate the non-equivalence of parental contributions.  
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1.2.2 Imprinted domains 
The discovery of the first imprinted genes in 1990-1991 (Bartolomei et al., 1991; 
DeChiara et al., 1990) paved the way for subsequent identification of numerous imprinted 
genes in both mouse and human. Imprinted genes often reside in clusters that are regulated 
by a germline CpG island differentially methylated region (gDMR) [reviewed in (Macdonald 
and Mann, 2014)].  A subset of gDMRs have been identified as imprinting control regions 
(ICRs), since experimental or congenital gDMR deletions cause loss of imprinted gene 
expression (Spahn and Barlow, 2003).  Differential chromatin modifications at the gDMR, 
including CpG methylation, modulate allelic expression (Macdonald and Mann, 2014) 
(Figure 1-3).  In the mouse, there are 24 known imprinted gDMRs: 21 are maternal-in-origin, 
where DNA methylation is established on the maternal alleles during oogenesis; while 3 are 
paternal-in-origin, where DNA methylation is acquired on paternal alleles during 
spermatogenesis (Macdonald and Mann, 2014). These differential methylation marks are 
subsequently maintained throughout preimplantation development (discussed in detail in 
section 1.3). Of the 24 mouse gDMRs, 17 exhibit differential methylation in human gametes 
and/or tissues, 1 has no human orthologue and 6 have not been fully ascertained.  Examples 
of conservation include mouse chromosome 7 and human chromosome 11p15.5, which 
harbor the H19 and KCNQ1OT1 (KCNQ1 overlapping transcript 1) imprinted domains 
(Mancini-DiNardo et al., 2003; Pandey et al., 2008; Srivastava et al., 2000), and mouse 
chromosome 7 and human chromosome 15q11-13 that contain the Small nuclear 
ribonucleoprotein N (SNRPN) domain (Bourc'his et al., 2001; El-Maarri et al., 2001; Geuns 
et al., 2003; Horsthemke, 1997; Shemer et al., 1997; Yang et al., 1998). These domains will 
be discussed below.  Importantly, abnormal CpG methylation levels at the ICRs of these 
domains leads to genomic imprinting disorders. 
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Figure 1-3: Genomic imprinting 
Expression of most genes occurs biallelically (red box; maternal expression, blue box; 
paternal expression).  Imprinted genes can be maternally-expressed and paternally-silent 
(grey box; silenced allele), or paternally-expressed and maternally-silent.  Generally, 
methylated CpGs (filled black circles) mark the silent allele, whereas unmethylated CpGs 
(unfilled white circles) occur on the expressed allele.   
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1.2.2.1 H19 imprinted domain 
The H19 imprinted domain was one of the first imprinted regions identified 
(Bartolomei et al., 1991) and is currently one of the best characterized.  It resides on distal 
chromosome 7 in the mouse and chromosome 11p15.5 in human.  In both mouse and human, 
the H19 gDMR acquires methylation on the paternal allele during spermatogenesis while the 
maternal allele is unmethylated in oocytes (Bartolomei et al., 1991; Borghol et al., 2006; 
Ibala-Romdhane et al., 2011; Jinno et al., 1996).  Genes in this domain include H19, Insulin-
like growth factor 2 (Igf2), and Insulin II (Ins2). Insulin-like growth factor 2 (Igf2) is protein-
coding gene that promotes fetal and placental growth (Constância et al., 2002; DeChiara et 
al., 1990), H19 is a non-coding RNA that also modulates growth (Gabory et al., 2009; Keniry 
et al., 2012) and tumor suppression (Yoshimizu et al., 2008), while Ins2 is involved in blood 
glucose regulation (Deltour et al., 1995; Duvillié et al., 1998; Giddings et al., 1994). The 
paternally-expressed Igf2 and Ins2 genes are located 90 kb upstream of the maternally-
expressed H19 gene (Bartolomei et al., 1991; DeChiara et al., 1991) and share common 
enhancer sequences located downstream H19 (Tremblay et al., 1997). Imprinted expression 
of Igf2, Ins2 and H19 is regulated by an enhancer-insulator mechanism (Figure 1-4).   
The H19 ICR is located 2 to 4 kb upstream from the H19 transcriptional start site and 
contains binding sites for the insulator protein CTCF [CCCTC-binding factor (zinc finger 
protein)] (Hark et al., 2000; Li et al., 2008a).  CTCF controls higher-order chromatin 
conformation by directing intrachromosomal loop formation through blocking, or insulating, 
interactions between promoter and enhancer elements.  Binding of CTCF is dependent on 
allelic ICR methylation.  CTCF binding to the unmethylated maternal H19 ICR blocks 
(“insulates”) interactions between the enhancer regulatory element and Igf2 and Ins2, 
consequently permitting interaction with the maternal H19 promoter (Hark et al., 2000; 
Kurukuti et al., 2006; Li et al., 2008a). In contrast, H19 ICR methylation on the paternal 
allele prevents CTCF binding, enabling intrachromosomal enhancer looping to the Igf2/Ins2 
control elements (Hark et al., 2000; Li et al., 2008a).  In addition to ICR-mediated regulation, 
Igf2 and Ins2 expression is also controlled by two additional somatic paternally methylated 
DMRs, DMR1 and DMR2.  DMR1 is located proximal to Igf2 and functions as a silencer of 
Igf2 expression in mesodermal tissues on the maternal allele, potentially through a tight loop 
structure generated by H19 ICR and matrix attachment region 3 (MAR3) interactions 
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(Constância et al., 2000; Kurukuti et al., 2006) (Figure 1-4).  Matrix attachment regions are 
DNA loci that localize to the nuclear matrix and are associated with repressed and active 
chromatin (Macdonald et al., 2015). In contrast, DMR2 is located within the sixth Igf2 exon 
where it functions as an methylated enhancer on the paternal allele to enable paternal Igf2 
transcription (Murrell et al., 2001). The H19 ICR is required for monoallelic expression of 
H19 and Igf2.  A maternally inherited deletion of the ICR that prevents CTCF binding leads 
to biallelic Igf2 expression while paternal deletion results in biallelic H19 expression (Engel 
et al., 2006; Thorvaldsen et al., 1998; Tremblay et al., 1997).  Furthermore, mutating CpG 
dinucleotides within the ICR prevents paternal imprinted methylation and enables CTCF 
binding that results in insulator activity and biallelic H19 expression (Engel et al., 2004).  
 Genetic and epigenetic errors at the H19 domain cause the imprinting disorder 
Beckwith-Wiedemann Syndrome (BWS) (OMIM #130650). BWS is an overgrowth disorder 
with clinical features that include macrosomia, macroglossia, abdominal wall defects, 
hemihyperplasia, visceromegaly and predisposition to malignancies (Choufani et al., 2010; 
2013; Weksberg et al., 2010).  In the general population, BWS incidence is estimated to be 1 
in 13, 700 (Weksberg et al., 2010). Microdeletions/microduplications, cytogenetic alterations 
and point mutations at chromosome 11p15 account for ~15% of BWS cases (Choufani et al., 
2010; 2013). An imprinting defect at the H19 ICR can also lead to BWS.  Five percent of 
BWS cases are due to an abnormal gain of methylation (hypermethylation) of the maternal 
H19 ICR (Choufani et al., 2010; Weksberg et al., 2010).   
In addition to BWS, abnormal loss of methylation (hypomethylation) at the H19 ICR 
leads to a growth restricted imprinting disorder, Silver Russell Syndrome (SRS)  (OMIM 
#180860).  SRS is a severe intrauterine growth restriction disorder associated with poor 
postnatal growth, craniofacial features that include pronounced forehead and triangular 
shaped face, and other minor malformations (Begemann et al., 2011; Eggermann et al., 2006; 
2010).  Hypomethylation of the paternal H19 ICR leads to SRS in >38% of patients 
(Begemann et al., 2011; Eggermann et al., 2006; Hannula et al., 2001). Maternal UPD of 
chromosome 11p15 has also been documented.  In contrast, 10% of SRS cases demonstrate 
uniparental disomy at another imprinted domain, Peg1 (paternally expressed gene 1), located 
on human chromosome 7q32 (mouse chromosome 6) (Begemann et al., 2011).  
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Figure 1-4: Structure and regulation of the H19 domain 
On the maternal allele (A, B), H19 ICR is unmethylated, allowing for CTCF binding and 
intrachromosomal loop formation. The ICR, DMR1 and MAR regions interact in a tight loop 
formation, excluding Igf2/Ins2 and bringing the enhancer elements to the H19 promoter.  In 
contrast on the paternally methylated allele (C, D), CTCF is unable to bind, generating a loop 
formation that brings the enhancer elements to the Igf2/Ins2 region, and preventing H19 
expression.  Somatic DMRs, DMR1 and DMR2, function in maternal Igf2 silencing and 
paternal Igf2 expression, respectively. 
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1.2.2.2 Kcnq1ot1 imprinted domain 
The Kcnq1ot1/KCNQ1OT1 imprinted domain is also located on the distal portion of 
mouse chromosome 7 and human chromosome 11p15.5.  This domain includes the paternally 
expressed Kcnq1ot1 lncRNA, 9 maternally expressed protein-coding genes, and 6 biallelic 
genes that escape imprinted regulation (Figure 1-5).  Of the 9 maternally expressed genes, 5 
exhibit placental-specific imprinted expression (oxysterol binding protein-like 5, Osbpl5; 
tumor-suppressing subchromosomal transferable fragment 4, Tssc4; CD81 antigen, Cd81; 
achaete-scute complex homolog 2, Ascl2; and tyrosine-hydroxylase, Th) while the remaining 
4 are imprinted in both placental and embryonic lineages (pleckstrin homology-like domain, 
family A, member 2, Phlda2; solute carrier family 22, member 18, Slc22a18; cyclin-
dependent kinase inhibitor 1C, Cdkn1c; and potassium voltage-gated channel, subfamily Q, 
member 1, Kcnq1) (Golding et al., 2011; Lewis et al., 2004; Mohammad et al., 2012; Umlauf 
et al., 2004).  
 The Kcnq1ot1 domain contains an ICR, within which the Kcnq1ot1 promoter is 
embedded.  In the mouse and human, this ICR is methylated during oogenesis, unmethylated 
in sperm, and maintains maternal methylation during embryogenesis (Beatty et al., 2006; 
Khoueiry et al., 2008; 2012). On the maternal allele, methylation at the Kcnq1ot1 ICR 
prevents Kcnq1ot1 transcription, thereby allowing expression of the 9 maternally transcribed 
genes. On the paternal allele, the Kcnq1ot1 ICR is unmethylated and Kcnq1ot1 is expressed, 
producing a 471 kb transcript that is involved in paternal repression of surrounding genes 
(Golding et al., 2011).  The complete mechanisms responsible for imprinting at the Kcnq1ot1 
cluster are not fully elucidated. However, it has been demonstrated that both the Kcnq1ot1 
ICR and Kcnq1ot1 long ncRNA (lncRNA)-mediated repression are important.  Loss of 
maternal methylation at the Kcnq1ot1 ICR results in biallelic Kcnq1ot1 expression and 
silencing of the normally expressed maternal alleles of the imprinted genes (Fitzpatrick et al., 
2002; Lewis et al., 2004; Smilinich et al., 1999). In contrast, deletion of the maternal 
Kcnq1ot1 ICR recapitulates the wildtype situation where a maternally methylated Kcnq1ot1 
ICR or a deleted Kcnq1ot1 ICR (and Kcnq1ot1 promoter) prevent production of the 
Kcnq1ot1 lncRNA, thereby permitting expression of maternally transcribed genes 
(Fitzpatrick et al., 2002).  Paternal inheritance of a deleted Kcnq1ot1 ICR also results in loss 
of Kcnq1ot1 expression, consequently re-activating the normally silent paternal alleles of 
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imprinted genes in the domain (Fitzpatrick et al., 2002; 2007; Mancini-DiNardo et al., 2003; 
Shin et al., 2008).  These data suggest that the Kcnq1ot1 ICR mediates imprinting at this 
domain by regulating expression of the Kcnq1ot1 lncRNA, although the exact role of the 
Kcnq1ot1 lncRNA in mediating the regulation of imprinting at this domain is still under 
debate.  Some studies suggest the Kcnq1ot1 lncRNA acts by coating the domain and 
preventing transcription by recruiting repressive complexes to the promoter regions of silent 
paternal alleles of imprinted genes within the domain (Mager et al., 2003; Pandey et al., 
2008; Terranova et al., 2008; Umlauf et al., 2004; Wagschal et al., 2008).  Furthermore, 
activation of paternally silent imprinted genes occurs when Kcnq1ot1 stability is decreased, 
paternal Kcnq1ot1 is truncated and repressive epigenetic marks are lost (Fitzpatrick et al., 
2002; Lewis et al., 2004; Mancini-DiNardo et al., 2006; Pandey et al., 2008; Shin et al., 
2008; Thakur et al., 2003; 2004).  Finally, a study conducted in our lab suggests that the act 
of transcription rather than the transcript itself is involved in domain regulation in embryo-
derived stem cells (Golding et al., 2011).    
 Genetic and epigenetic errors at the KCNQ1OT1 domain also cause the imprinting 
disorder Beckwith-Wiedemann Syndrome (BWS) (OMIM #130650). Here, 50% of BWS 
cases result from hypomethylation of the maternal KCNQ1OT1 ICR (Choufani et al., 2010; 
2013; Horike et al., 2000).  An additional 5-10% of BWS patients have mutations within 
CDKN1C, a maternally expressed gene in the KCNQ1OT1 cluster. Finally, 20% of cases 
consist of paternal uniparental disomy (UPD) involving chromosome 11p15, involving both 
the KCNQ1OT1 and H19 domains (Choufani et al., 2010; 2013). 
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Figure 1-5: Structure and regulation of the Kcnq1ot1 domain 
Imprinting at the Kcnq1ot1 domain is controlled by differential methylation at the maternal 
(upper strand) and paternal (bottom strand) ICRs. Maternal methylation of the ICR represses 
Kcnq1ot1 transcription, permitting maternal expression of surrounding genes. On the paternal 
allele, the ICR is unmethylated, the Kcnq1ot1 lncRNA is expressed and surrounding genes 
are repressed. 
  
17 
 
1.2.2.3 Snrpn imprinted domain 
The small nuclear ribonucleoprotein N (Snrpn/SNRPN) imprinted domain is located 
on the central region of mouse chromosome 7 and human chromosome 15q11-q13.  The 
Snrpn/SNRPN ICR within the promoter and exon 1 is methylated during oogenesis, 
unmethylated in sperm, and maintains maternal-specific methylation throughout 
preimplantation (El-Maarri et al., 2003; Geuns et al., 2003; Shemer et al., 1997). This 
imprinted cluster contains numerous genes expressed exclusively from the paternal 
chromosome, including Snurf-Snrpn (Snrpn upstream reading frame-Snrpn), Frat3 
(frequently rearranged in advanced T-cell lymphomas 3), Mkrn3 (makorin ring finger protein 
3), Magel2 (melanoma antigen-like 2), Ndn (Necdin), Ipw (imprinted in Prader-Willi 
Syndrome), over 70 snoRNA genes and a Snrpn lncRNA transcript (Snrpnlt) (Figure 1-6). 
This lncRNA, which is over 470 kb in human and 1,000 kb in mouse, includes Snrpn and 
extends through Ipw, the snoRNAs and Ube3a (ubiquitin protein ligase E3A), also known as 
the Ube3a antisense transcript, Ube3a-as (Horsthemke and Wagstaff, 2008; Landers et al., 
2005; Runte et al., 2001) (Figure 1-6).  Maternal-specific expression of the Ube3a/UBE3A 
gene is restricted to the brain in both human and mouse, maternal expression of ATP10C 
(ATPase, class V, type 10C) is imprinted in human brain and fibroblasts (Herzing et al., 
2001; Meguro et al., 2001), although there are conflicting reports as to whether Atp10c is 
imprinted in the mouse (Kashiwagi et al., 2003; Kayashima et al., 2003). 
 The Snrpn ICR is located in the Snrpn promoter and extends into exon 1.  Regulation 
of the Snrpn imprinted domain is not fully understood; however, both the Snrpn ICR and 
Snrpnlt are likely required.  A PWS family with paternal SNRPN ICR deletions exhibited 
loss of MKRN3, MAGEL2, NDN and SNRPN expression (Bielinska et al., 2000).  This effect 
was recapitulated in a mouse model harboring a similar deletion (Bielinska et al., 2000) as 
well as in mice inheriting a paternal 42 kb deletion covering Snrpn exons 1-6 and 23 kb 
upstream (Yang et al., 1998).  In contrast, a smaller 0.9 kb microdeletion including the 
majority of the mouse Snrpn promoter and exon 1 did not affect Mkrn3, Ndn, Magel2 and 
Ube3a expression, while a small deletion (4.8 kb) produced mosaic effects. With respect to 
the Snrpnlt lncRNA, it is thought that imprinted expression of Ube3a/UBE3A is the result of 
transcriptional interference of the Snrpnlt, but this still remains to be validated (Chamberlain 
and Brannan, 2001; Chamberlain et al., 2014; Rougeulle et al., 1998; Runte et al., 2001).  
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Figure 1-6: Structure and regulation of the Snrpn domain 
The Snrpn domain consists of a bipartite ICR (AS-IC and PWS-IC).  On the paternal allele, 
the unmethylated PWS-IC region of the ICR permits Snrpnlt expression and enables paternal 
transcription of surrounding genes Frat3, Mkrn3, Magel2, Ndn, Snrpn, Ipw, and snoRNA 
genes, and represses Ube3a and Atp10c.  In contrast, on the maternal allele, Snrpn ICR 
methylation at PWS-IC prevents Snrpnlt transcription and enables Ube3a and Atp10c 
expression in a brain-specific manner. 
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On the paternal allele, the Snrpn ICR is unmethylated, the Snrpn lncRNA is 
transcribed, directing expression of other paternally expressed genes, while interfering with 
transcription of Ube3a and Atp10c (Horsthemke and Wagstaff, 2008).  In contrast, on the 
maternal allele, the Snrpn ICR is methylated, the Snrpn lncRNA is not transcribed and Ube3a 
and Atp10c are expressed in a brain-specific manner (El-Maarri et al., 2001; Horsthemke and 
Wagstaff, 2008).  For this domain, ICR regulation is more complicated since the 
Snrpn/SNRPN ICR has a bipartite structure, containing two specific regions termed the 
Angelman Syndrome imprinting centre (AS-IC) and Prader-Willi Syndrome IC (PWS-IC) 
(Horsthemke, 1997).  The PWS-IC is a 4.3 kb sequence located around the SNRPN 
promoter/exon1 (Ohta et al., 1999), while the AS-IC is 880 bp and is located approximately 
35 kb upstream of the SNRPN transcriptional start site (Buiting et al., 1999).  On the maternal 
allele, exons within the unmethylated AS-IC are transcribed, which leads to methylation at 
the PWS-IC (Horsthemke and Wagstaff, 2008; Kantor et al., 2004; Shemer et al., 2000). This 
in turn silences the Snrpnlt lncRNA and permits expression of Ube3a and Atp10c 
(Horsthemke and Wagstaff, 2008). On the paternal allele, AS-IC is methylated, blocking 
transcription of exons within the AS-IC (Horsthemke and Wagstaff, 2008; Kantor et al., 
2004; Shemer et al., 2000). Thus, PWS-IC is unmethylated, enabling Frat3, Mkrn3, Magel2, 
Ndn, Snrpn, Snrpnlt, Ipw, snoRNAs and transcription, and silencing Ube3a and Atp10c (El-
Maarri et al., 2001).   
Genetic and epigenetic errors at the SNRPN domain cause the imprinting disorders 
Angelman Syndrome (AS) (OMIM #105830) and Prader-Willi Syndrome (PWS) (OMIM 
#176279). Angelman Syndrome is a neurological syndrome characterized by severe 
intellectual and motor retardation, limited speech, ataxia, hypotonia and unusual facies such 
as open-mouthed expression (Van Buggenhout and Fryns, 2009). Its incidence is 
approximately 1 in 15, 000 newborns  (Horsthemke, 1997; Van Buggenhout and Fryns, 
2009).  Maternal deletions of the 15q11.2-q13 region (including AS-IC microdeletions, 60-
75%), paternal UPD (2-5%) and mutations in the UBE3A gene (10%) cause AS (Van 
Buggenhout and Fryns, 2009).  Less than 5% of cases result from loss of maternal 
methylation at the SNRPN ICR (Horsthemke, 1997; Van Buggenhout and Fryns, 2009).  In 
contrast to AS, Prader-Willi Syndrome is characterized by intellectual disability, decreased 
fetal activity, obesity, small hands and feet, muscular hypotonia, short stature and 
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hypogonadotropic hypogonadism.  The incidence of PWS is about 1 in 20, 000 and results 
from a lack of paternal-specific gene expression from the domain due to paternal 15q11.2-
q13 deletions (including PWS-IC microdeletions, 65-75%), maternal UPD (20-30%) and 
gain of methylation at the paternal SNRPN ICR (1-3%) (Cassidy et al., 2012).  
1.2.3 Evolution of genomic imprinting and the placenta 
The importance of imprinted genes in fetal and placental growth and development 
was originally identified by nuclear transplantation experiments as well as uniparental 
disomies of specific chromosomal regions containing imprinted genes (Cattanach, 1986; 
Cattanach and Kirk, 1985; Searle and Beechey, 1990) (see 1.2.1).  Failed embryo 
development in androgenetic and gynogenetic embryos, in part due to defects in the 
trophoblast, indicated that imprinted genes likely play a role in placental development and 
function.  Furthermore, there is an evolutionary link between imprinted genes and the 
placenta, as existence of imprinting seemingly evolved at the same time Therian mammals 
(marsupial and placental mammals) separated from egg-laying monotremes (Ager et al., 
2007; Killian et al., 2000; Renfree and Pask, 2011; Smits et al., 2008; Suzuki et al., 2011; 
Weidman et al., 2004). Consequently numerous theories have arisen regarding the emergence 
genomic of imprinting.  The parental conflict theory states that imprinting arose to balance 
the opposing interests between maternal and paternal genomes with respect to maternal-fetal 
nutrient transfer (Moore and Haig, 1991).  In contrast, another theory suggests that 
imprinting evolved to protect the female from trophoblast invasion, or ectopic trophoblast 
(Hall, 1990; Varmuza and Mann, 1994).  The latter theory relates to the fact that the 
trophoblast must invade the uterine epithelium for successful pregnancy.  This theory states 
that genomic imprinting protects females from excessive trophoblast invasion in the ovary 
when oocytes spontaneously activate by suppressing maternal genes involved in placental 
development (Hall, 1990; Varmuza and Mann, 1994).  Irrespective of their differences, the 
above theories suggest that a subset of genes must be appropriately regulated by imprinting 
to balance proper embryonic and placental development, and maternal survival. 
The specific functions of a numerous imprinted genes in the placenta have been 
determined (Figure 1-7) (Tunster et al., 2013).  For example, both the H19 and Kcnq1ot1 
imprinted domains play an important role in placental function and resulting growth (Tunster 
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et al., 2013).  With respect to the H19 domain, loss of paternal Igf2 expression results in 
reduced placental weight and growth restriction while elevated Igf2/loss of expression of H19 
results in fetal overgrowth (Angiolini et al., 2011; Lefebvre, 2012; Sandovici et al., 2012).  
The role of the H19 domain in placental function and growth is conserved in the human and 
also causes growth deficiencies or overgrowth abnormalities in human babies (Bouwland-
Both et al., 2013; Demetriou et al., 2014; Gonzalez-Rodriguez et al., 2016; Kappil et al., 
2015; McMinn et al., 2006) including Beckwith-Wiedemann Syndrome (Aoki et al., 2011) 
and Silver Russell Syndrome (Yamazawa et al., 2008).  Furthermore, numerous genes within 
the Kcnq1ot1 cluster have been implicated in placental function.  Specifically, 5 out of the 9 
maternally expressed genes in this domain exhibit placental-specific imprinted expression 
(Osbpl5, Tssc4, Cd81, Ascl2 and Th) while the remaining 4 genes are imprinted in both the 
placenta and embryo (Phlda2, Slc22a18, Cdkn1c, Kcnq1) (Golding et al., 2011; Lewis et al., 
2004; Mohammad et al., 2012; Umlauf et al., 2004).  The roles of Ascl2, Cdkn1c and Phlda2 
in placental function have been analyzed (Fitzpatrick et al., 2002; Mancini-DiNardo et al., 
2006).  Briefly, decreased Ascl2 impairs placental and in turn embryonic growth (Tunster et 
al., 2010), loss of Cdkn1c results in placental and fetal overgrowth (Takahashi et al., 2000) 
while Phlda2 overexpression impairs fetal growth during late gestation (Tunster et al., 2010). 
Similar to the H19 domain, the role of the Kcnq1ot1 region in controlling placental growth 
and function has been identified in the human (Kanber et al., 2009; López-Abad et al., 2016; 
Mandò et al., 2014; McMinn et al., 2006), including its role in Beckwith-Wiedemann 
Syndrome (Bourque et al., 2011).   
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Figure 1-7: Imprinted genes with demonstrated placental function in the mouse 
Mouse imprinted genes with known placental functions are shown beside identified gametic 
DMRs.  Imprinted genes with an asterisk indicate suspected placental function.  Blue 
rectangles, paternal allele; red rectangles, maternal allele; black triangles, centromere; white 
circles, unmethylated CpGs; black circles, methylated CpGs. Chromosome number is 
indicated below each chromosome set. 
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1.3 DNA methylation reprogramming in mouse and human 
As mentioned above, imprinted gDMRs acquire allele-specific methylation during 
gametogenesis, which is then maintained throughout preimplantation development.  In 
general, global and imprinted DNA methylation marks are dynamically regulated during 
early mammalian development (Bartolomei and Ferguson-Smith, 2011). There are three 
major waves of DNA methylation reprogramming that occur during gamete and 
preimplantation development (Figure 1-8).  First, global and imprinted DNA methylation 
marks from previous generations are erased in primordial germ cells (PGCs).  Subsequently, 
maternal and paternal-specific DNA methylation and imprints are acquired differentially 
during oocyte and sperm development.  Finally, imprints are maintained during 
preimplantation development when the remainder of the genome undergoes an erasure stage 
to establish totipotency of the early embryo.   This section describes the three phases of DNA 
methylation reprogramming in mouse, and concludes with a description of the conservation 
of these phases in the human [reviewed in (White et al., 2016)]. 
1.3.1 DNA methylation erasure during mouse primordial germ cell 
development 
The first phase of epigenetic programming is DNA methylation erasure. Here, 
previous parental DNA methylation marks are removed in sexually uncommitted primordial 
germ cells (PGCs). In the mouse, global DNA methylation loss occurs in two distinct waves.  
In stage I, DNA methylation erasure is initiated at embryonic day 8.0 (E8.0) (Hajkova et al., 
2002a; Saitou et al., 2012; Seki et al., 2005). Global 5mC levels progressively decline in a 
passive, replication-dependent manner to E9.0, reducing global methylation levels to ~30% 
(Guibert et al., 2012; Seisenberger et al., 2012; Seki et al., 2005). Although the maintenance 
methyltransferase Dnmt1 remains highly expressed at these stages, its recruitment cofactor 
Uhrf1/Np95 is not, likely accounting for methylation loss (Kurimoto et al., 2008).  Stage II 
methylation erasure produces a further decline in 5mC levels between E10.5-13.5. Here, 
erasure occurs via active demethylation, resulting from ten-eleven translocation 1 and 2 
(TET1, TET2) oxidation of 5mC to the intermediate 5-hydroxymethylcytosine (5hmC) 
(Hajkova et al., 2008; 2010; Piccolo et al., 2013; Yamaguchi et al., 2013) (Figure 1-9). The 
base excision repair pathway may also have a role in active demethylation, involving 
activation-induced cytidine deaminase and thymine-DNA glycosylase (TDG) (Cortellino et 
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al., 2011; Hajkova et al., 2010; Morgan et al., 2004; Popp et al., 2010). At E13.5, 5mC 
declines to its lowest levels (Guibert et al., 2012; Popp et al., 2010; Saitou et al., 2012; 
Seisenberger et al., 2012; Yamaguchi et al., 2013), representing the epigenetic ground state 
of the germline genome (Hajkova, 2011).   
In comparison to the whole genome, DNA methylation erasure at imprinted gDMRs 
is delayed. Onset of erasure begins after E9.5 and is complete at or after E13.5 (Guibert et al., 
2012; Hackett et al., 2013; Hajkova et al., 2002a; Kagiwada et al., 2013; Kobayashi et al., 
2013).  More specifically, of the 18 maternal gDMRs and 3 paternal gDMRs analyzed, only 7 
still retain some level of methylation (~20% methylation or less) at E13.5, while 
demethylation is completed at the remaining 14 gDMRs (Kobayashi et al., 2013). Current 
studies investigating imprinted gDMR methylation loss in PGCs indicate roles for both 
passive and active demethylation. Passive replication-dependent demethylation, beginning at 
E9.5 (Kagiwada et al., 2013), is supported by repression of Uhrf1 (Kurimoto et al., 2008). By 
comparison, active demethylation occurs through TET1 conversion of 5mC to 5hmC 
commencing at E10.5 (Hackett et al., 2013; Piccolo et al., 2013; Vincent et al., 2013) (Figure 
1-9). There is little evidence for demethylation through the base excision repair pathway at 
imprinted gDMRs (Hackett et al., 2013; Kagiwada et al., 2013; Popp et al., 2010). 
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Figure 1-8: DNA methylation dynamics during gametogenesis and preimplantation 
development 
Global DNA methylation (orange line) and imprinted DNA methylation (purple line) is first 
erased in primordial germ cells.  Then, sex-specific DNA methylation is acquired both 
globally and at imprinted gDMRs during gametogenesis.  Specifically global (dark blue) and 
imprinted (light blue) methylation is established early during spermatogenesis, with 
methylation mostly completed at birth.  In contrast, DNA methylation acquisition globally 
(red) and at imprinted domains (pink) is delayed in oogenesis, occurring after birth and 
beginning in growing oocytes up to MII ovulated oocytes.  Despite global DNA 
demethylation of the paternal (blue) and maternal (red) genomes after fertilization during 
preimplantation development, imprinted DNA methylation is maintained at imprinted genes 
(light blue, pink).  Assisted reproductive technologies occur during imprint acquisition and 
imprint maintenance phases, with examples shown in grey italicized text. E, embryonic day; 
P, postnatal day; MI, meiosis I; MII, meiosis II; Prospg, prospermatogonia; Spg, 
spermatogonia; Scy, spermatocyte; RS, round spermatid; ES, elongating spermatid; IVF, in 
vitro fertilization; ICSI, intracytoplasmic sperm injection. 
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1.3.2 DNA methylation acquisition during mouse gametogenesis 
Following erasure, the next phase of DNA methylation programming is DNA 
methylation acquisition.  In males, global DNA methylation acquisition commences in 
E14.5-E16.5 mitotically-arrested fetal prospermatogonia, reaching 50% methylation levels 
by E16.5, and continues to rise through to the spermatogonia stage (Kobayashi et al., 2013), 
where the highest global methylation levels are present during spermatogenesis (Kobayashi 
et al., 2013; Niles et al., 2011; Seisenberger et al., 2012; Vlachogiannis et al., 2015). In 
mature sperm, ~80% of cytosines are methylated (Kobayashi et al., 2012).  This pattern was 
recently confirmed in a genome-wide DNA methylation study, where overall 5mC levels 
increased from 30% in E16.5 prospermatogonia to 76%, ~77% and 79% in postnatal day 0.5 
(P0.5) prospermatogonia, P7.5 spermatogonia and adult spermatozoa, respectively (Kubo et 
al., 2015).  In mature sperm, ~78-90% of cytosines are methylated (Kobayashi et al., 2012; 
Kubo et al., 2015; Smith et al., 2012; Wang et al., 2014).  Mechanistically, DNA methylation 
acquisition occurs through the de novo DNA methyltransferases, DNMT3A and DNMT3B, 
and accessory protein DNMT3L (Kato et al., 2007) (Figure 1-9). 
In contrast to male germ cells, E16.5 diplotene stage female germ cells (Ewen and 
Koopman, 2010) remain globally hypomethylated (Kobayashi et al., 2012). Instead, 
acquisition of global de novo methylation is delayed until oocytes enter the growth phase 
(Smallwood et al., 2011). By the time oocytes are at the germinal-vesicle and mature MII 
stages, acquisition of DNA methylation is complete (Kobayashi et al., 2012; Shirane et al., 
2013; Smallwood et al., 2011; Smith et al., 2012; Tomizawa et al., 2011). Globally, ~40-55% 
of cytosines are methylated in oocytes (Kobayashi et al., 2012; Smallwood et al., 2011; 
Smith et al., 2012; Wang et al., 2014).  Mechanistically, DNMT3A and DNMT3L are 
indispensable for DNA methylation acquisition in female germ cells (Kobayashi et al., 2012; 
Smallwood et al., 2011) (Figure 1-9).  
Recently, CpG island DNA methylation acquisition in oocytes has also been linked to 
transcription (Veselovska et al., 2015).  Transcription initiating from alternative 
transcriptional start sites throughout oogenesis is highly correlated with hypermethylated 
CpG domains in fully grown GV oocytes (Veselovska et al., 2015).  This occurs in part 
during transcription elongation where disposition of histone 3 lysine 36 trimethylation 
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(H3K36me3) enhances DNMT3A activity (Dhayalan et al., 2010; Veselovska et al., 2015; 
Zhang et al., 2010).  
For imprinted DNA methylation, acquisition occurs with similar timing to that of the 
whole genome. In the male germline, imprinted methylation acquisition at H19, Gtl2 and 
Rasgrf1 has begun by E14.5, increasing progressively through to E18.5 in fetal 
prospermatogonia until being completed in P0 mitotically arrested spermatogonia (Davis et 
al., 2000; Kaneda et al., 2004; Kato et al., 2007; Kobayashi et al., 2013; Lee et al., 2010; 
Lucifero et al., 2002; Ueda et al., 2000). The two parental alleles undergo differential 
methylation acquisition, with de novo methylation initiating earlier (E14.5) on the previous 
paternally-methylated H19, Gtl2 and Rasgrf1 alleles than on the previous maternally-
unmethylated alleles (E16.5) (Davis et al., 2000; 1999; Kato et al., 2007; Ueda et al., 2000).  
This differential acquisition indicates that some previous parental identity is retained in the 
absence of DNA methylation.  H19 and Gtl2 imprinted methylation acquisition during 
spermatogenesis is dependent on DNMT3A and DNMT3L, while Rasgrf1 additionally 
requires DNMT3B (Bourc'his and Bestor, 2004; Hirasawa et al., 2008; Kaneda et al., 2004; 
Kato et al., 2007; Vlachogiannis et al., 2015; Webster et al., 2005) (Figure 1-9).   
In E16.5 female germ cells, imprinted gDMRs have low methylation levels 
(Kobayashi et al., 2013). DNA methylation acquisition at the Snrpn, Igf2r, Peg1, Peg3, 
Kcnq1ot1, Zac1, Meg1 and Impact gDMRs is delayed compared to male imprint acquisition, 
which occurs prenatally. Instead, DNA methylation is acquired during oocyte growth in a 
size-dependent manner from the primary to antral follicle stage, and is completed by the 
ovulated metaphase II (MII) stage (Denomme et al., 2012; Hiura et al., 2006; Lucifero, 2004; 
Lucifero et al., 2002; Obata and Kono, 2002).  In oocytes, as in sperm, allelic identity also 
influences DNA methylation acquisition. Specifically, de novo methylation is initiated earlier 
(P10) on the previous maternally-methylated Snrpn, Zac1 and Peg1 alleles than on the 
previous paternally-unmethylated alleles (P15) (Davis et al., 2000; Hiura et al., 2006; Kato et 
al., 2007; Lee et al., 2010; Lucifero, 2004). This again indicates that epigenetic memory of 
parental identity is DNA methylation-independent. Expression of de novo 
methyltransferases, Dnmt3A, Dnmt3B and Dnmt3L, occurs during 10-25 days post partum 
(dpp), increasing co-ordinately with oocyte diameter (Lucifero et al., 2007) and DNA 
methylation acquisition (Lucifero, 2004). However, imprinted DNA methylation 
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establishment is dependent on DNMT3A and DNMT3L (Bourc'his et al., 2001; Hata et al., 
2002; Kaneda et al., 2010; Lucifero, 2004; Lucifero et al., 2002; Obata and Kono, 2002) but 
not DNMT3B  (Kaneda et al., 2010) (Figure 1-9). Similar to global DNA methylation 
acquisition, imprinted DNA methylation acquisition at gDMRs within the oocyte is 
dependent on transcription through gDMRs, as shown for Snrpn (Smith et al., 2011), Gnas 
(Chotalia et al., 2009), and Zac1/Plagl1 (Veselovska et al., 2015).  
1.3.3 DNA methylation dynamics during mouse preimplantation 
development 
Preimplantation development represents the third epigenetic reprogramming phase 
where DNA methylation loss occurs globally through the zygote to blastocyst stages, albeit 
not to the epigenomic ground state level seen in PGCs.  Following fertilization, there is 
active loss of DNA methylation globally in zygotes (Okamoto et al., 2016; Smith et al., 
2012) and 2-cell embryos (Wang et al., 2014).  As the latter study did not analyze zygotes 
(Wang et al., 2014), active DNA methylation loss was hypothesized to occur at the 1-cell 
stage, consistent with loss of global 5mC staining in the paternal pronucleus 4-6 hours 
following in vitro fertilization  (Santos et al., 2002; 2013).  Based on 5hmC staining and 
DNA methylation analyses of Tet3-deficient zygotes, active demethylation of the paternal 
pronucleus occurs via TET3-mediated 5mC conversion to 5hmC (Gu et al., 2011; Guo et al., 
2014a; Inoue and Zhang, 2011; Inoue et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2011) 
(Figure 1-9). Consistent with this, Tet3 mRNA is more abundant than Tet1 and Tet2 
transcripts in oocytes and zygotes (Okae et al., 2014; Wossidlo et al., 2011), and TET3 
protein along with 5hmC levels are restricted to/overabundant in the paternal compared to 
maternal pronucleus (Gu et al., 2011; Inoue and Zhang, 2011; Inoue et al., 2011; Shen et al., 
2014; Wang et al., 2014).  Having said this, TET3 hydroxylation and the spike in 5hmC 
levels may be restricted to S-phase (pronuclear stage 3, PN3) (Santos et al., 2013), which 
occurs subsequent to initiation of DNA demethylation (Amouroux et al., 2016; Okamoto et 
al., 2016), indicating a role for additional mechanisms in this initial demethylation event. In 
fact, abrogated 5hmC formation via small molecule TET inhibitors or oocyte Tet3 deletion 
had no effect on paternal 5mC loss in early PN3 zygotes (Amouroux et al., 2016). Thus, 
additional mechanisms are likely involved in pre-replicative active DNA demethylation of 
the paternal pronucleus (Amouroux et al., 2016). In post-replicative PN3 to PN4 zygotes, 
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genome-wide CpG sites exhibited methylation loss both actively (TET3-dependent) and/or 
passively (replication-dependent) (Guo et al., 2014a). The latter includes repetitive elements, 
where DNA demethylation in the paternal pronucleus possessed hemimethylated CpG 
dinucleotides due to replication-dependent dilution, with minor replication-independent 
active demethylation (Amouroux et al., 2016; Arand et al., 2015). Interestingly, production of 
5hmC by TET3 is linked to DNMT1 and DNMT3A in late P4 zygotes, suggesting that de 
novo methylated cytosines may be targets of hydroxylation (Amouroux et al., 2016). Overall, 
such evidence supports both active and passive pathways in paternal pronuclear 
demethylation.  
In comparison to the paternal pronucleus, the maternal pronucleus is protected from 
5mC demethylation. Protection from DNA demethylation is accomplished via maternal 
effect proteins, which are synthesized by the oocyte and required in the preimplantation 
embryo. In zygotes, the maternal effect protein developmental pluripotency associated factor 
3 (DPPA3/Stella/PGC7) binds to maternal chromatin containing histone 3 lysine 9 
dimethylation (H3K9me2), thereby inhibiting TET3 activity (Nakamura et al., 2007; 2012; 
Nakatani et al., 2015) (Figure 1-9). DPPA3 binding to chromatin may be dependent on the 
H3K9me2 methyltransferase protein euchromatic histone lysine methyltransferase 2 
(EHMT2/G9a) as well as on its heterodimeric partner, EHMT1/GLP, since their deletion in 
embryonic stem cells results in reduced DNA methylation at promoter regions (Nakamura et 
al., 2012; Zhang et al., 2016).  Despite this protection, active demethylation may lead to 
partial DNA methylation loss on the maternal genome, since low 5hmC levels are present in 
maternal pronuclei of zygotes (Salvaing et al., 2012; Wossidlo et al., 2011). In support of 
this, haploid parthenogenetic embryos (only maternal genome) display pre-S-phase 5mC 
depletion 6 hours post-activation (Amouroux et al., 2016; Okamoto et al., 2016); and Tet3-
deficient zygotes show impaired DNA demethylation on both paternal and maternal 
pronuclei (Guo et al., 2014a).   
After the first cleavage division, demethylation of the majority of the maternal 
genome is initiated in a passive, replication-coupled manner. Thus, DNA methylation loss of 
~50% at each cell cycle leads to the lowest levels by the early blastocyst stage (Mayer et al., 
2000; Oswald et al., 2000; Santos et al., 2002).  The absence of highly concentrated oocyte-
specific DNMT1o in nuclei, except for at the 8-cell stage, and the presence of small amounts 
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of the somatic DNMT (DNMT1s) in nuclei during preimplantation development, are the 
contributing factors to passive DNA demethylation (Cirio et al., 2008a; 2008b; Hirasawa et 
al., 2008). However, DNA methylation loss may not occur solely through replication 
dilution. A recent genome-wide, allele-specific study has documented 5mC, 5hmC, and 
subsequent oxidized derivatives 5fC and 5caC in 2-cell to 4-cell embryos, identifying a role 
for active demethylation of the paternal and maternal genome at these stages (Wang et al., 
2014).  Thus, passive replicative dilution of maternal DNA methylation may be delayed until 
the 4-cell stage. However, the loss of paternal genomic 5hmC is controversial as evidence 
has been presented for active BER pathways (Guo et al., 2014a; He et al., 2011; Santos et al., 
2013) as well as passive replication-dependent dilution (Arand et al., 2015; Guo et al., 2014a; 
Inoue and Zhang, 2011; Inoue et al., 2011; Shen et al., 2014). For the latter, there is a 
progressive decline in asymmetric 5hmC, 5fC and 5caC staining on the presumptive paternal 
metaphase chromatids from the 2-cell to 8-cell stage, pointing to passive replication-
dependent dilution of these oxidized derivatives (Inoue and Zhang, 2011; Inoue et al., 2011; 
Shen et al., 2014). Future studies are needed to uncover the mechanisms and dynamics of 
demethylation during preimplantation development. 
Genome-wide data have reported higher than expected DNA methylation levels in the 
blastocyst if subjected to passive demethylation (Kobayashi et al., 2012). This is attributed to 
maintenance methylation at oocyte gDMRs, imprinted gDMRs and repetitive elements, 
which retain DNA methylation though preimplantation development.  For imprinted gDMRs, 
several proteins have been identified that maintain/protect imprinted methylation during 
preimplantation development. In zygotes, maternally (Peg1, Peg3 and Peg10) and paternally 
[H19 and Rasgrf1 (Ras protein-specific guanine nucleotide-releasing factor 1)] imprinted 
gDMRs are protected from TET3 demethylation of 5mC to 5hmC by maternally-derived 
DPPA3 binding to H3K9me2 (Nakamura et al., 2007; 2012) (Figure 1-9). After the 1-cell 
stage, maternal and embryonic zinc finger protein 57 (ZFP57) likely protects imprinted 
gDMRs from passive demethylation by binding to CpG methylation (Li et al., 2008b; 
Quenneville et al., 2011; Zuo et al., 2012) and recruiting repressive complex machinery, that 
includes tripartite motif 28 protein (TRIM28), the H3K9me3 histone methyltransferase SET 
domain bifurcated 1 (SETDB1), and DNMT1s/1o (Alexander et al., 2015; Bilodeau et al., 
2009; Cirio et al., 2008a; 2008b; Howell et al., 2001; Kurihara et al., 2008; Li et al., 2008b; 
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Lorthongpanich et al., 2013; Messerschmidt et al., 2012; Quenneville et al., 2011; Ratnam et 
al., 2002; Schultz et al., 2002; Zuo et al., 2012) (Figure 1-9). As studies involving ZFP57 
have been performed in later stage embryos (E11.5) and ES cells, future studies are required 
to validate this mechanism in preimplantation embryos. Overall, current evidence indicates 
that imprinted gDMRs are protected from both active and passive forms of demethylation 
during preimplantation development by maternal effect DNA methylation protector proteins. 
Further investigations are also required to elucidate the mechanisms and dynamics of 
methylation maintenance at non-imprinted oocyte gDMRs and repetitive elements. 
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Figure 1-9: Maternal effect products 
Upon erasure of methylation marks from the previous generation by TET1/TET2 (light 
purple circle), imprints are established differentially by DNMT3A/DNMT3L/DNMT3B 
(light green circle) in spermatocytes and DNMT3A (green circle)/DNMT3L (maroon circle) 
in oocytes.  During this period of imprint establishment during oogenesis, mitochondria 
numbers rapidly increase from a small progenitor pool in PGCs (maroon dotted line).  After 
fertilization DPPA3 (dark purple circle) protects the maternal genome and paternally 
methylated ICRs from TET3 (bright green circle)-catalyzed active demethylation of the 
paternal genome.  DNMT1 (DNMT1o/s, grey circle) maintains imprinted methylation during 
the S-phase of cleavage divisions while ZFP57 (dark blue circle) and additional complex 
members regulate methylation maintenance beginning at the 8-cell stage. Mitochondrial 
DNA is not replicated during preimplantation development, suggesting that total 
mitochondrial numbers remain relatively constant though preimplantation. Consequently, 
mitochondrial numbers per blastomere would be halved after each cell division. 
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1.3.4 Conservation of DNA methylation dynamics between mouse 
and human 
While a greater body of data exists on DNA methylation dynamics during gamete and 
preimplantation development for the mouse compared to the human, available data in the 
human highlight striking similarities between these species.   
1.3.4.1 Conservation of DNA methylation erasure in human PGCs 
Prior to comparing DNA methylation erasure in mouse and human, it is important to 
correlate developmental time points.  PGC development takes place between E6.25-E13.5 in 
the mouse, with PGC development occurring during weeks 2-9 of gestation in humans (De 
Felici, 2013; Ewen and Koopman, 2010; Leitch et al., 2013; Tang et al., 2015). More 
specifically, PGC migration and colonization of the developing genital ridge occurs between 
E8-E10.5 in mouse, which corresponds to ~3-5 weeks gestation in humans (Park et al., 2009; 
Tang et al., 2015).  Mouse PGCs at E11.5-12.5 were most similar to week 7-9 human PGCs 
(Tang et al., 2015).  At E13.5 in mouse and after week 9 in human, germ cell sexual 
differentiation has produced oogonia and prospermatogonia in female and male gonads, 
respectively (Ewen and Koopman, 2010; Kocer et al., 2009; Tang et al., 2015). To study 
earlier stages of PGC development, human PGC-like cells have been generated from 
embryonic stem cells and are representative of E6.5-E7.5 premigratory mouse PGCs (Tang et 
al., 2015). 
Overall, studies on PGC methylation erasure dynamics in human have yielded 
comparable results to mouse.   Stage I of methylation erasure in mouse occurring prior to 
E10.5 (Guibert et al., 2012; Hajkova et al., 2002b; Saitou et al., 2012; Seisenberger et al., 
2012; Seki et al., 2005)  likely initiates prior to week 5.5 gestation in human (Tang et al., 
2015).  Similar stage II methylation erasure events have been reported globally in human 5-
19 week PGCs  (Driscoll and Migeon, 1990; Gkountela et al., 2015; Guo et al., 2015; Tang et 
al., 2015; Wermann et al., 2010), corresponding to stage II of methylation erasure in mouse 
E10.5-13.5 PGCs  (Hajkova et al., 2008; 2010; Piccolo et al., 2013; Yamaguchi et al., 2013).  
Globally for both mouse and human, this erasure produces the greatest loss of DNA 
methylation throughout development (Gkountela et al., 2015; Guo et al., 2015; Hajkova, 
2011; Tang et al., 2015). Mechanistically, active demethylation may contribute to erasure of 
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stage I and/or II global methylation in human since TET1 protein, 5hmC, and BER pathway 
members are present (Gkountela et al., 2015; 2013; Guo et al., 2015; Tang et al., 2015).  This 
indicates a potential conserved role to mouse for TET1, 5hmC (Hajkova et al., 2008; 2010; 
Piccolo et al., 2013; Yamaguchi et al., 2013) and BER (Cortellino et al., 2011; Hajkova et al., 
2010; Morgan et al., 2004; Popp et al., 2010) in PGC methylation erasure.  For DNA 
methylation erasure dynamics at imprinted domains in humans, one group showed similar 
delayed DNA methylation erasure (Gkountela et al., 2013; 2015) as in mouse (Kobayashi et 
al., 2013), while other studies reported DNA methylation erasure initiating coincident with 
global erasure (Guo et al., 2015; Tang et al., 2015). In both cases, imprinted methylation 
erasure was more protracted than global erasure. Like mouse (Hackett et al., 2013; Piccolo et 
al., 2013; Vincent et al., 2013), imprinted gDMR methylation loss in PGCs may occur by 
active DNA demethylation, since oxidation of 5mC to 5hmC was evident at  H19 and GNAS 
ICRs (Tang et al., 2015), and at the PEG3 DMR (Gkountela et al., 2013).  The role of passive 
demethylation has not been investigated. 
1.3.4.2 Conservation of DNA methylation acquisition in human 
gametes 
Regarding methylation acquisition in gametes, available data point to spatial, 
temporal and mechanistic conservation of global and imprinted methylation acquisition in 
sperm and oocytes between mouse and human (Guo et al., 2014b; Kobayashi et al., 2012; 
Okae et al., 2014; Smallwood et al., 2011; Smith et al., 2012; 2014; Wang et al., 2014).  Both 
species establish global DNA methylation profiles prenatally during spermatogenesis 
(Kobayashi et al., 2013; Wermann et al., 2010) and postnatally during oocyte growth 
(Kobayashi et al., 2012; Shirane et al., 2013; Smallwood et al., 2011; Smith et al., 2012; 
Tomizawa et al., 2011; Wermann et al., 2010).  Similarly, imprinted DNA methylation 
acquisition is already fully acquired in human adult spermatogonia, spermatocytes, round and 
elongating spermatids and mature ejaculated spermatozoa (Boissonnas et al., 2010; Kerjean 
et al., 2000; Kobayashi et al., 2007; Marques et al., 2008; 2011; Sato et al., 2011), and 
therefore likely occurs prior to birth as in mouse (Davis et al., 2000; Kaneda et al., 2004; 
Kato et al., 2007; Kobayashi et al., 2013; Lee et al., 2010; Lucifero et al., 2002; Ueda et al., 
2000). Maternal imprint acquisition in human occurs in an oocyte size-dependent manner 
(Arima and Wake, 2006; Sato et al., 2007), similar to the mouse (Arima and Wake, 2006; 
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Denomme et al., 2012; Lucifero, 2004; Sato et al., 2007).  With respect to mechanistic 
conservation, mouse and human gametes possess DNMT3A and DNMT3B transcripts at 
similar levels in comparative oocyte analysis (Okae et al., 2014) and corresponding 
DNMT3A and DNMT3B protein products have been detected in human (Petrussa et al., 
2014). However, unlike the mouse (Kato et al., 2007; La Salle et al., 2007; Niles et al., 2013), 
DNMT3L transcripts/protein have not been detected in human spermatogenic cells or oocytes 
(Huntriss et al., 2004; Okae et al., 2014; Petrussa et al., 2014), suggesting divergence in its 
role in global and imprinted methylation acquisition.  Further investigations should also be 
aimed at the specific roles of DNMT3A, DNMT3B and DNMT3L in human sperm and pre-
GV methylation acquisition in oocytes.   
1.3.4.3 Conservation of DNA methylation programming during 
preimplantation development 
In the preimplantation embryo, DNA methylation dynamics are more complex than 
expected. Globally in zygotes, active DNA demethylation of the paternal genome by the TET 
family likely occurs in both species, with potential for roles at maternal genomes (Beaujean 
et al., 2004; Fulka et al., 2008; 2004; Gu et al., 2011; Guo et al., 2014b; Inoue and Zhang, 
2011; Inoue et al., 2011; Iqbal et al., 2011; Pendina et al., 2011; Wossidlo et al., 2011).  Both 
mouse and human oocytes express elevated Tet3/TET3 compared to Tet1/TET1 and 
Tet2/TET2, in addition to expressing the protective Dppa3/DPPA3 factor (Kobayashi et al., 
2012; Okae et al., 2014; Wossidlo et al., 2011; Yan et al., 2013). A confirmed role for these 
proteins in human zygotes remains to be elucidated.  However, since the human maternal 
pronucleus harbors greater 5mC and lower 5hmC than the paternal pronucleus, it is likely 
that at least a portion of the maternal genome must be protected from active demethylation 
(Fulka et al., 2004; 2008; Pendina et al., 2011).  During cleavage divisions, DNA methylation 
and hydroxymethylation marks display an asymmetric chromatid localization, which are 
passively diluted though replication in both species (Efimova et al., 2015; Inoue and Zhang, 
2011; Inoue et al., 2011; Shen et al., 2014; Wang et al., 2014).  However, a role for active 
demethylation also exists for both mouse (Smith et al., 2012) and human (Efimova et al., 
2015), possibly in a stage-specific and sequence-specific manner. Mechanistically in mouse, 
passive loss of DNA methylation during preimplantation development was attributed to 
DNMT1o exclusion from nuclei (except at the 8-cell stage) and low nuclear DNMT1s levels 
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at all preimplantation stages (Cirio et al., 2008a; 2008b; Hirasawa et al., 2008; Howell et al., 
2001; Kurihara et al., 2008; Ratnam et al., 2002).  In humans, DNMT1o nuclear localization 
occurs throughout preimplantation, while nuclear localization of DNMT1s is restricted to 
nuclei of 6-cell to morula stage embryos (Petrussa et al., 2014). Not withstanding this 
difference, it appears that DNMT1o and DNMT1s are present at sufficient levels to maintain 
imprinted methylation during mouse and human preimplantation development.  Further 
research is required to delineate the functions of these DNMT1 isoforms.  
With regards to imprinted DNA methylation, genome-wide methylation studies of 
human gametes and preimplantation embryos indicate preservation of maintenance of DNA 
methylation at imprinted gDMRs (Guo et al., 2014b; Kobayashi et al., 2012; Okae et al., 
2014).  As in mouse (Nakamura et al., 2007; 2012),  high abundance of DPPA3 in human 
oocytes (Goto et al., 2002; Kobayashi et al., 2012; Yan et al., 2013) suggests a conserved role 
for this protein in protecting imprinted gDMRs from active DNA methylation loss in zygotes. 
During cleavage division, the presence of DNMT1o/DNMT1o and DNMT1s/DNMT1s and 
nuclear localization of DNMT1o/DNMT1s during human preimplantation development 
(Huntriss et al., 2004; Petrussa et al., 2014) suggests conservation to mouse (Cirio et al., 
2008a; 2008b) in maintaining DNA methylation at imprinted gDMRs.  With regard to the 
DNMT1 interacting partner ZFP57, limited data exists for its role in human embryos.  
However, to assess its function, mouse embryonic stem cells were transfected with human 
ZFP57. The mouse and human ZFP57 proteins are interchangeable in maintaining imprinted 
DNA methylation as well as binding to TRIM28 (Takikawa et al., 2013).  In line with this, in 
human embryonic stem cells, TRIM28 is recruited to the majority of human imprinted DMRs 
by KRAB-containing zinc finger proteins (KRAB-ZFPs)(Jacobs et al., 2014; Turelli et al., 
2014) (Table 1). Since ZFP57 and TRIM28 are maternal effect proteins in mouse, their 
expression has also been examined in human oocytes. Although TRIM28 mRNA abundance 
was similar between human and mouse oocytes (Okae et al., 2014), human oocytes were 
reported to lack ZFP57 transcripts (Okae et al., 2014; Yan et al., 2013), with embryonic 
ZFP57 expression commencing at the morula stage (Yan et al., 2013). This requires further 
validation since ZFP57 protein levels were not assessed. Overall, current evidence indicates 
that imprinted gDMRs are maintained during human preimplantation development, with 
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potential conservation of DNA methylation protector proteins that bar active and passive 
demethylation. 
In conclusion, regulation of DNA methylation dynamics during gamete and 
preimplantation development is complex.  While a greater body of data exists for the mouse 
compared to the human, available data highlight striking similarities between these species.  
Regardless of differences that may exist, in both species it is evident that proper regulation of 
imprinted DNA methylation dynamics is necessary for successful preimplantation embryo 
development.  Consequently, any disruption of imprinted DNA methylation dynamics during 
this period could lead to aberrant or failed development or genomic imprinting disorders. 
1.4 Mitochondria 
Mitochondrial dysfunction has confirmed roles in mitochondrial disease, failed 
reproductive success and age-related infertility.  Many studies have confirmed the vital role 
mitochondria play as important determinants of developmental competence throughout 
oocyte and preimplantation embryo growth.  As mitochondria are dynamically regulated and 
critically required during this early period of development, defects in mitochondrial 
distribution, quantity, and/or activity have negative developmental consequences in multiple 
species, including mouse and human (Ge et al., 2012; Thouas et al., 2004; Van Blerkom et 
al., 1995; 2000; Van Blerkom, 2004; 2008; 2009; 2011; Wakefield et al., 2011).    
1.4.1 Mitochondrial dynamics during oogenesis and preimplantation 
development 
At fertilization in the fully grown mature oocyte, the mitochondrial complement has 
been derived from approximately 10-20 mitochondria in PGCs that increases rapidly via 
mitochondrial biogenesis and mitochondrial DNA replication during mouse and human 
oocyte growth up to the MII stage (Cummins, 2002; Jansen, 2000; St John et al., 2010; Van 
Blerkom, 2011). In the human, mitochondrial numbers reach about 100,000 to 400,000 in the 
mature MII oocyte (Cummins, 2002; Jansen, 2000; Jansen and de Boer, 1998; Jansen and 
Burton, 2004), similar to the 92,500 ± 7000 identified in the mouse egg (Pikó and 
Matsumoto, 1976).  This oocyte mitochondrial pool represents the sole source of 
mitochondria present during oogenesis, preimplantation development and throughout life.  
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After fertilization in both human and mouse, mitochondrial DNA molecules are not 
replicated until the blastocyst stage of preimplantation development (Larsson et al., 1998; 
Pikó and Chase, 1973; Pikó and Taylor, 1987; Thundathil et al., 2005).  Thus, mitochondrial 
numbers are anticipated to remain relatively constant within the preimplantation embryo. 
This would mean that mitochondrial numbers decrease by half per blastomere with each 
successive cleavage division (Motta et al., 2000; Sathananthan and Trounson, 2000; St John 
et al., 2010; Thundathil et al., 2005; Van Blerkom, 2011; Zamboni, 1971) (Figure 1-9).  After 
implantation, the molecular machinery for mitochondrial DNA replication becomes active, 
with mitochondrial DNA copy number and mitochondrial biogenesis increasing first 
primarily in trophectodermal cells then subsequently in the epiblast (Assou et al., 2006; 
Larsson et al., 1998; St John et al., 2010; Thundathil et al., 2005).   
Although mitochondria are in a state of replicative senescence during preimplantation 
development, the organelles undergo dynamic changes in morphology.  In oocytes and early 
embryos, mitochondria are small, spherical and structurally underdeveloped but still 
functional and active in generating ATP (Motta et al., 2000; Pikó and Chase, 1973).  As 
preimplantation development continues, mitochondria elongate, increase cristae numbers, 
and by the expanded blastocyst stage they begin to resemble forms present in differentiated 
somatic cells, again predominantly in trophectoderm (Motta et al., 2000; Pikó and Chase, 
1973; Van Blerkom et al., 1973).  These structural changes occur in parallel to increased 
respiration to meet the energy demands for blastocyst formation and the development of the 
fluid filled cavity by trophectoderm cells (Houghton, 2006).  Most of the energy produced in 
blastocyst trophectoderm is hypothesized to drive and support activity of the ATP-dependent 
Na+/K+-ATPase (sodium-potassium adenosine triphosphatase) (Houghton, 2006; Van 
Blerkom, 2008), which is known to be vital for blastocyst formation/cavitation (Madan et al., 
2007; Watson et al., 2004).   
In addition to dynamic morphological changes, mitochondria also actively translocate 
to specific regions of the cytoplasm during oogenesis and preimplantation development.  
Perinuclear translocation of active mitochondria occurs during meiosis, with nuclear 
localization coinciding with bursts of ATP production specifically during nuclear maturation 
(germinal vesicle break down (GVBD), metaphase I (MI) spindle migration, MI to MII 
transition, and polar body (PB) extrusion) (Van Blerkom, 1991; Yu et al., 2010).  At the 
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ovulated MII stage, both perinuclear mitochondrial localization (Kan et al., 2011; Nagai et 
al., 2006) and a homogenous distribution throughout the cytoplasm (Tokura et al., 1993; Van 
Blerkom, 2004; Yu et al., 2010) has been documented.  In addition to this distribution of 
active mitochondria during oogenesis, a persistent subcortical high potential mitochondrial 
ring in the oocyte exists and is required for sperm penetration, fertilization and meiotic 
maturation (Van Blerkom and Davis, 2007).  The localization of mitochondria during 
preimplantation development is less characterized. However, perinuclear localization at the 
2-cell stage (Van Blerkom et al., 2000; Van Blerkom, 2009), symmetrical distribution of 
mitochondria between pronuclei/blastomeres from the pronuclear 1-cell to 8-cell stage (Van 
Blerkom et al., 2000), and higher mitochondrial activity in trophectoderm cells (TE) versus 
inner cell mass (ICM) cells in blastocysts (Houghton, 2006) have all been reported. 
1.4.2 The role of mitochondria in developmental competence 
Recently, many studies performed in mouse and human have concentrated on 
analyzing mitochondrial parameters with respect to reproductive success of the oocyte and 
preimplantation embryo.  With regards to oocyte competence, nuclear and meiotic 
maturation (and consequently fertilization) are dependent on ATP generation (Dumollard et 
al., 2004; St John et al., 2010; Yu et al., 2010). Those oocytes with sufficient ATP and 
mitochondria numbers generate higher-quality blastocyst embryos (Takeuchi et al., 2005) 
and exhibit an increased potential for continued embryogenesis, implantation  (Van Blerkom 
et al., 1995), and postimplantation development (Wai et al., 2010). Perinuclear accumulation 
of active mitochondria is also necessary for oocyte competence (Van Blerkom, 1991; Van 
Blerkom and Runner, 1984; Yu et al., 2010). 
As during oogenesis, mitochondrial function and the ability to generate sufficient 
ATP is required for successful cleavage throughout preimplantation development (Liu et al., 
2000; May-Panloup et al., 2005; Thouas et al., 2004).  Upon successful fertilization, failure 
to accumulate mitochondria to the perinuclear region in zygotes is associated with decreased 
blastocyst developmental rates (Zhao et al., 2009).  Furthermore, decreased ATP content 
occurs in mouse embryos undergoing a 2-cell block in development (Wang et al., 2009). 
With regard to mitochondrial distribution, 1-cell zygote to 8-cell stage preimplantation 
embryos exhibiting an asymmetrical segregation of mitochondria surrounding pronuclei and 
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between blastomeres undergo increased developmental arrest, with lysis of blastomeres 
inheriting lower amounts of mitochondria (Van Blerkom et al., 2000).  Finally, mitochondrial 
inhibition during preimplantation development leads to impaired ATP production, 
incrementally reduced blastocyst development, decreased blastocyst ICM and TE cell 
numbers, and reduced fetal and placental growth, thus highlighting the importance of 
mitochondria both during preimplantation and postimplantation development (Wakefield et 
al., 2011). 
In conclusion, appropriate regulation of mitochondrial dynamics is critical for 
successful development of human and mouse oocytes and preimplantation embryos.  
Consequently, perturbations in mitochondrial dynamics during this critical period have the 
potential to negatively impact developmental outcomes. 
1.5 Assisted Reproductive Technologies (ARTs) 
1.5.1 Infertility and ART 
Infertility is generally defined as the inability to conceive naturally after 1 year of 
unprotected sex.  Recent figures alarmingly estimate that approximately 48.6 million couples 
worldwide are unable to conceive after 5 years of unprotected sex (Mascarenhas et al., 2012).  
In Canada and the United States, infertility affects 16% and 10-15% of couples, respectively, 
tripling Canadian rates since 1984 (5.4%) (Bushnik et al., 2012; Chandra et al., 2013).  
Medically assisted reproductive technologies (ARTs) represent infertility treatment methods 
that give infertile/subfertile couples the best chance to conceive.  These techniques include 
ovarian stimulation, in vitro oocyte maturation, in vitro fertilization (IVF), intracytoplasmic 
sperm injection (ICSI), in vitro embryo culture, blastocyst hatching, preimplantation genetic 
diagnosis (PGD), embryo transfer, oocyte and embryo cryopreservation, and recently 
mitochondrial replacement therapy and AUGMENT (discussed in section 1.5.3). 
Due to the rising prevalence of infertility, since the birth of Louise Brown, the first 
human infant conceived through ARTs in July of 1978 (Steptoe and Edwards, 1978), the use 
of ARTs has drastically increased.  Now, the proportion of infants born following ARTs is 
approximately 1.6% of all births in the United States (Sunderam et al., 2015), reaching as 
high as 4.5% of births in developed countries (Ferraretti et al., 2013). In Canada, 32 of 33 
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clinics reported completion of approximately 16, 062 ART cycles in 2013, with an overall 
live birth rate of 25% (Human Assisted Reproduction 2014).  However, when treatment is 
successful (< 40%), it carries an increased risk of perinatal complications even within 
singleton pregnancies, including; (1) preterm birth; (2) intrauterine growth restriction; (3) 
low birth weight (Helmerhorst et al., 2004; Jackson et al., 2004; McGovern et al., 2004; 
Okun and Sierra, 2014; Reddy et al., 2007; Savage et al., 2011; Schieve et al., 2002; 
Sunderam et al., 2014; Wisborg et al., 2010); (4) large for gestational age (Hansen and 
Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014; Pinborg et al., 
2014; Sazonova et al., 2012; Wennerholm et al., 2013); and (5) higher incidences of the 
genomic imprinting disorders, (a) Beckwith-Wiedemann Syndrome (DeBaun et al., 2003; 
Doornbos et al., 2007; Gicquel et al., 2003; Maher et al., 2003a; Sutcliffe et al., 2006; 
Vermeiden and Bernardus, 2013), (b) Angelman Syndrome (Cox et al., 2002; Doornbos et 
al., 2007; Ludwig et al., 2005; Maher et al., 2003a; Ørstavik et al., 2003), and (c) Silver-
Russell Syndrome (SRS) (Bliek et al., 2006; Chiba et al., 2013; Chopra et al., 2010; Cocchi 
et al., 2013; Hiura et al., 2012; Kagami et al., 2007; Lammers et al., 2012; Vermeiden and 
Bernardus, 2013).  
1.5.2 ART and imprinting disorders 
The overall risk for an imprinting disorder such as BWS, AS or SRS after ART is 
approximately 1 in 5,000 children (Okun and Sierra, 2014).  This is compared to the low risk 
in the general population for BWS (1 in 13,700), AS (1 in 15,000) and SRS (unknown 
prevalence).   Specifically, the risk of BWS is 3-16 times greater in ART-conceived children 
compared to the general population (DeBaun et al., 2003; Gicquel et al., 2003; Gosden et al., 
2003; Halliday et al., 2004; Hiura et al., 2012; Lim et al., 2009; Lucifero et al., 2004; Maher 
et al., 2003a; 2003b; Rossignol et al., 2006; Sutcliffe et al., 2006; van Montfoort et al., 2012; 
Vermeiden and Bernardus, 2013).  Within BWS patients conceived by ART, imprinted 
methylation errors occur at a greater frequency, with over 90% of ART cases showing 
KCNQ1OT1 hypomethylation compared to 50% in the general population (DeBaun et al., 
2003; Gicquel et al., 2003; Gosden et al., 2003; Halliday et al., 2004; Hiura et al., 2012; Lim 
et al., 2009; Maher et al., 2003a; 2003b; Rossignol et al., 2006; Sutcliffe et al., 2006), and 
conversely, 17% of ART cases showing H19 hypermethylation compared to 5% in general 
(DeBaun et al., 2003; Lennerz et al., 2010; Rossignol et al., 2006).  Likewise for AS, 46% of 
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patients conceived by ARTs possessed imprinting defects at the SNRPN ICR (Cox et al., 
2002; Ludwig et al., 2005; Ørstavik et al., 2003) compared to 5% in general (Horsthemke 
and Wagstaff, 2008; Van Buggenhout and Fryns, 2009) while for SRS, 11 out of 12 (92%) 
ART patients harboured H19 hypomethylation (Bliek et al., 2009; Chopra et al., 2010; 
Cocchi et al., 2013; Hiura et al., 2012; Kagami et al., 2007; Lammers et al., 2012; Vermeiden 
and Bernardus, 2013) compared to 40% in the general population (Chiba et al., 2013).  
Overall, studies suggest that ARTs increase imprinting disorders, likely through alterations in 
epigenetic regulation of imprinted gene expression.  Specifically, one explanation for this 
risk is that gamete and embryo manipulations disrupt acquisition and/or maintenance of 
genomic imprints during gametogenesis and preimplantation development.  It is therefore 
essential to determine where imprinted methylation errors are occurring and which aspect(s) 
of ARTs lead to these adverse epigenetic effects. 
1.5.2.1 Mouse model system 
Much of what we know regarding imprinting disorders and ARTs has been 
discovered using the mouse model system.  This system has specifically been instrumental in 
the investigation of the effects of individual ARTs on genomic imprint acquisition during 
gametogenesis and maintenance throughout preimplantation development. Additionally, the 
mouse model allows for controlled studies without issues of confounding infertility that are 
unavoidable when studying human assisted conception.  Major findings from mouse studies 
indicate that imprinted methylation acquisition is not perturbed by superovulation (Denomme 
et al., 2011) or in vitro oocyte maturation in oocytes (Anckaert et al., 2009; 2010; Geuns et 
al., 2003; 2007), but instead imprint maintenance in preimplantation embryos is disrupted by 
superovulation (Hajj et al., 2011; Market-Velker et al., 2010b), in vitro fertilization (IVF) 
(Fauque et al., 2010), in vitro embryo culture (Li et al., 2005; Mann et al., 2004; Market-
Velker et al., 2010a; 2012) and oocyte vitrification (Cheng et al., 2014).  Within these 
studies, imprinted methylation errors in preimplantation embryos occurred at a relatively 
high frequency, with errors present in 10-90% of embryos analyzed.  Studies in our lab have 
specifically analyzed the effect of ovarian stimulation, or superovulation, on imprinted 
methylation at both low (6.25 IU) and high (10 IU) hormone doses.  Superovulation using 
high and low hormone-doses did not perturb imprinted methylation acquisition in individual 
oocytes at Snrpn, Peg3, Kcnq1ot1 or H19  (Denomme et al., 2011).  In contrast, individual 
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blastocyst-stage embryos derived from superovulated females exhibited a dose-dependent 
loss of methylation at imprinted domains, specifically Snrpn, Peg3, Kcnq1ot1 and H19  
(Market-Velker et al., 2010b).  Consequently, we demonstrated that superovulation alone 
perturbs imprinted methylation in blastocyst embryos at a high frequency.  This finding is 
additionally supported by two studies in human that discovered patients receiving ovarian 
stimulation alone as an ART gave birth to BWS and AS children (Chang et al., 2005; Ludwig 
et al., 2005).   
1.5.2.2 Discrepancy between human and mouse 
Disparity has arisen concerning the frequency of imprinting errors produced by ARTs 
in humans compared to mice. When comparing the overall risk for an imprinting disorder, 
10-90% of treated preimplantation mouse embryos show abnormal imprint maintenance 
(Fauque et al., 2010; Hajj et al., 2011; Market-Velker et al., 2010b; 2012), while only 1 in 
5, 000 ART children are at risk for BWS, AS or SRS (Okun and Sierra, 2014).  Overtly, it 
would therefore appear that the mouse is more sensitive than the human with respect to the 
incidence of ART-induced imprinting errors. This has lead to questioning whether the effects 
of ARTs on imprint regulation in the mouse recapitulate those processes involved in humans.  
However, one key difference in studies between these species is the time of analysis. The 
majority of mouse studies have focused on preimplantation or mid-gestation development, 
while human studies are primarily retrospective studies of ART children with imprinting 
disorders. Although few studies on human preimplantation embryos exist (Chen et al., 2010; 
Geuns et al., 2003; 2007; Ibala-Romdhane et al., 2011; Khoueiry et al., 2012; Shi et al., 
2014), most embryos that have been analyzed were poor quality embryos unsuitable for 
transfer.  Therefore it becomes essential to identify the risk for imprinting errors in high 
quality human preimplantation embryos. 
1.5.3 Mitochondria in Assisted Reproductive Technologies 
The importance of mitochondria during gametogenesis and preimplantation has 
recently been acknowledged in human Assisted Reproductive Technologies (ARTs; 
discussed in detail section 1.5).  Fertility clinics around the world are now actively 
addressing the role mitochondria play during preimplantation development by utilizing novel 
techniques to overcome perturbed mitochondrial function.  For example, dietary coenzyme 
44 
 
Q10, or CoQ10, an essential component of the electron transport chain, is used in human 
clinics to increase mitochondrial activity with the intention of improving oocyte quality 
(Ben-Meir et al., 2015; Bentov et al., 2010; 2014; Chappel, 2013; Meldrum et al., 2016).  
Additionally, more invasive procedures are also being implemented.  Specifically, 
mitochondrial replacement therapy (MRT) is currently being used in the United Kingdom 
(UK) to circumvent the inheritance of mitochondrial DNA mutations and mitochondrial 
disease to offspring of affected mothers (Reinhardt et al., 2013).  In this technology, 
pronuclear DNA of the intended parents is injected into an enucleated donor oocyte 
containing “mutation-free” mitochondria.  This technique was originally performed in mice 
(Sato et al., 2005), and before implementation in human was also used to produce macaque 
babies (Tachibana et al., 2009).  Currently, juvenile macaque offspring born through 
mitochondrial replacement therapy are seemingly healthy with normal metabolic profiles 
(Tachibana et al., 2013).  However as of now, concern from the United States Food and Drug 
Agency (FDA) has prevented the use of this technology until more data are available to 
support its safety (Couzin-Frankel, 2015).  Consistent with this, results in the mouse suggest 
that MRT could potentially alter respiration, growth, and exercise and learning ability in 
adults (Nagao et al., 1998; Roubertoux et al., 2003).  This could be due to disrupted cross-
talk between genes encoded in the nucleus and the mitochondria, as coordinated interactions 
between mitochondria and nuclear alleles are favored, and these are disrupted by MRT (Muir 
et al., 2016; Reinhardt et al., 2013; Woodson and Chory, 2008).  Nonetheless, although 
controversial, MRT is currently being used in the UK to avoid inherited mitochondrial 
disease. 
 Another mitochondrial treatment has recently been made available to assist 
conception in women of advanced reproductive age or in couples with repetitive failed in 
vitro fertilization (IVF) cycles.  The US-based company OvaScience developed a new 
fertility treatment, termed Autologous Germline Mitochondrial Energy Transfer 
(AUGMENT), and it is based on improving oocyte quality through supplying the egg with a 
supposedly germline-derived source of mitochondria from the ovarian cortex (Woods and 
Tilly, 2015).  Again, the FDA has prohibited its current use in the US. However, it is offered 
at the Toronto Centre for Advanced Reproductive Technology (TCART) clinic in Canada, as 
well in London UK, Istanbul, Japan, Panama, Spain, Turkey and Dubai (Motluk, 2015).  This 
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technique is different from the MRT technique that is used for disease prevention, since 
AUGMENT does not require donor mitochondria but depends on the existence of 
controversial (Zhang et al., 2012), patient-matched cells that are extracted from the ovary 
(Bukovsky et al., 2004; Johnson et al., 2004; Pacchiarotti et al., 2010; Virant-Klun et al., 
2013; White et al., 2012; Zou et al., 2009).  These putative cells are in the ovarian cortex and 
studies in mouse have shown that when reintroduced into adult ovaries they can produce 
mature oocytes and viable preimplantation embryos, including blastocysts (White et al., 
2012).  Additionally, a separate group that transfected these ovarian cells with a GFP virus 
reported production of live offspring that inherited the GFP transgene, birthed from 
transplanted infertile females (Zou et al., 2009).  Importantly, the role of these cells in normal 
folliculogenesis is unknown (Begum et al., 2008).  The AUGMENT technique isolates 
mitochondria from a patient’s own cells extracted from the ovary and injects them into the 
oocyte at the time of intracytoplasmic sperm injection (ICSI) (Tilly and Sinclair, 2013; 
Woods and Tilly, 2015).  Although controversial, the world’s first AUGMENT baby was 
born in Toronto over 1 year ago, on April 13th, 2015. 
1.5.3.1 Effects of ARTs on mitochondria 
Many studies have focused on mitochondrial dynamics during gametogenesis and the 
preimplantation period.  However, much of what we know is based on samples obtained by 
assisted reproductive technologies (ARTs).  ART treatments coincide with critical time 
points where mitochondria are drastically increased during oogenesis, translocated to provide 
stage-specific spatial ATP requirements, and sustained in a non-replicative state during 
preimplantation development while still functioning as the primary ATP source. Few studies 
in mouse and human have addressed the effect of ARTs on mitochondrial dynamics and 
function, with the majority of these focusing on oocyte freezing.  Albeit, a few studies have 
analyzed the effect of ovarian stimulation on mitochondria in mouse (Combelles and 
Albertini, 2003; Ge et al., 2012; Shu et al., 2015) and macaque (Gibson et al., 2005).  These 
studies have shown that ovarian stimulation decreases mitochondrial DNA copy number, 
ATP levels and mitochondrial membrane potential in resulting mouse oocytes (Combelles 
and Albertini, 2003; Ge et al., 2012; Shu et al., 2015) and increases mitochondrial DNA 
deletions in macaque oocytes (Gibson et al., 2005). 
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1.6 Rationale 
With the use of ARTs rising worldwide (Dyer et al., 2016), there is a continual 
emergence of new techniques being implemented in human IVF, including mitochondrial 
replacement therapy (Reinhardt et al., 2013; Wolf et al., 2015) and AUGMENT (Woods and 
Tilly, 2015).  Furthermore, due to the announcement of ART funding in Ontario, which was 
implemented December 2015 (Motluk, 2016), and the absence of strict regulation of ARTs in 
Canada (Assisted Human Reproduction Act), it is becoming increasingly important for 
researchers to investigate the effects of these treatments on the manipulated oocyte and 
preimplantation embryo.   This is especially important as ART techniques coincide with 
critical time points where imprinted DNA methylation marks are being maintained and 
mitochondria are very dynamic (Figure 1-9). As discrepancy in the field exists between risk 
for imprinting disorders in preimplantation mouse embryos and human infants born through 
ARTs, it is essential to identify the risk for imprinting abnormalities in early human embryos.  
Furthermore, with the advent of novel treatments targeting mitochondria, the effects of 
widely used ARTs on mitochondria, such as the indispensible procedure of ovarian 
stimulation, must be determined.   
1.7 Hypothesis 
My overall hypothesis is that imprinted DNA methylation maintenance and 
mitochondrial dynamics are disrupted by ARTs during preimplantation development. 
Specifically, I hypothesize that imprinted methylation errors occur at similar frequencies in 
donated, good quality, human preimplantation embryos compared to those identified in 
mouse. Furthermore, I hypothesize that ovarian stimulation disrupts maternally derived 
mitochondria in oocytes and preimplantation embryos derived from hormone-treated 
females.  
1.8 Objectives 
1. To determine the effect of ARTs on imprinted DNA methylation in human 
preimplantation embryos.  Specifically, this objective will address whether donated 
human ART-produced preimplantation embryos harbour aberrant imprinted 
methylation at similar incidences to that observed in the mouse. 
47 
 
a. Determine baseline imprinted DNA methylation levels at SNRPN, KCNQ1OT1 
and H19 in untreated human buccal cell samples. 
b. Determine whether imprinted methylation errors occur in human day 3 (~6-8 
cells) and blastocyst-stage embryos, and whether short or extended culture 
produces a greater frequency of imprinted methylation errors. 
c. Determine whether aberrant imprinted methylation in human day 3 and blastocyst 
embryos correlates with parental biometrics or clinical treatment. 
2. My second objective further extends analyses on the effects of ART treatments on 
resulting embryos by analyzing the effects of ovarian simulation on mitochondria in 
the oocyte and throughout preimplantation development. 
a. Determine whether superovulation disrupts the pool of total mitochondria, active 
mitochondria, and mitochondrial distribution in oocytes and during 
preimplantation development 
b. Determine whether resulting blastocyst embryos exhibit perturbed mitochondrial 
function. 
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Chapter 2  
The work in this chapter originates from the following peer-reviewed article: 
White, C.R., Denomme, M.M., Tekpetey, F.R., Feyles, V., Power, S.G.A., and Mann, 
M.R.W. (2015). High Frequency of Imprinted Methylation Errors in Human Preimplantation 
Embryos. Sci Rep 5, 17311. 
 
2 High frequency of imprinted methylation errors in human 
preimplantation embryos 
Assisted reproductive technologies (ARTs) represent the best chance for infertile 
couples to conceive, although increased risks for morbidities exist, including imprinting 
disorders.  This increased risk could arise from ARTs disrupting genomic imprints during 
gametogenesis or preimplantation.  The few studies examining ART effects on genomic 
imprinting primarily assessed poor quality human embryos. Here, we examined day 3 and 
blastocyst stage, good to high quality, donated human embryos for imprinted SNRPN, 
KCNQ1OT1 and H19 methylation.  Seventy-six percent of day 3 embryos and 50% of 
blastocysts exhibited perturbed imprinted methylation, demonstrating that extended culture 
did not pose greater risk for imprinting errors than short culture. Comparison of embryos 
with normal and abnormal methylation didn’t reveal any confounding factors. Notably, two 
embryos from male factor infertility patients using donor sperm harboured aberrant 
methylation, suggesting errors in these embryos cannot be explained by infertility alone.  
Overall, these results indicate that ART human preimplantation embryos possess a high 
frequency of imprinted methylation errors. 
2.1 Introduction 
Alarming figures indicate that an estimated 48.5 million couples worldwide are unable 
to conceive after 5 years of unprotected sex (Mascarenhas et al., 2012). For these couples, 
medically assisted reproductive technologies (ARTs) represent the best chance to conceive. 
However, when treatment is successful (< 40%), there is an increased risk of perinatal 
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complications even within singletons, including preterm birth, intrauterine growth restriction, 
low birth weight (Mascarenhas et al., 2012; Okun and Sierra, 2014; Savage et al., 2011) and 
the genomic imprinting disorders; (1) Beckwith-Wiedemann Syndrome (BWS) (DeBaun et 
al., 2003; Doornbos et al., 2007; Gicquel et al., 2003; Maher et al., 2003a; Sutcliffe et al., 
2006), (2) Angelman Syndrome (AS) (Cox et al., 2002; Doornbos et al., 2007; Ludwig et al., 
2005; Maher et al., 2003a; Ørstavik et al., 2003), and (3) Silver-Russell Syndrome (SRS) 
(Bliek et al., 2006; Chiba et al., 2013; Chopra et al., 2010; Cocchi et al., 2013; Hiura et al., 
2012; Kagami et al., 2007; Lammers et al., 2012).  
 Genomic imprinting is an epigenetic phenomenon that restricts expression to one 
parental allele while the other allele is in an inactivated state.  Imprinted genes are regulated 
by a master control switch known as a gametic differentially methylated region (gDMR) or 
imprinting control region (ICR). Importantly, abnormal cytosine methylation levels at the 
ICR can lead to imprinting disorders such as BWS, AS and SRS.  
Risk association studies have found increased risks of imprinting disorders in ART 
children. The risk of BWS is 3-16 times greater in children in the ART population compared 
to those in the general population (DeBaun et al., 2003; Gicquel et al., 2003; Halliday et al., 
2004; Hiura et al., 2012; Lim et al., 2009; Maher et al., 2003b; Maher, 2005; Rossignol et al., 
2006; Sutcliffe et al., 2006; van Montfoort et al., 2012). Epigenetic errors at KCNQ1OT1, 
namely maternal hypomethylation, are observed in more than 90% of ART BWS cases 
compared to 50% in the general population (DeBaun et al., 2003; Gicquel et al., 2003; 
Halliday et al., 2004; Hiura et al., 2012; Horike et al., 2000; Lim et al., 2009; Maher et al., 
2003b; Maher, 2005; Rossignol et al., 2006; Sutcliffe et al., 2006; Weksberg et al., 2010), 
while H19 maternal hypermethylation occurs in 17% of ART BWS cases compared to 5% in 
the general population (DeBaun et al., 2003; Lennerz et al., 2010; Rossignol et al., 2006; 
Weksberg et al., 2010).  Of the small number of patients analyzed, 46% of AS patients 
conceived by ARTs possessed imprinting defects at the SNRPN ICR compared to 5% in the 
general population (Cox et al., 2002; Ludwig et al., 2005; Van Buggenhout and Fryns, 2009; 
Ørstavik et al., 2003), while 92% of SRS patients conceived by ARTs harboured H19 
hypomethylation compared to 40% in the general population (Bliek et al., 2006; Chiba et al., 
2013; Chopra et al., 2010; Cocchi et al., 2013; Hiura et al., 2012; Kagami et al., 2007; 
Lammers et al., 2012),. The overall risk for an imprinting disorder such as BWS, AS or SRS 
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in ART children is estimated to be around 1 in 5,000 (Okun and Sierra, 2014).  Thus, 
disparity has arisen concerning the frequency of imprinting errors produced by ARTs in 
humans compared to mice, as mouse studies have identified between 10% to 90% of treated 
preimplantation embryos showing abnormal imprint maintenance (Fauque et al., 2007; Hajj 
et al., 2011; Mann et al., 2004; Market-Velker et al., 2012; 2010).  However, one key 
difference in studies between these species is the time of analysis. The majority of mouse 
studies have focused on preimplantation or mid-gestation development, while human studies 
are primarily retrospective studies of ART children with imprinting disorders. Consequently, 
we sought to determine whether donated human ART-produced preimplantation embryos 
harbour aberrant imprinted methylation at similar incidences to that observed in the mouse 
(Fauque et al., 2007; Hajj et al., 2011; Mann et al., 2004; Market-Velker et al., 2010; 2012). 
Additionally, we analyzed whether short or extended culture produces a greater frequency of 
imprinted methylation errors, and whether aberrant imprinted methylation correlates with 
parental biometrics or clinical treatment. We analyzed methylation levels at SNRPN, 
KCNQ1OT1 and H19 ICRs in individual good to high quality day 3 cleavage and blastocyst 
stage ART-produced human embryos.  
2.2 Materials and Methods 
2.2.1 Donated human embryos 
Twenty-three patients who had completed their fertility treatment at The Fertility 
Clinic at London Health Sciences Centre donated for research 24 day 3 cleavage and 29 
blastocyst-stage human embryos that were no longer needed for their treatment.  Buccal cells 
(B1-B4) were obtained from 4 healthy, non-patient adults (<30 years old). Research ethics 
approval was obtained through the Western University’s Health Science Research Ethics 
Board (102659) and the methods were carried out in accordance with the approved 
guidelines.  Informed consent was obtained from patients donating embryos and non-patient 
adults providing buccal cell samples.  All embryos were cultured in the glucose/phosphate-
free preimplantation stage 1 (P1) culture medium  (Irvine Scientific, California) to day 3, 
then in Blastocyst Medium (BM) in a sequential media protocol (Irvine Scientific, 
California) to the blastocyst stage.  Embryos were slow frozen between the years 2000-2007 
and thawed between October 2013-August 2014.  Slow freezing was performed according to 
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the Testart's (propanediol) freezing method (Testart et al., 1986) using Sydney IVF 
Cryopreservation Kits. 
Day 3 human embryos were graded by blastomere number, and morphological 
fragmentation levels by either the former A through F grading system or the currently used 
G1 through G6 system: A, even, regular, no fragments; B, uneven, irregular, no fragments; 
slight C (slC), slight fragmentation; C, minor (<25%) fragmentation; D, major (between 25-
50%) fragmentation; E, extensive (>50%) fragmentation; F, degenerate; or by fragmentation 
levels: G1, <5% fragmentation; G2, 5-10% fragmentation; G3, 11-25% fragmentation; G4, 
26-50% fragmentation; G5, >50% fragmentation; and G6, degenerate (Hardy et al., 2003; 
Rijnders and Jansen, 1998; Sjöblom et al., 2006).  Following thawing, the majority of 
embryos were G1-G3 grade and had an average of 4 cells (data not shown). 
Blastocyst grading was according to blastocyst cavity size/hatching, inner cell mass 
characteristics and trophoblast cell number giving a numeric-alpha-alpha score based on the 
Gardner and Schoolcraft scoring system (Gardner and Schoolcraft, 1999). Cavity size or 
hatching score was graded as 1, early blastocyst with cavity less than half the embryo 
volume; 2, blastocyst with cavity greater than half the embryo volume; 3, full blastocyst, 
cavity full; 4, expanded blastocyst, cavity expanded beyond earlier embryo size with thinning 
zona; 5, hatching blastocyst; 6, hatched blastocyst.  Inner cell mass (ICM) grading was A, 
tightly packed ICM, many cells; B, loosely grouped ICM, several cells; and C, very few 
cells, and trophectoderm was graded as A, many cells with cohesive epithelium; B, few cells 
with loose epithelium; and C, very few large cells.  All embryos were immediately processed 
for methylation analysis following thawing. 
2.2.2 Isolation of Control Cells 
 Buccal cells were collected using the end of a sterile 20 μL pipet tip and diluted into 
approximately 1000, 100, 50 and 5-10 cells in 20 μL of 1 X PBS (Phosphate-Buffered 
Saline). Buccal cells were then embedded into a 2:1 3% LMP agarose and lysis solution, and 
then subjected to imprinted DNA methylation analysis. One confluent well of a 6-well dish 
(~1x106 cells) of HES2 human ESCs (WiCell Research Institute Inc.) was washed once with 
1X PBS (Sigma) and incubated in TrypLE Express (GIBCO) in Dulbecco’s PBS (DPBS).  
Trypsin was inactivated by addition of DMEM and 10% Fetal Bovine Serum (FBS) medium. 
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Detached hESCs were collected, pelleted gently, washed with 1X PBS and re-suspended in 
1000 μL of 1X DPBS. Approximately 1 μL of cells (~1000 cells) was embedded into a 2:1 
3% LMP agarose and lysis solution, then subjected to bisulfite mutagenesis. 
2.2.3 Imprinted DNA Methylation Analysis 
 Immediately following thawing individual embryos were embedded under mineral oil 
(Sigma) into 10 μL of a 2:1 mixture of 3% LMP agarose (Sigma) and lysis solution [100 mM 
Tris–HCl, pH 7.5 (Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA, pH 8.0 (Sigma), 1% 
LiDS (Bioshop), and 5 mM DTT (Sigma), 1 μl 2mg/ml proteinase K (Sigma), and1 μl 10% 
Igepal (Sigma)]. DNA methylation analysis was performed using the bisulfite mutagenesis 
and clonal sequencing method as previously described (Denomme et al., 2011).  Samples 
were placed on ice for 10 minutes to generate an agarose/lysis bead and subsequently 
incubated overnight in SDS lysis buffer for 20 hours in a 50°C water bath.  Lysis buffer was 
removed and replaced with 300 μL of mineral oil and embryos were either frozen at -20°C 
for a maximum of 3 days or immediately processed for bisulfite mutagenesis.  Briefly, for 
bisulfite treatment, samples were incubated at 90°C to inactivate proteinase K (Sigma) for 
2.5 minutes and transferred to ice for 10 minutes. DNA denaturation was performed in 1 mL 
of 0.1 M NaOH at 37°C for 15 minutes.  Samples were covered with 300 μL of mineral oil 
and 500 μL of 2.5 M bisulfite solution for a 3.5-hour bisulfite conversion at 50°C.  After 
conversion, desulfonation was performed in 1 mL of 0.3 M NaOH at 37°C for 15 minutes.  
Negative controls (beads containing no embryo or buccal cell sample) were processed with 
each bisulfite reaction.  For first round PCR amplification, agarose bead with bisulfite 
converted DNA (10 μL) was added directly to 15 μL of Hot Start Ready-To-Go (RTG) (GE 
Healthcare) PCR bead that contained 0.5 μL of each 10 μM gene-specific external primer, 
1 μL of 240 ng/mL transfer RNA and water with a 25 μL mineral oil overlay. Multiplexing 
of H19 and KCNQ1OT1 was performed during the first round of PCR. SNRPN amplification 
was performed individually.  Five microliters of first round PCR product was added to 20 μL 
of RTG beads mixed with 19 μL 0.5 μL of each 10 μM internal primer and water for nested 
PCR.  Separate second round PCR reactions were performed for H19 and KCNQ1OT1.   
The KCNQ1OT1 PCR bisulfite primers were described previously (Ibala-Romdhane 
et al., 2011; Khoueiry et al., 2012).  The KCNQ1OT1 region analyzed contained a G 
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(94.7%)/A (6.3%) SNP (rs56134303).  For the H19 region (GenBank Af087017, 6161-6409), 
external primers used were as described previously (Khoueiry et al., 2012).  Due to SNPs 
residing in the previously described inner primers (Khoueiry et al., 2012), newly designed 
forward inner primer 5’-TTGGTTGTAGTTGTGGAAT-3’ and H19 reverse inner primer 5’-
AACCATAACACTAAAACCCT-3’ were used for nested PCR, amplifying a 249 base pair 
sequence encompassing 20 CpGs and rs2071094 A (33.6%)/C (66.4%) and rs2107425 G 
(55.5%)/A (44.5%) common SNPs. For SNRPN, nested primers (UCSC, chr15:25, 200, 009-
25, 200, 379) were designed to amplify a 360 base pair region encompassing 24 CpGs and a 
G (84.8%)/A (15.2%) SNP (rs220029) within the ICR as follows, SNRPN outer forward, 5’-
TAGTGTTGTGGGGTTTTAGGG-3’; SNRPN outer reverse, 5’-
TACCCACCTCCACCCATATC-3’; SNRPN inner forward, 5’-
AGGGAGGGAGTTGGGATTT-3’; SNRPN inner reverse, 5’-
CACAACAACAAACCTCTAAACATTC-3’.  All PCR reactions were performed as 
previously described (Al-Khtib et al., 2011), 94°C for 10 minutes followed by 55 cycles of 
94°C for 15 seconds, 56°C for 20 seconds and 72°C for 20 seconds, with a final 72°C for 10 
minute extension.  
PCR products were ligated into the pGEM-T EASY vector system (Promega), 
transformed into Z-competent DH5α Escherichia coli cells (Zymo Research) and following 
blue/white selection and colony PCR, samples were sent for sequencing at Bio Basic Inc. 
(Markham, ON, Canada) (Market-Velker et al., 2010). For both day 3 and blastocyst-stage 
embryos, 30-65 clones were sequenced per embryo per gene.  Methylation patterns were 
determined using online software (BISMA). Identical clones (identical location and number 
of unconverted CpG-associated cytosines and identical location and number of unconverted 
non-CpG-associated cytosines) were included only once and represented one individual DNA 
strand. Only clones with ≥85% conversion rates were included.  Total DNA methylation for 
each gene, or for each allele of a gene, if parental identity was assigned, was calculated as a 
percentage of the total number of methylated CpG/the total number of CpG dinucleotides. 
2.2.4 Statistical Analysis 
Student’s t-test was used to examine significance between embryos with normal methylation 
and those with abnormal methylation for maternal age, hormone dose, and stimulation 
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response (E2 levels).  Statistical analyses for patient diagnosis, hormone induction method, 
fertilization method, and embryo grade was determined using the nonparametric 
Kolmogorov-Smirnov (KS) test to analyze differences between groups.  A p-value of <0.05 
was considered to be significantly different. 
2.3 Results 
2.3.1 Imprinted methylation in control samples 
 As with previous studies, non-ART-treated, human preimplantation embryos cannot 
be obtained for experimental purposes. I therefore determined the imprinted methylation 
levels in readily obtainable cells from adults as a control. Imprinted DNA methylation at the 
SNRPN, KCNQ1OT1 and H19 ICR was first assessed in untreated human buccal cell (Bu) 
samples from 4 young, non-patient adults. Bisulfite clonal sequencing was used to analyze 
20-24 CpGs per gene. For all controls, a total of 30-65 clones were sequenced to obtain 
representative DNA strands.  Sequences with identical CpG methylation profiles and 
unconverted cytosines were considered to be identical and were included once to eliminate 
clonal bias. Each region of analysis included a single nucleotide polymorphism (s) (SNP) that 
when present in heterozygous samples could distinguish between parental alleles (Table 2-1). 
Since we did not have access to patient samples, we consider the methylated strands as the 
presumptive paternal H19, maternal SNRPN and maternal KCNQ1OT1 alleles, and the 
unmethylated strands as the maternal H19, paternal SNRPN and paternal KCNQ1OT1 alleles, 
as was done in previous studies (Ibala-Romdhane et al., 2011; Khoueiry et al., 2012). 
For the SNRPN ICR, a 360 bp-region was analyzed comprising 24 CpGs and a G/A 
SNP (rs220029) that occurs at a general population frequency of 84.8% and 15.2%, 
respectively (Figure 2-1A). All control samples were homozygous at this SNP (Table 2-1), 
and thus no allelic assignment could be made. Total SNRPN methylation levels in buccal cell 
controls (~1000 cells) were Bu1-1000 46%, Bu2-1000 45%, Bu3-1000 43% and Bu4-1000 
40% (Figure 2-1B).  Since buccal samples exhibited a mean SNRPN methylation level less 
than anticipated (43%), we analyzed SNRPN methylation in human embryonic stem cells 
(hESCs), an undifferentiated cell type that more closely matched preimplantation embryos.  
In hESCs, SNRPN methylation levels were 41% (Figure 2-1B), consistent with those in 
buccal cells. To assess cell numbers similar to blastocyst and day 3 embryos, methylation 
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levels were analyzed in ~50 or ~100 cells (Figure 2-1C) and 5-10 cells (denoted hereafter as 
10 cells) (Figure 2-1D) for Bu1 and Bu3 samples.  Total SNRPN methylation levels were 
Bu1-100 39%, Bu1-50 41% (Figure 2-1C), Bu1-10 44% and 41% (Figure 2-1D), and Bu3-
100 49%, Bu3-50 44% (Figure 2-1C), Bu3-10 38% and 42% (Figure 2-1D).  Thus within 
sample, methylation level mean and standard deviation were 42.2±2.8 for Bu1 and 43.2±4.0 
for Bu3.  
For the KCNQ1OT1 ICR, a 265 bp-region was analyzed encompassing 22 CpGs 
(Khoueiry et al., 2012) and a G (94.7%)/A (6.3%) SNP (rs56134303), that eliminated the 
first CpG (Figure 2-2A).  All controls were homozygous at the KCNQ1OT1 SNP (Table 2-1). 
Total KCNQ1OT1 methylation levels in control samples were Bu1-1000 63%, Bu2-1000 
57%, Bu3-1000 58% and Bu4-1000 65%  (Figure 2-2B). Since the mean KCNQ1OT1 
methylation level was greater than anticipated (60%), KCNQ1OT1 methylation was assessed 
in hESCs. KCNQ1OT1 methylation levels were hESC-1000 65% (Figure 2-2B), consistent 
with those in buccal cells.  At cell numbers similar to blastocyst and day 3 embryos, 
KCNQ1OT1 methylation levels were Bu1-100 57%, Bu1-50 65%, (Figure 2-2C), Bu1-10 
64% and 64% (Figure 2-2D), and Bu3-100 54%, Bu3-50 57% (Figure 2-2C), Bu3-10 54% 
and 57% (Figure 2-2D).  Thus within sample, methylation level mean and standard deviation 
were 62.6±3.2 for Bu1 and 56.0±1.8 for Bu3.   
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Figure 2-1: SNRPN imprinted methylation in buccal cell and human embryonic stem 
cell (hESC) control samples.  
 (A) Map of the SNRPN region analyzed. Accession numbers are located below genes, primer 
locations are marked with arrows, and SNPs are indicated by arrowheads. Methylation 
analyses in (B) four buccal cell (Bu1-4) and human embryonic stem cell (hESC) control 
samples with ~1000 cells, (C) in buccal cell samples with ~50 or ~100 cells, as indicated, 
representing blastocysts, and (D) with buccal cell samples ~10 cells, representing day 3 
cleavage embryos. Each group of circles represents an individual human sample. Each line is 
an individual DNA strand. Methylated CpGs are filled black circles and unmethylated CpGs 
are open circles.  Percent methylation is indicated above each set of DNA strands for a gene 
or parental allele and was calculated as the number of methylated CpGs divided by the total 
number of CpG dinucleotides.  
90 
 
 
Figure 2-2: KCNQ1OT1 imprinted methylation in buccal cell and hESC control samples 
 (A) Map of the KCNQ1OT1 region analyzed.  Methylation analyses in (B) buccal cell (Bu) 
and human embryonic stem cell (hESC) control samples with ~1000 cells, (C) in buccal cell 
samples with ~50 or ~100 cells (as indicated), representing blastocysts, and (D) with buccal 
cell samples ~10 cells, representing day 3 cleavage embryos. See Figure legend 2-1 for 
details. 
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Samples assessed for KCNQ1OT1 methylation levels were also analyzed for DNA 
methylation at the H19 ICR.  We initially began our analysis for a 234 bp-region within the 
H19 imprinting control region that included 18 CpGs (Khoueiry et al., 2012) and a common 
A (33.6%)/C (66.4%) SNP (rs2071094) (Figure 2-3A).  However, we observed biased allelic 
recovery and subsequently found two additional SNPs present in the forward and reverse 
inner nested primers. Thus, we designed new internal primers for a larger 249 bp-region 
within the H19 ICR containing 20 CpGs, the rs2071094 (A, 33.6%; C, 66.4%) SNP and 
rs2107425 (G, 55.5%; A, 44.5%) SNPs (Figure 2-3A). For buccal cell samples, Bu3 was 
heterozygous at both H19 SNPs, Bu4 was heterozygous at one SNP, while Bu1 and Bu2 
were homozygous for both H19 SNPs (Table 2-1). Samples Bu1-1000 and Bu2-1000 had 
total H19 methylation levels of 57% and 61%, respectively. Sample Bu3-1000 had 96% 
methylation on the presumptive paternal H19 allele and 11% methylation on the presumptive 
maternal H19 allele (56% total methylation), while Bu4-1000 had 94% and 11% methylation 
on the presumptive paternal and maternal H19 alleles, respectively (52% total methylation) 
(Figure 2-3B).  Thus, total methylation levels fell with a mean (56%) expected for paternally 
methylated and maternally unmethylated alleles. For smaller cell numbers, total H19 
methylation levels were Bu1-100 55%, Bu1-50 60% (Figure 2-3C), Bu1-10 63% and 53% 
(Figure 2-3D), and Bu3-100 59%, Bu3-50 50% (Figure 2-3C), Bu3-10 52% and 54% (Figure 
2-3D), with 94-98% and 3-12% methylation on the presumptive paternal and maternal H19 
alleles, respectively. Thus within samples, methylation level mean and standard deviation 
were 57.6±4.0 for Bu1 and 54.2±3.5 (Pat 95.6±1.5; Mat 8.8±3.6) for Bu3.    
Given the SNRPN, KCNQ1OT1 and H19 methylation levels in all control samples, 
conservatively, we considered a methylation range of 4 times the standard deviations 
above/below the mean as a normal methylation level. For SNRPN, the mean methylation 
level was 42.2%±3.0, generating a 30%-54% normal methylation range. For KCNQ1OT1, the 
mean methylation level was 60.0%±4.4, giving a normal methylation range of 42%-78%.  
The mean methylation level for H19 was 56.0%±4.1, generating a 40%-72% normal 
methylation range.   For embryos with heterozygous SNPs, conservatively ≥70% methylation 
on the presumptive maternal SNRPN, maternal KCNQ1OT1 and paternal H19 alleles and 
≤20% methylation on the presumptive paternal SNRPN, paternal KCNQ1OT1 and maternal 
H19 alleles were considered as normal methylation levels. 
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Figure 2-3: H19 imprinted methylation in buccal cell control samples 
 (A) Map of the H19 region analyzed.  Methylation analyses in (B) buccal cell (Bu) and 
human embryonic stem cell (hESC) control samples with ~1000 cells, (C) in buccal cell 
samples with ~50 or ~100 cells (as indicated), representing blastocysts, and (D) with buccal 
cell samples ~10 cells, representing day 3 cleavage embryos.  Grey circles are not included in 
methylation analyses as they represent a C/T SNP that cannot be distinguished following 
bisulfite conversion. Alleles are separated into presumptive maternal (Mat) and paternal (Pat) 
strands in samples with heterozygous SNPs. See Figure legend 2-1 for details.  
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2.3.2 Aberrant imprinted methylation in day 3 embryos 
During fertility treatment, embryos were cultured to day 3, after which embryos were 
either transferred to the mother, or cryopreserved and stored for future cycles, or cultured to 
the blastocyst stage then cryopreserved and stored for future cycles. For identification 
purposes, embryos were given an alphanumeric ID that included patient number (1-23), 
freeze stage [day 3 cleavage (C) or blastocyst (B)], and embryo number (1-6), for example 
“9C2” represents patient 9, day 3 cleavage embryo 2. Individual, cryopreserved day 3 
cleavage embryos were analyzed for maintenance of imprinted methylation. For all day 3 and 
blastocyst-stage embryos, a total of 30-65 clones were sequenced to obtain representative 
DNA strands and to sequence all possible unique DNA strands following thawing and 
bisulfite treatment.  Data were obtained for 9 of 12 day 3 embryos for SNRPN; 7 of 12 day 3 
embryos for KCNQ1OT1; and 7 of 12 day 3 embryos for H19.  
SNRPN is normally methylated on the silent maternal allele, while the paternal allele 
is unmethylated. All day 3 embryos were homozygous at the rs220029 SNP (Table 2-1) and 
thus were examined for total methylation levels. Of the 9 day 3 cleavage embryos analyzed, 
normal methylation levels were observed for 4 embryos (Figure 2-4A). By comparison, 5 
embryos had abnormal SNRPN methylation levels, with 4 embryos exhibiting aberrant 
hypermethylation (1C1, 62%; 1C5, 67%; 1C6, 59%; 18C1, 62%) while 1 embryo (21C1) 
displaying aberrant hypomethylation of 18%. Overall, 56% of day 3 cleavage embryos had 
abnormal SNRPN imprinted methylation.  
KCNQ1OT1 is also normally methylated on the silent maternal allele, while the 
paternally inherited allele is unmethylated. All 7 day 3 embryos were homozygous at the 
rs56134303 SNP (Table 2-1), and thus, total methylation levels were analyzed.  One embryo 
had methylation levels within the normal range (Figure 2-4B).  Of the remaining 6 embryos, 
1 embryo had abnormal hypermethylation (9C1, 80%) while 5 embryos exhibited aberrant 
KCNQ1OT1 hypomethylation (12C1, 19%; 7C1, 33%; 7C2, 35%; 6C1, 22%; 4C1, 19%).  In 
total, 86% of day 3 cleavage embryos had aberrant KCNQ1OT1 imprinted methylation. 
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Figure 2-4: Methylation of the (A) SNRPN, (B) KCNQ1OT1 and (C) H19 ICRs in day 3 
human cleavage-stage embryos	
Each group of DNA strands is an individual day 3 embryo with embryo ID (top left), and 
percent methylation and presumptive maternal/paternal allele designation (top right) 
indicated.  Normal (N) and abnormal (A) embryos are designated next to percent methylation 
values (top right).  The pre-freeze and post-thaw cell numbers, respectively, are indicated in 
brackets beside each embryo name. Grey circles are not included in methylation analyses as 
they represent a C/T SNP that cannot be distinguished following bisulfite conversion.  See 
Figure legend 2-1 for details.  
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H19 is normally methylated on the paternal allele, while the maternally inherited 
allele is unmethylated. Three day 3 cleavage embryos (4C1, 7C1, 7C2) were heterozygous at 
both rs2071094 and rs2107425, 1 embryo (6C2) was heterozygous at rs2071094 and 2 
embryos (6C1, 9C1) were heterozygous at rs2107425 (Table 2-1), allowing for allelic 
assignment. Only one embryo (3C1) was homozygous at the rs2071094 and rs2107425 SNPs 
and was examined for total methylation levels. Out of 7 day 3 embryos, 2 had a normal 
methylation pattern with methylation ≥70% on the presumptive paternal allele and ≤20% 
hypomethylation on the presumptive maternal allele (Figure 2-4C). Of the remaining 5 
embryos, 3 showed loss of methylation on the presumptive paternal H19 allele (6C1, 35%; 
6C2, 61%) and 2 displayed a gain of methylation on the presumptive maternal allele (7C1, 
85%; 7C2, 71%).  Finally, for the homozygous embryo (3C1), there was a loss of total H19 
methylation (38%). Overall, 71% of day 3 cleavage embryos were abnormally hypo- and/or 
hypermethylated at H19. Furthermore, of the 6 embryos successfully assessed for both 
KCNQ1OT1 and H19 methylation, 3 embryos (50%) displayed aberrant methylation levels at 
both genes (7C1; 7C2; 6C1). 
2.3.3 Abnormal imprinted methylation in blastocyst stage embryos 
Individual, cryopreserved blastocysts were also analyzed for maintenance of 
imprinted methylation. Data were obtained for 12 of 15 blastocysts for SNRPN; 13 of 14 
blastocysts for KCNQ1OT1; and 14 of 14 blastocysts for H19. For SNRPN, 3 blastocyst-stage 
embryos (22B1, 9B2, 17B1) were heterozygous at rs220029, while the remaining 9 embryos 
were homozygous at the rs220029 SNP (Table 2-1).  Four embryos had total methylation 
levels within the normal range (30%-54%) (Figure 2-5).  Of the 8 remaining embryos, 3 
homozygous embryos showed a gain of total SNRPN methylation (10B3, 63%; 14B3, 57%; 
and 14B4, 62%), and 2 homozygous blastocysts exhibited SNRPN hypomethylation (16B2, 
28%; and 23B1, 15%), while 1 heterozygous blastocyst (9B2) exhibited a gain of paternal 
SNRPN methylation (24% Pat) and 2 heterozygous blastocysts possessed both a loss of 
maternal SNRPN methylation and a gain of paternal SNRPN methylation (17B1, 65% Mat, 
26% Pat; and 22B1, 48% Mat, 26% Pat) (Figure 2-5).  In total, 67% of blastocyst embryos 
exhibited abnormal SNRPN imprinted methylation. 
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For KCNQ1OT1, all embryos were homozygous at the rs56134303 SNP (Table 2-1), 
allowing total methylation levels to be determined. Normal KCNQ1OT1 methylation levels 
(42%-78%) were observed in 9 blastocysts (Figure 2-6).  For the remaining 4 blastocysts, a 
loss of KCNQ1OT1 methylation was observed (14B2, 16%; 11B1, 19%; 19B1, 37%; and 
2B2, 39%).  Overall, 4 of 13 (31%) blastocysts had abnormal KCNQ1OT1 methylation 
levels.  
The same 14 embryos analyzed for KCNQ1OT1 imprinted methylation were assessed 
for H19 imprinted methylation.  Three blastocysts (4B1, 8B1, 14B2) were heterozygous at 
rs2071094 and rs2107425, 3 blastocysts (9B1, 19B1, 2B1) were heterozygous at rs2071094, 
and 2 blastocysts (2B2 and 13B1) were heterozygous for rs2107425 (Table 2-1). The 
remaining 6 blastocysts (14B1, 11B1, 15B1, 21B1, 4B2 and 20B1) were homozygous for 
both H19 SNPs (Table 2-1). All blastocysts, except 2, fell within the normal H19 methylation 
range (40%-72%) (Figure 2-7).  One blastocyst displayed a loss of total H19 methylation 
(20B1, 29%) and one displayed abnormal gain of maternal H19 methylation (14B2, 87% Pat, 
36% Mat).  Overall, 14% of blastocysts had an abnormal H19 methylation profile.  
Blastocyst 20B1, with aberrant H19 methylation, had normal KCNQ1OT1 methylation, while 
blastocyst 14B2 had abnormal methylation at both H19 and KCNQ1OT1. In total for all three 
genes, 76% day 3 embryos and 50% blastocysts exhibited abnormal imprinted methylation 
(Figure 2-8). 
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Figure 2-5: Methylation of the SNRPN ICR in human blastocyst-stage embryos 
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent 
methylation and presumptive maternal/paternal allele designation (top right) indicated. 
Normal (N) and abnormal (A) embryos are designated next to percent methylation values 
(top right).  See Figure legend 2-1 for details. 
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Figure 2-6: Methylation of the KCNQ1OT1 ICR in human blastocyst-stage embryos 
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent 
methylation and presumptive maternal/paternal allele designation (top right) indicated.  
Normal (N) and abnormal (A) embryos are designated next to percent methylation values 
(top right).  See Figure legend 2-1 for details. 
  
100 
 
 
Figure 2-7: Methylation of the H19 ICR in human blastocyst-stage embryos 
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent 
methylation and presumptive maternal/paternal allele designation (top right) indicated.  
Normal (N) and abnormal (A) embryos are designated next to percent methylation values 
(top right).  Grey circles are not included in methylation analyses as they represent a C/T 
SNP that cannot be distinguished following bisulfite conversion.  See Figure legend 2-1 for 
details. 
101 
 
 
Figure 2-8: Graphical representation for (A) SNRPN, (B) KCNQ1OT1 and (C) H19 
methylation levels in control buccal and ESC samples, and day 3 cleavage and 
blastocyst-stage embryos 
Black diamonds, control sample methylation levels with grey shaded area indicating normal 
methylation range. Green diamonds, total methylation levels in day 3 embryos and blastocyst 
embryos. Red diamonds indicate presumptive SNRPN, KCNQ1OT1 and H19 maternal alleles 
and blue diamonds indicate presumptive SNRPN, KCNQ1OT1 and H19 paternal alleles, with 
grey dashed lines representing ≥70% methylation and ≤20% methylation allelic cutoffs. 
Asterisk (*) represents a data point for which more than one embryo exists. 
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2.3.4 Intra-patient comparison of imprinted methylation in embryos at 
different preimplantation stages 
The design of this study allowed multiple embryos from the same patient to be 
compared for their imprinted methylation status. Out of 22 patients for whom data were 
obtained, 10 patients had more than one embryo analyzed (Table 2-2). For two patients, 6 
and 7, all in vitro-produced embryos experienced perturbations in imprinted methylation 
(KCNQ1OT1/H19 or H19). The remaining 8 patients had a portion of embryos with normal 
and a portion of embryos with abnormal methylation levels. For patient 1, 3/6 day 3 embryos 
had aberrant SNRPN imprinted methylation.  For patients 2, 10, 14 and 16, 1/2 (abnormal 
KCNQ1OT1), 1/3 (abnormal SNRPN), 3/5 (aberrant KCNQ1OT1/aberrant H19; aberrant 
SNRPN) and 1/2 (abnormal SNRPN) blastocysts had aberrant methylation levels, 
respectively. Finally, three patients had both day 3 cleavage and blastocyst-stage embryos. 
For patient 21 and 4, the day 3 embryos had aberrant methylation (abnormal SNRPN; 
abnormal KCNQ1OT1), while the blastocysts displayed normal methylation levels.  Finally, 
for patient 9, 1 day 3 embryo and 1 blastocyst possessed normal methylation levels, while 1 
day 3 embryo and 1 blastocyst had perturbed methylation (abnormal KCNQ1OT1; abnormal 
SNRPN). Overall, all 10 patients had at least one embryo with aberrant imprinted 
methylation.  Since there were embryos with and without imprinted methylation errors from 
the same patient, and there were genes with and without aberrant imprinted methylation in 
the same embryo, methylation errors were likely stochastic in nature.  Furthermore, the 
presence of methylation errors in both day 3 cleavage and blastocyst-stage embryos indicates 
that methylation errors arise as early as the 6-8 cell stage, and that extended culture does not 
pose a greater risk for imprinting errors than short culture. 
2.3.5 Correlation between parental biometrics, clinical treatment and 
aberrant imprinted methylation 
Medical records were examined for parental biometrics, clinical treatment and 
pregnancy outcomes. Clinical pregnancy rates for fresh embryo transfers as determined by 
gestational sac by ultrasound were 65% for the same cycle in which the surplus embryos 
were cryopreserved and donated. Live birth rate was 61% and live births/embryo transfer was 
36% (Table 2-3). Of all live births, 45% (9/20) of newborns (2 singletons, 3 sets of twins, 
and 1 of the triplets) were outside clinically normal birth weight, with 1 high birth weight 
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(>4000 g), 5 low birth weight (<2500), 1 very low birth weight (<1500 g) and 2 extremely 
low birth weight (<1000 g). Gestational age was not obtained.  To discern any confounding 
factors related to parental biometrics or clinical treatment, embryos with methylation levels 
in the normal range were compared to embryos with aberrant methylation for maternal age, 
patient diagnosis, induction method, hormone dose, stimulation response (E2 levels), 
fertilization method (IVF/ICSI), and embryo grade (Table 2-4).  Note that for all embryos, 
the same conditions and reagents were used for in vitro culture and slow-freezing 
cryopreservation, and thus no comparison could be made. For this analysis, the premise was 
that each embryo could have a different response to influences/exposures, although we 
acknowledge that embryos from the same mother may have similar exposures to maternal 
factor treatment. To make a comparison at the patient level for maternal age, hormone dose 
and estrogen response, separate analyses was also done for patients with only one embryo 
(12/22), since the remaining 10 patients with more than one embryo had a least one embryo 
with abnormal methylation. Data from both stages were combined for analyses, except for 
embryo grade.  
Maternal age range for patients in this study was 23-42 years. Mean maternal age for 
embryos with normal methylation levels was 34 years while that for embryos with aberrant 
methylation was 33 years (Figure 2-9A), which was not statistically different (p=0.21). 
Excluding patients with more than one embryo, maternal age for embryos with normal 
methylation levels was 33 years while that for embryos with abnormal methylation was 30 
years (results not shown) (p=0.38). Multiple etiologies contributing to infertility were 
diagnosed in patients. The four most common patient diagnoses were bilateral tubal 
obstruction/occlusion (BTO, 29.4% normal, 26.9% abnormal), male factor (MF, 17.6% 
normal, 15.4% abnormal), blocked tubes with endometriosis (BTO+ENDO, 11.8% normal, 
15.4% abnormal) and polycystic ovarian syndrome (PCOS, 11.8% normal, 11.5% abnormal) 
(Figure 2-9B). Thus, patient diagnoses were not statistically different between embryos with 
normal and abnormal methylation levels (p>0.99).  For induction method, Nafarelin 
(Synarel®) and Follitropin-alpha (Gonal-F®) was the most common hormone combination 
for patients with both normal (70.6%) and abnormal (69.2%) embryo groups, followed by 
Urofollitropin (Bravelle®) and Ganirelix Acetate (Orgalutran®) (11.8% normal and 7.7% 
abnormal) (Figure 2-9C). Thus, no significant difference was observed for hormone 
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induction method (p=0.80).  Mean hormone dose and estrogen response (E2) was calculated 
at 2894.1 IU and 15084.4 pM/L for the normal group and at 2361.5 IU and 12484.7 pM/L for 
the abnormal group (Figure 2-9D,E), which was not significantly different (p=0.18 and 0.20, 
respectively).  Excluding patients with more than one embryo, dose and estrogen response 
(E2) was 4150 IU and 15394.3 pM/L for the normal group and 2233.3 IU and 11546.6 pM/L 
(results not shown), which was not significantly different (p=0.06 and p=0.43, respectively). 
For fertilization method, percentage of embryos in the normal group was 62.5% IVF and 
47.5% ICSI, and in the abnormal group was 57.7% IVF and 42.3% ICSI (Figure 2-9F), 
which did not differ statistically (p=0.33). For day 3 embryo grade, embryos with normal 
methylation levels exhibited a grade of slight C/G2 (slC/G2) (3 embryos) and C/G3 (1 
embryo) while those with abnormal methylation levels had a grade of A/B/G1 (4 embryos), 
slC/G2 (8 embryos) and C (1 embryo) (Figure 2-9G).  Importantly, embryos transferred to 
patients (Table 2-3, 28A/B/G1, 15 slC/G2 and 12 C/G3) had similar grading information to 
those that were frozen. For blastocysts, 10 of the 13 embryos with normal methylation levels 
had grading information; 3 were AA, 1 AB, 1 BA, 2 BB, 1 BC, 1CA and 1 CB (Figure 2-
9H).  For embryos with abnormal methylation levels, 6 of the 13 had grading information: 5 
were AA and 1 BA. These grades were not statistically different (p=0.25). A comparison of 
these grading criteria separately showed that for stage (all 26 embryos included), embryos 
with normal methylation (5 stage 2, 2 stage 3, 6 stage 4) were not significantly different 
(p>0.99) from embryos with abnormal methylation (1 stage 1, 7 stage 2, 3 stage 3, 2 stage 4). 
For ICM grade, embryos with normal methylation (4 A, 4 B, and 2 C) were not statistically 
different (p=0.40) than embryos with abnormal methylation levels (5 A, 1 B). For TE grade, 
embryos with normal methylation (5 A, 4 B, 1 C) were not statistically different (p=0.60) 
from embryos with abnormal methylation levels (6 A).   Overall, no specific parameter was 
identified to have an association with abnormal imprinted methylation. Importantly, we 
found that embryos of the highest quality with day 3 A/B/G1 and blastocyst AA grading can 
have abnormal methylation.  
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Figure 2-9: Patient characteristics and embryo outcome for embryos with normal and 
abnormal imprinted methylation 
Day 3 cleavage and blastocyst-stage embryos exhibiting normal imprinted methylation 
(purple bars; n=17) were compared to those with abnormal methylation (orange bars; n=26) 
for (A) maternal age (t-test), (B) patient diagnosis (KS test), (C) induction method (KS test), 
(D) hormone dose (t-test), (E) estrogen levels (t-test), and (F) fertilization method (KS test).  
Means are indicated by black line for maternal age, hormone dose and estrogen levels.  (G) 
Grading of day 3 embryos with normal (n=4) and abnormal methylation (n=13) (no statistical 
analysis). (H) Blastocysts with normal [n=13 (stage), n=10 (grade)] and abnormal 
methylation [n=13 (stage), n=6 (grade)] were compared for embryo stage and grade (KS 
test). No significant difference was observed for any parameter between embryos with 
normal and abnormal methylation. BTO, bilateral tubal obstruction/occlusion; MF, male 
factor; ENDO, endometriosis; PCOS, polycystic ovarian syndrome; AMA, advanced 
maternal age; IDIO, idiopathic; ANOV, anovulatory; TD, tubal disease; (donor), donor 
sperm; FPES Fresh/frozen percutaneous epididymal/testicular sperm aspiration sample; Syn, 
Synarel® (Nafarelin); G-F, Gonal-F® (Follitropin-alpha); Brav, Bravelle® (Urofollitropin); 
Org, Orgalutran® (Ganirelix Acetate); Lup, Lupron® (Leuprolide Acetate); Rep, Repronex® 
(Menotropins); Men, Menopur® (Menotropins); Pur, Puregon® (Follitropin-beta); Fert, 
Fertinorm® (Urofollitrophin); IVF, in vitro fertilization; ICSI intracytoplasmic sperm 
injection. See methods for embryo grades.   
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2.4 Discussion 
Although mouse models have been instrumental in analyzing the effects of ARTs on 
genomic imprinting in oocytes and early embryos, it is important to assess the effects of these 
technologies in donated human counterparts.  This is especially important, as imprinting 
errors were perceived to be more common in mouse preimplantation embryos than in ART-
conceived children.  In this study, we observed that 76% day 3 embryos exhibited perturbed 
imprinted methylation, with 56%, 86% and 71% day 3 embryos possessing aberrant SNRPN, 
KCNQ1OT1 and H19 imprinted methylation, respectively. Furthermore, 50% blastocyst-
stage embryos exhibited abnormal methylation levels with 67%, 31% and 14% blastocysts 
having aberrant SNRPN, KCNQ1OT1 and H19 imprinted methylation, respectively.  Both 
losses and gains of imprinted methylation were observed, and in some cases, both within the 
same embryo (ex. 17C1, 22B1).  Additionally, 50% of day 3 and one blastocyst embryo 
exhibited both KCNQ1OT1 and H19 imprinted methylation perturbations (6C1, 7C1, 7C2, 
14B2).  This is similar to the multi-locus loss of imprinting we previously observed in the 
mouse (Market-Velker et al., 2010) and that others have reported in BWS and SRS children 
(Azzi et al., 2009; Bliek et al., 2009; Chang et al., 2005; DeBaun et al., 2003; Hiura et al., 
2012; Lennerz et al., 2010; Lim et al., 2009; Rossignol et al., 2006; Turner et al., 2010).  
 Very few studies have examined the effects of ARTs on genomic imprinting in 
donated human preimplantation embryos (Chen et al., 2010; Geuns et al., 2003; 2007; Ibala-
Romdhane et al., 2011; Khoueiry et al., 2012; Shi et al., 2014). Moreover, these studies were 
primarily performed on poor quality embryos that were unsuitable for transfer. Nevertheless, 
their results were similar to what is reported here.  For SNRPN, 8/9 day 3 embryos (89%) 
possessed a loss or gain of methylation (Geuns et al., 2003). For KCNQ1OT1, 7/67 day 3 
embryos (10%) (Shi et al., 2014) and 9/16 poor quality blastocysts (56%) harboured aberrant 
methylation (Khoueiry et al., 2012). Finally for H19, 3 studies reported aberrant imprinted 
methylation in 6/32 day 3 embryos (17%) (Chen et al., 2010), 9/21 poor quality morula-
blastocysts (43%) (Ibala-Romdhane et al., 2011), and 5/60 blastocysts (8%) (Shi et al., 2014), 
while the remaining study did not observe any alterations in H19 imprinted methylation in 8 
low quality blastocysts (0%) (Khoueiry et al., 2012). In addition to these genes, previous 
studies identified 11/65 day 3 embryos (17%) with abnormal PEG1 imprinted methylation 
(Shi et al., 2014) and 18/24 day 3 embryos (75%) with aberrant GTL2 imprinted methylation 
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(Geuns et al., 2007). All together, our study along with previous publications demonstrate 
that the frequency of imprinting errors in human donated preimplantation embryos (6-89%) 
occurs at a similar frequency to that produced in mouse preimplantation embryos (10-90%) 
(Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010; 2012).  
Of the above studies, two examined imprinted methylation in good quality, in vitro 
produced embryos. For KCNQ1OT1, 2/5 high quality (40%) blastocysts harboured aberrant 
methylation (Khoueiry et al., 2012), which was similar to what we report here (4/13; 31%). 
For H19, 0/5 high quality (0%) morula-blastocysts (Ibala-Romdhane et al., 2011) and 0/5 
high quality blastocysts (0%) possessed aberrant methylation (Khoueiry et al., 2012). This 
contrasted with our study where we observed 2/14 blastocysts (14%) with aberrant H19 
methylation. This discrepancy may relate to the number of embryos analyzed in these 
studies. 
The design of our study allowed comparison of short culture to day 3 cleavage stages 
and extended culture to the blastocyst stage. Our data together with previous studies found 
imprinted methylation errors at both stages; SNRPN day 3 (56%, 89%) versus blastocysts 
(67%); KCNQ1OT1 day 3 (86%, 10%) versus blastocysts (31%, 40%, 56%); and H19 day 3 
(71%, 17%) versus blastocysts (14%, 8%, 0%) (Chen et al., 2010; Ibala-Romdhane et al., 
2011; Khoueiry et al., 2012; Shi et al., 2014).  Thus, the presence of methylation errors in 
embryos undergoing both short (55% embryos) and extended (31% embryos) culture 
indicates that methylation errors arise as early as the 6-8 cell stage. Furthermore, extending 
culture from day 3 to the blastocyst stage does not appear to pose any greater risk for 
imprinting errors. Consequently, our study offers additional support for extended culture to 
the blastocyst stage to select the most developmentally competent embryos.   
Although the frequency of imprinting errors was similar between mice and human 
preimplantation embryos, disparity still exists between frequencies of imprinting errors in 
human preimplantation embryos compared to frequencies of imprinting errors reported in 
ART children. One explanation for this discrepancy may be that imprinting errors in the early 
embryo lead to reduced levels of implantation or pregnancy failure. Alternatively, 
blastomeres with aberrant imprinted methylation may be preferentially relegated to the 
extraembryonic lineages. Previous studies in the mouse provide support for the latter 
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explanation, since we and others have observed a selective loss of imprinting in the placenta 
compared to the embryo in midgestation mouse embryos following preimplantation 
development in culture (de Waal et al., 2014; Mann et al., 2004; Rivera et al., 2008). 
Infertility rates have increased around the world (Chandra et al., 2013; Mascarenhas 
et al., 2012). Advanced maternal age (>35 years) is directly related to this rise, consequently 
leading to the question of whether delayed childbearing in ART women may contribute to 
increased imprinting errors in ART children. Additionally, current evidence indicates that the 
supra-physiological hormonal milieu of ovarian stimulation may produce adverse outcomes 
in ART pregnancies. For example, similar incidences of low birth weight and preterm low 
birth weight were present in ART children produced from donor oocytes from fertile women 
compared to oocytes from subfertile mothers (Kalra and Barnhart, 2011).  This birth weight 
variation in in vitro-conceived children may be explained by alterations in DNA methylation 
levels at growth-related genes, as detected in newborn cord blood and placenta (Turan et al., 
2012). With respect to imprinting disorders, ovarian stimulation has also been linked to BWS 
and AS in ART-conceived children (Chang et al., 2005; Ludwig et al., 2005; Sutcliffe et al., 
2006), and for some of these children, the only procedure used was ovarian stimulation 
(Chang et al., 2005; Ludwig et al., 2005).  Our comparison of maternal age, induction 
method, hormone dosage levels and stimulation response in embryos with and without 
aberrant methylation revealed no significant difference between these groups.  These results 
were not all that surprising, since embryos with and without methylation errors may have had 
similar exposures to maternal factor treatment and/or parental biometrics; and all embryos 
were generated using supra-physiological hormone dosages and the same conditions for in 
vitro culture and slow-freezing cryopreservation. Similarly, no significant difference in 
fertilization method (IVF/ICSI) or blastocyst grade was observed between embryos with 
normal or abnormal imprinted methylation. However, it should be noted that even the highest 
quality day 3 cleavage (A/B/G1) and blastocyst-stage (AA) embryos harbour abnormal 
methylation levels. This finding has significant bearing on future studies employing high 
quality embryos as their control group. One further observation of note was that two embryos 
(19B1, 20B1), produced via donor sperm for male factor infertility, possessed abnormal 
imprinted methylation. This suggests that imprinting errors in these embryos cannot be 
explained by inherent infertility, but instead may point to ART-induced errors. Further 
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studies are required to investigate imprinted methylation errors in in vitro-produced embryos 
using donor oocytes and sperm 
 There were several limitations of this study. Similar to other studies on ART human 
embryos, our investigation lacks naturally conceived controls, which is ethically 
unavoidable. Additionally, due to limited availability of donated embryos, this study and 
others employed small numbers in analyses. However, the statistical analyses used in this 
type of study remains valid within the embryo population analyzed, and may allow 
cumulative analysis of larger sample sizes in the future. Finally, although our study 
controlled for operating procedure in the clinic, donated embryos analyzed here were 
obtained from a single fertility clinic.  
Going forward, future research should focus on determining differences between 
human embryos with and without imprinting errors with respect to embryo properties, the 
timing and origin of these errors, as well as the molecular factors responsible for inducing 
imprinted methylation errors in ART embryos. Animal models will be instrumental in these 
studies prior to investigation in human embryos.  
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Table 2-1: Buccal cell sample, hESCs and embryo genotype 
  SNRPN KCNQ1OT1 H19 H19 
Study ID rs220029 rs56134303 rs2071094 rs2107425 
   (Mat/Pat)*  (Mat/Pat)*  (Mat/Pat)*  (Mat/Pat)* 
Controls     
Bu1 G/G G/G A/A G/G 
Bu2 G/G G/G T/T A/A 
Bu3 G/G G/G T/A A/G 
Bu4 G/G G/G A/T G/G 
hESCs G/G G/G   
Day 3     
1C1 G/G     
1C2 G/G    
1C3 G/G    
1C4 G/G    
1C5 G/G    
1C6 G/G    
9C2 G/G    
18C1 G/G    
21C1 G/G    
3C1  G/G A/A G/G 
3C2  IC IC IC 
4C1  G/G T/A A/G 
6C1  G/G T/T A/G 
6C2  IC T/A G/G 
7C1  G/G T/A A/G 
7C2  G/G T/A A/G 
9C1  G/G A/A A/G 
12C1  G/G IC  
Blastocyst     
9B2 A/G    
10B1 G/G    
10B2 G/G    
10B3 G/G    
14B3 G/G    
14B4 G/G    
14B5 G/G    
16B1 G/G    
16B2 G/G    
17B1 A/G    
22B1 G/A    
23B1 G/G    
2B1  G/G T/A G/G 
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2B2  G/G T/T G/A 
4B1  G/G T/A A/G 
4B2  G/G A/A G/G 
8B1  G/G T/A A/G 
9B1  G/G A/T G/G 
11B1  G/G A/A G/G 
13B1  G/G T/T A/G 
14B1  G/G A/A G/G 
14B2  G/G T/A A/G 
15B1  G/G A/A G/G 
19B1  G/G A/T G/G 
20B1  G/G A/A G/G 
21B1   IC A/A G/G 
* presumptive maternal and paternal alleles 
Bu, buccal cell samples; hESCs, human embryonic stem cells; Mat, maternal; Pat, paternal; 
C, day 3 cleavage stage embryo; B, blastocyst stage embryo; ND, not determined; IC, 
inconclusive. 
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Table 2-2: Comparison of imprinted methylation status of patients with single and 
multiple embryos 
Patients with a single embryo 
Emb 3 12 18 8 11 13 15 17 19 20 22 23 
 
C1 
K 
65 
 
K 
19 
 
S 
62 
         
H 
38 
         
 
 
B1 
   K 
62 
K 
19 
K 
70 
K 
74 
S 
65M 
26P 
K 
37 
K 
51 
 
S 
48M 
26P 
 
S 
15 
H 
88P 
9M 
H 
45 
H 
89P 4M 
H 
61 
 H 
89P 
14M 
H 
29 
Patients with multiple embryos 
Emb 6 7 1 2 10 14 15 21 4 9 
 
 
C1 
K 
22 
K 
33 S 
62     
S 
18 
K 
19 
K 
80 
 
H 
35P 
5M 
H 
95P 
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K 
35 S 
42       
S 
52 H 94P 
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C3   S 46        
C4   S 42        
C5   S 67        
C6   S 59        
 
 
B1    
K 
57 S 
33 
K 
76 S 
42 
H 
66 
K 
48 
K 
48 
H 
90P 
10M 
H 
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H 
89P 
9M 
H 
88P 
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K 
39 S 
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K 
16 S 
28  
K 
45 S 
77M 
24P 
H 
88P 
9M 
H 
87P 
36M 
H 
41 
B3     S 63 S 57     
B4      S 62     
B5      S 33     
Emb, embryo; S, SNRPN; K, KCNQ1OT1; H, H19; Numbers, % methylation; P, paternal; M, 
maternal; purple, normal methylation levels; orange, abnormal methylation levels. 
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Table 2-3: Pregnancy outcome for each patient 
Patient  # ET Embryo grade Pregnancy Live birth BW (g) Category 
1 2 8B,10slC No -   
2 3 8B,8B,7B No -   
3 2 9slC,8A Yes Y (twins) 925, 820 EL,EL 
4 2 8B, 9B No -   
5 3 8A,8A,8slC Yes Y (twins) 2240, 2466 L,L 
6 3 10slC,8A,8A Yes Y 1185 VL 
7 2 9slC,10slC Yes Y 3856 N 
8 2 10C,8B No -   
9 3 8B,8slC,8A Yes Y (twins) 2722, 2665 N,N 
10 2 8slC,9C Yes Y 3600 N 
11 2 8slC,6slC Yes Y 3260 N 
12 3 8A,7C,A* Yes Y 2920  
13 3 7C,4B,5C No -   
14 3 8A,8B,8B Yes Y (triplets) 2268, 2551, 2551 L, N, N 
15 2 7C,10C No -   
16 2 6slC,6C Yes N   
17 2 7B,7slC Yes Y 2948 N 
18 2 8B,10B Yes Y 4678 H 
19 2 8slC,10C No -   
20 3 8B,8slC,8A Yes Y 3912 N 
21 3 8C,8C,8C Yes Y (twins) 2325, 2041 L,L 
22 2 7A,9A Yes Y 3515 N 
23 2 10slC,8A No -     
ET, embryos transferred; BW, birth weight; N, normal BW; L, low BW; VL, very low BW; 
EL, extremely low BW. Asterisk indicates embryo was compacting. Gestational age was not 
obtained. 
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Table 2-4: Patient biometrics and clinical treatment 
Emb, embryo; Mat, maternal; C, day 3 cleavage stage embryo; B, blastocysts; E2, serum 
estrogen on day of hCG trigger; ICSI, intracytoplasmic sperm injection; IVF, in vitro 
fertilization; MF, male factor; ENDO, endometriosis; BTO, bilateral tubal 
obstruction/occlusion; IDIO, idiopathic; PCOS, polycystic ovarian syndrome; AMA, 
advanced maternal age; ANOV, anovulatory; TD, tubal disease; DONOR, donor sperm; 
FPES, Fresh/frozen percutaneous epididymal/testicular sperm aspiration sample; --, no grade 
available. 
116 
 
2.5 References 
Al-Khtib, M., Perret, A., Khoueiry, R., Ibala-Romdhane, S., Blachère, T., Greze, C., 
Lornage, J., and Lefèvre, A. (2011). Vitrification at the germinal vesicle stage does not affect 
the methylation profile of H19 and KCNQ1OT1 imprinting centers in human oocytes 
subsequently matured in vitro. Fertil. Steril. 95, 1955–1960. 
Azzi, S., Rossignol, S., Steunou, V., Sas, T., Thibaud, N., Danton, F., Le Jule, M., Heinrichs, 
C., Cabrol, S., Gicquel, C., et al. (2009). Multilocus methylation analysis in a large cohort of 
11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) 
reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum. Mol. 
Genet. 18, 4724–4733. 
Bliek, J., Terhal, P., van den Bogaard, M.-J., Maas, S., Hamel, B., Salieb-Beugelaar, G., 
Simon, M., Letteboer, T., van der Smagt, J., Kroes, H., et al. (2006). Hypomethylation of the 
H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an 
SRS-like phenotype. Am. J. Hum. Genet. 78, 604–614. 
Bliek, J., Verde, G., Callaway, J., Maas, S.M., De Crescenzo, A., Sparago, A., Cerrato, F., 
Russo, S., Ferraiuolo, S., Rinaldi, M.M., et al. (2009). Hypomethylation at multiple 
maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-
Wiedemann syndrome. Eur. J. Hum. Genet. 17, 611–619. 
Chandra, A., Copen, C.E., and Stephen, E.H. (2013). Infertility and impaired fecundity in the 
United States, 1982-2010: data from the National Survey of Family Growth. Natl Health Stat 
Report 1–18–1pfollowing19. 
Chang, A.S., Moley, K.H., Wangler, M., Feinberg, A.P., and DeBaun, M.R. (2005). 
Association between Beckwith-Wiedemann syndrome and assisted reproductive technology: 
a case series of 19 patients. Fertil. Steril. 83, 349–354. 
Chen, S.-L., Shi, X.-Y., Zheng, H.-Y., Wu, F.-R., and Luo, C. (2010). Aberrant DNA 
methylation of imprinted H19 gene in human preimplantation embryos. Fertil. Steril. 94, 
2356–8–2358.e1. 
Chiba, H., Hiura, H., Okae, H., Miyauchi, N., Sato, F., Sato, A., and Arima, T. (2013). DNA 
methylation errors in imprinting disorders and assisted reproductive technology. Pediatr Int 
55, 542–549. 
Chopra, M., Amor, D.J., Sutton, L., Algar, E., and Mowat, D. (2010). Russell-Silver 
syndrome due to paternal H19/IGF2 hypomethylation in a patient conceived using 
intracytoplasmic sperm injection. Reprod. Biomed. Online 20, 843–847. 
Cocchi, G., Marsico, C., Cosentino, A., Spadoni, C., Rocca, A., De Crescenzo, A., and 
Riccio, A. (2013). Silver-Russell syndrome due to paternal H19/IGF2 hypomethylation in a 
twin girl born after in vitro fertilization. Am. J. Med. Genet. A 161A, 2652–2655. 
Cox, G.F., Bürger, J., Lip, V., Mau, U.A., Sperling, K., Wu, B.-L., and Horsthemke, B. 
(2002). Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am. J. 
117 
 
Hum. Genet. 71, 162–164. 
de Waal, E., Mak, W., Calhoun, S., Stein, P., Ord, T., Krapp, C., Coutifaris, C., Schultz, 
R.M., and Bartolomei, M.S. (2014). In vitro culture increases the frequency of stochastic 
epigenetic errors at imprinted genes in placental tissues from mouse concepti produced 
through assisted reproductive technologies. Biol. Reprod. 90, 22. 
DeBaun, M.R., Niemitz, E.L., and Feinberg, A.P. (2003). Association of in vitro fertilization 
with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am. J. 
Hum. Genet. 72, 156–160. 
Denomme, M.M., Zhang, L., and Mann, M.R.W. (2011). Embryonic imprinting perturbations 
do not originate from superovulation-induced defects in DNA methylation acquisition. Fertil. 
Steril. 96, 734–738.e2. 
Doornbos, M.E., Maas, S.M., McDonnell, J., Vermeiden, J.P.W., and Hennekam, R.C.M. 
(2007). Infertility, assisted reproduction technologies and imprinting disturbances: a Dutch 
study. Human Reproduction 22, 2476–2480. 
Fauque, P., Jouannet, P., Lesaffre, C., Ripoche, M.-A., Dandolo, L., Vaiman, D., and 
Jammes, H. (2007). Assisted Reproductive Technology affects developmental kinetics, H19 
Imprinting Control Region methylation and H19 gene expression in individual mouse 
embryos. BMC Dev. Biol. 7, 116. 
Gardner, D.K., and Schoolcraft, W.B. (1999). Towards Reproductive Certainty: Fertility and 
Genetics Beyond 1999: The Plenary Proceedings of the 11th Congress on In Vitro 
Fertilization and Human Reproductive Genetics (eds Jansen, R. & Mortimer, D.)  Ch. 47, 
378–388 (Parthenon Pub. Group, 1999)  
Geuns, E., De Rycke, M., Van Steirteghem, A., and Liebaers, I. (2003). Methylation imprints 
of the imprint control region of the SNRPN-gene in human gametes and preimplantation 
embryos. Hum. Mol. Genet. 12, 2873–2879. 
Geuns, E., De Temmerman, N., Hilven, P., Van Steirteghem, A., Liebaers, I., and De Rycke, 
M. (2007). Methylation analysis of the intergenic differentially methylated region of DLK1-
GTL2 in human. Eur. J. Hum. Genet. 15, 352–361. 
Gicquel, C., Gaston, V., Mandelbaum, J., Siffroi, J.-P., Flahault, A., and Le Bouc, Y. (2003). 
In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the 
abnormal imprinting of the KCN1OT gene. Am. J. Hum. Genet. 72, 1338–1341. 
Hajj, El, N., Trapphoff, T., Linke, M., May, A., Hansmann, T., Kuhtz, J., Reifenberg, K., 
Heinzmann, J., Niemann, H., Daser, A., et al. (2011). Limiting dilution bisulfite 
(pyro)sequencing reveals parent-specific methylation patterns in single early mouse embryos 
and bovine oocytes. Epigenetics 6, 1176–1188. 
Halliday, J., Oke, K., Breheny, S., Algar, E., and Amor, D.J. (2004). Beckwith-Wiedemann 
syndrome and IVF: a case-control study. Am. J. Hum. Genet. 75, 526–528. 
118 
 
Hardy, K., Stark, J., and Winston, R.M.L. (2003). Maintenance of the inner cell mass in 
human blastocysts from fragmented embryos. Biol. Reprod. 68, 1165–1169. 
Hiura, H., Okae, H., Miyauchi, N., Sato, F., Sato, A., Van De Pette, M., John, R.M., Kagami, 
M., Nakai, K., Soejima, H., et al. (2012). Characterization of DNA methylation errors in 
patients with imprinting disorders conceived by assisted reproduction technologies. Hum. 
Reprod. 27, 2541–2548. 
Horike, S., Mitsuya, K., Meguro, M., Kotobuki, N., Kashiwagi, A., Notsu, T., Schulz, T.C., 
Shirayoshi, Y., and Oshimura, M. (2000). Targeted disruption of the human LIT1 locus 
defines a putative imprinting control element playing an essential role in Beckwith-
Wiedemann syndrome. Hum. Mol. Genet. 9, 2075–2083. 
Ibala-Romdhane, S., Al-Khtib, M., Khoueiry, R., Blachère, T., Guérin, J.F., and Lefèvre, A. 
(2011). Analysis of H19 methylation in control and abnormal human embryos, sperm and 
oocytes. Eur. J. Hum. Genet. 19, 1138–1143. 
Kagami, M., Nagai, T., Fukami, M., Yamazawa, K., and Ogata, T. (2007). Silver-Russell 
syndrome in a girl born after in vitro fertilization: partial hypermethylation at the 
differentially methylated region of PEG1/MEST. J Assist Reprod Genet 24, 131–136. 
Kalra, S.K., and Barnhart, K.T. (2011). In vitro fertilization and adverse childhood outcomes: 
what we know, where we are going, and how we will get there. A glimpse into what lies 
behind and beckons ahead. Fertil. Steril. 95, 1887–1889. 
Khoueiry, R., Ibala-Romdhane, S., Al-Khtib, M., Blachère, T., Lornage, J., Guérin, J.F., and 
Lefèvre, A. (2012). Abnormal methylation of KCNQ1OT1 and differential methylation of 
H19 imprinting control regions in human ICSI embryos. Zygote 1–10. 
Lammers, T.H.M., van Haelst, M.M., Alders, M., and Cobben, J.M. (2012). Het Silver-
Russell-syndroom in Nederland. Tijdschr. Kindergeneeskunde 80, 86–91. 
Lennerz, J.K., Timmerman, R.J., Grange, D.K., DeBaun, M.R., Feinberg, A.P., and 
Zehnbauer, B.A. (2010). Addition of H19 “loss of methylation testing” for Beckwith-
Wiedemann syndrome (BWS) increases the diagnostic yield. J Mol Diagn 12, 576–588. 
Lim, D., Bowdin, S.C., Tee, L., Kirby, G.A., Blair, E., Fryer, A., Lam, W., Oley, C., Cole, 
T., Brueton, L.A., et al. (2009). Clinical and molecular genetic features of Beckwith-
Wiedemann syndrome associated with assisted reproductive technologies. Hum. Reprod. 24, 
741–747. 
Ludwig, M., Katalinic, A., Gross, S., Sutcliffe, A., Varon, R., and Horsthemke, B. (2005). 
Increased prevalence of imprinting defects in patients with Angelman syndrome born to 
subfertile couples. J. Med. Genet. 42, 289–291. 
Maher, E.R., Afnan, M., and Barratt, C.L. (2003a). Epigenetic risks related to assisted 
reproductive technologies: epigenetics, imprinting, ART and icebergs? Human Reproduction 
18, 2508–2511. 
119 
 
Maher, E.R., Brueton, L.A., Bowdin, S.C., Luharia, A., Cooper, W., Cole, T.R., Macdonald, 
F., Sampson, J.R., Barratt, C.L., Reik, W., et al. (2003b). Beckwith-Wiedemann syndrome 
and assisted reproduction technology (ART). J. Med. Genet. 40, 62–64. 
Maher, E.R. (2005). Imprinting and assisted reproductive technology. Hum. Mol. Genet. 14 
Spec No 1, R133–R138. 
Mann, M.R.W., Lee, S.S., Doherty, A.S., Verona, R.I., Nolen, L.D., Schultz, R.M., and 
Bartolomei, M.S. (2004). Selective loss of imprinting in the placenta following 
preimplantation development in culture. Development 131, 3727–3735. 
Market-Velker, B.A., Denomme, M.M., and Mann, M.R.W. (2012). Loss of genomic 
imprinting in mouse embryos with fast rates of preimplantation development in culture. Biol. 
Reprod. 86, 143–1–16. 
Market-Velker, B.A., Zhang, L., Magri, L.S., Bonvissuto, A.C., and Mann, M.R.W. (2010). 
Dual effects of superovulation: loss of maternal and paternal imprinted methylation in a 
dose-dependent manner. Hum. Mol. Genet. 19, 36–51. 
Mascarenhas, M.N., Flaxman, S.R., Boerma, T., Vanderpoel, S., and Stevens, G.A. (2012). 
National, regional, and global trends in infertility prevalence since 1990: a systematic 
analysis of 277 health surveys. PLoS Med. 9, e1001356. 
Okun, N., and Sierra, S. (2014). Pregnancy outcomes after assisted human reproduction. J 
Obstet Gynaecol Can 36, 64–83. 
Rijnders, P.M., and Jansen, C.A. (1998). The predictive value of day 3 embryo morphology 
regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer 
following in-vitro fertilization or intracytoplasmic sperm injection. Human Reproduction 13, 
2869–2873. 
Rivera, R.M., Stein, P., Weaver, J.R., Mager, J., Schultz, R.M., and Bartolomei, M.S. (2008). 
Manipulations of mouse embryos prior to implantation result in aberrant expression of 
imprinted genes on day 9.5 of development. Hum. Mol. Genet. 17, 1–14. 
Rossignol, S., Steunou, V., Chalas, C., Kerjean, A., Rigolet, M., Viegas-Pequignot, E., 
Jouannet, P., Le Bouc, Y., and Gicquel, C. (2006). The epigenetic imprinting defect of 
patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is 
not restricted to the 11p15 region. J. Med. Genet. 43, 902–907. 
Savage, T., Peek, J., Hofman, P.L., and Cutfield, W.S. (2011). Childhood outcomes of 
assisted reproductive technology. Hum. Reprod. 26, 2392–2400. 
Shi, X., Chen, S., Zheng, H., Wang, L., and Wu, Y. (2014). Abnormal DNA Methylation of 
Imprinted Loci in Human Preimplantation Embryos. Reprod Sci. 
Sjöblom, P., Menezes, J., Cummins, L., Mathiyalagan, B., and Costello, M.F. (2006). 
Prediction of embryo developmental potential and pregnancy based on early stage 
morphological characteristics. Fertil. Steril. 86, 848–861. 
120 
 
Sutcliffe, A.G., Peters, C.J., Bowdin, S., Temple, K., Reardon, W., Wilson, L., Clayton-
Smith, J., Brueton, L.A., Bannister, W., and Maher, E.R. (2006). Assisted reproductive 
therapies and imprinting disorders--a preliminary British survey. Human Reproduction 21, 
1009–1011. 
Testart, J., Lassalle, B., Belaisch-Allart, J., Hazout, A., Forman, R., Rainhorn, J.D., and 
Frydman, R. (1986). High pregnancy rate after early human embryo freezing. Fertil. Steril. 
46, 268–272. 
Turan, N., Ghalwash, M.F., Katari, S., Coutifaris, C., Obradovic, Z., and Sapienza, C. (2012). 
DNA methylation differences at growth related genes correlate with birth weight: a 
molecular signature linked to developmental origins of adult disease? BMC Med Genomics 
5, 10. 
Turner, C.L.S., Mackay, D.M., Callaway, J.L.A., Docherty, L.E., Poole, R.L., Bullman, H., 
Lever, M., Castle, B.M., Kivuva, E.C., Turnpenny, P.D., et al. (2010). Methylation analysis 
of 79 patients with growth restriction reveals novel patterns of methylation change at 
imprinted loci. Eur. J. Hum. Genet. 18, 648–655. 
Van Buggenhout, G., and Fryns, J.-P. (2009). Angelman syndrome (AS, MIM 105830). Eur. 
J. Hum. Genet. 17, 1367–1373. 
van Montfoort, A.P.A., Hanssen, L.L.P., de Sutter, P., Viville, S., Geraedts, J.P.M., and de 
Boer, P. (2012). Assisted reproduction treatment and epigenetic inheritance. Human 
Reproduction Update 18, 171–197. 
Weksberg, R., Shuman, C., and Beckwith, J.B. (2010). Beckwith-Wiedemann syndrome. 
Eur. J. Hum. Genet. 18, 8–14. 
Ørstavik, K.H., Eiklid, K., van der Hagen, C.B., Spetalen, S., Kierulf, K., Skjeldal, O., and 
Buiting, K. (2003). Another case of imprinting defect in a girl with Angelman syndrome who 
was conceived by intracytoplasmic semen injection. Am. J. Hum. Genet. 72, 218–219. 
 
121 
 
Chapter 3  
3 Superovulation disrupts mitochondria in mouse oocytes 
and preimplantation embryos 
3.1 Introduction 
Mitochondria are vital for oocyte and preimplantation embryo developmental 
competence.  This has been perpetually demonstrated over the years in multiple different 
species, including mouse and human [reviewed in (Chappel, 2013; Schatten et al., 2014; Van 
Blerkom, 2011)]. Consequently, in the assisted reproductive technology (ART) field, fertility 
clinics around the world have been exploring experimental techniques that target 
mitochondria to improve IVF success.  For example, three-parent mitochondrial replacement 
therapy (MRT) was approved for human clinical investigation in the United Kingdom on 
February 3rd, 2015. This technique has emerged to bypass inheritance of mitochondrial 
disease from affected mothers to offspring by injecting the pronuclei of intended parents into 
an enucleated donor oocyte (Reinhardt et al., 2013).  Furthermore, AUGMENT (for 
autologous germline mitochondrial energy transfer), a novel and controversial technique, is 
currently being offered in one city in North America, first originating at the Toronto Centre 
for Advanced Reproductive Technology (TCART) clinic, in addition to being offered in 
London, Japan, Panama, Spain, Turkey and Dubai (Motluk, 2015) 
(http://www.augmenttreatment.com/#find-a-clinic).  This technique injects patient-matched 
mitochondria obtained from a population of cells existing within the woman’s ovarian cortex 
into the oocyte at the time of intracytoplasmic sperm injection (ICSI) (Motluk, 2015; Tilly 
and Sinclair, 2013; Woods and Tilly, 2015).  The idea behind AUGMENT is to supplement 
the mitochondrial pool in oocytes from women of advanced reproductive age or in couples 
with multiple failed rounds of infertility treatments (Motluk, 2015; Woods and Tilly, 2015).  
The world’s first AUGMENT baby was born in Toronto in April of 2015. However, despite 
this success, there are still many unanswered questions regarding the risks these treatments 
pose to the resulting offspring. Furthermore, little research has been conducted to determine 
what effects common ART treatments, such as ovarian stimulation, have on the oocyte and 
preimplantation embryo during in vitro development. 
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The mature human MII oocyte contains about 100,000 to 400,000 mitochondria 
(Cummins, 2002; Jansen, 2000; Jansen and de Boer, 1998; Jansen and Burton, 2004), which 
is similar to the number originally identified in mouse eggs (92,500 ± 7000) (Pikó and 
Matsumoto, 1976). In somatic cells the number of mitochondria vary depending on ATP 
requirements but are orders of magnitude lower than the MII oocyte, ranging from 265 ± 40 
in mouse fibroblasts to 308 ± 47 in human lung fibroblasts (Robin and Wong, 1988).  The 
mitochondrial complement in the MII oocyte is derived from approximately 10-20 
mitochondria in primordial germ cells (PGCs), which increases during oocyte growth 
through mitochondrial DNA replication and biogenesis (Cummins, 2002; Jansen, 2000; St 
John et al., 2010; Van Blerkom, 2011). The resultant mitochondrial population in MII 
oocytes represents the only source of mitochondria in resulting offspring.   
Given the large size of the mature oocyte, adequate mitochondria numbers and proper 
mitochondrial distribution are necessary to fulfill spatial ATP requirements.  In the mouse, 
bursts of ATP production coincide with perinuclear mitochondrial translocation throughout 
meiotic maturation, specifically during germinal vesicle breakdown (GVBD), metaphase I 
(MI) spindle migration, MI to MII transition, and polar body (PB) extrusion (Van Blerkom, 
1991; Yu et al., 2010).  At the MII ovulated stage, some reports suggest mitochondria 
organize to the perinuclear region (Calarco, 1995; Kan et al., 2011; Nagai et al., 2006), while 
others indicate mitochondria are homogeneously distributed throughout the cytoplasm 
(Tokura et al., 1993; Van Blerkom, 2004; Yu et al., 2010).  In addition, a subcortical ring of 
high potential mitochondria is necessary for sperm penetration and consequently fertilization 
and meiotic maturation (Van Blerkom and Davis, 2007). 
Upon oocyte meiotic maturation, mitochondrial DNA replication ceases and does not 
resume until post-implantation (Larsson et al., 1998; Pikó and Chase, 1973; Pikó and Taylor, 
1987; Thundathil et al., 2005). This absence of mitochondrial DNA replication during 
cleavage stages of embryogenesis has been confirmed in mice (Ebert et al., 1988; Larsson et 
al., 1998; Pikó and Chase, 1973; Pikó and Taylor, 1987), rats (Meziane et al., 1989), pigs 
(Kameyama et al., 2007), and frogs (Shourbagy et al., 2006). Although mitochondrial 
numbers are anticipated to remain relatively constant within the preimplantation embryo, 
paradoxically after fertilization, this means that the mitochondrial complement per 
blastomere halves with each cell division in concert with an increased demand for ATP (Van 
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Blerkom, 2009; 2011).  Spatial distribution of mitochondria is also important throughout 
preimplantation development.  In mouse and human, mitochondria predominantly exhibit 
perinuclear localization in 1-cell (Tokura et al., 1993; Van Blerkom, 2000; Van Blerkom et 
al., 2000; Van Blerkom, 2009; Zhao et al., 2009) and 2-cell (Tokura et al., 1993; Van 
Blerkom et al., 2000; Van Blerkom, 2009; Wilding et al., 2001) embryos.  During cell 
cleavage, symmetrical segregation of mitochondria surrounding the pronuclei in 1-cell 
embryos and between blastomeres of 2-cell to 8-cell embryos is associated with enhanced 
developmental competence (Van Blerkom et al., 2000). By comparison, asymmetric 
distribution of mitochondria in early cleavage embryos can result in arrested division and 
lysis (Van Blerkom et al., 2000).  Beyond the 8-cell stage, mitochondria segregate 
differentially between outer and inner blastomeres (Van Blerkom et al., 2000) to ultimately 
establish a higher mitochondrial content in trophectoderm (TE) cells compared to inner mass 
cells (Assou et al., 2006; Houghton, 2006; St John et al., 2010; Thundathil et al., 2005).  This 
asymmetric distribution is likely required during cavitation to power the sodium-potassium 
adenosine triphosphatase (Na+/K+-ATPase) pump, which is present on the basolateral surface 
of TE cells, to enable blastocoel cavity formation (Houghton, 2006; Van Blerkom, 2008). 
Although numerous studies have analyzed mitochondrial dynamics during 
gametogenesis and preimplantation development, this knowledge is based on oocytes and 
embryos obtained through assisted reproductive technologies (ARTs).  However, ART 
treatments coincide with critical time points where mitochondria are highly replicative and 
drastically increase in numbers during oogenesis, distributed to provide stage-specific spatial 
ATP requirements, and sustained in a non-replicative state during preimplantation 
development. Few studies in mouse and human have described negative effects of ARTs on 
mitochondrial dynamics and function, with most focusing on oocyte freezing (Demant et al., 
2012; Jones et al., 2004; Lei et al., 2014; Manipalviratn et al., 2011; Martino et al., 2013; 
Wilding et al., 2001; Zander-Fox et al., 2013; Zhao et al., 2009).  These studies also have the 
confounding effects of superovulation/ovarian stimulation. Finally, there is an emerging 
interest in the role mitochondria play in epigenetic gene regulation (Martinez-Pastor et al., 
2013; Rathmell and Newgard, 2009; Wallace, 2010; Wallace and Fan, 2010; Wellen et al., 
2009).  More specifically, mitochondria provide the cell with its source of ATP, which 
powers chromatin-remodeling complexes and is needed for conversion of methionine to S-
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adenosylmethionine (SAM), the cells sole methyl donor required for histone and DNA 
methylation (Martinez-Pastor et al., 2013; Wallace, 2010). Additionally acetyl-coA required 
for histone acetylation is mainly derived from citrate, a byproduct derived solely from the 
mitochondria through the tricarboxylic acid (TCA) cycle (Wallace, 2010; Wallace and Fan, 
2010; Wellen et al., 2009).   Therefore, disruptions in mitochondrial numbers, dynamics 
and/or function could lead to perturbations in epigenetic gene regulation.   
Here, I investigated, for the first time, the effect of ovarian stimulation on 
mitochondrial levels, distribution, and function in mouse oocytes and preimplantation 
embryos under control and stimulated conditions.  As a detailed analysis of mitochondrial 
properties throughout all stages of preimplantation development has not been obtained, I 
analyzed mitochondrial dynamics in oocytes, and 1-cell, 2-cell, 4-cell, 8-cell, morula- and 
blastocyst-stage embryos. To assess if mitochondrial perturbation coincides with disrupted 
DNA methylation, I investigated levels of CHDH, an inner mitochondrial membrane enzyme 
required in the betaine pathway of methylation production, in control embryos and embryos 
obtained after hormone stimulation. Overall, the results of this novel study improves our 
knowledge of mitochondrial dynamics in control oocytes and preimplantation embryos, in 
addition to providing insight on the effect of hormone treatment on mitochondrial dynamics. 
3.2 Materials and Methods 
3.2.1 Ethics Statements, source of animals 
Experiments were performed in compliance with the guidelines set by the Canadian 
Council for Animal Care and the policies and procedures approved by the University of 
Western Ontario Council on Animal Care. 
3.2.2 Oocyte and embryo collection 
Metaphase II (MII) oocytes were collected from C57BL6/CAST7p6 [B6(CAST7p6)] 
x C57BL/6 (Charles River) F1 females at 6-8 weeks of age. These females have a Mus 
musculus castaneous (CAST) chromosome 7 and partial regions of chromosome 6 on a 
C57BL/6 (B6) background.  To obtain spontaneously ovulated oocytes, untreated females 
were examined for estrus and at noon the following day, the oviduct/ampulla was dissected 
and flushed in warmed M2 media (Sigma) to retrieve cumulus-oocyte-complexes.  For 
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superovulated oocytes, females were injected intraperitoneally (ip) with 6.25 IU or 10 IU 
equine chorionic gonadotropin (eCG) (Intervet Canada), followed 44-48 hours later by 
6.25 IU or 10 IU human chorionic gonadotropin (hCG) (Intervet Canada), respectively.  
Hormone concentrations of 6.25 IU and 10 IU were considered low and high hormone 
dosages, respectively. At noon the following day, superovulated cumulus-oocyte-complexes 
were flushed into warmed M2 media.  Spontaneous and superovulated oocytes were washed 
in 2-3 drops of M2 media containing 0.3 mg/mL hyaluronidase (Sigma) under mineral oil 
(Sigma) to denude surrounding cumulus cells. Pronuclear to blastocyst-stage embryos were 
derived from control and hormone-treated B6(CAST7p6) females crossed to B6 males. 
Embryos were retrieved from oviducts/uteri at 0.5 days postcoitum (dpc) (1-cell), 1.5 dpc (2-
cell), 2 dpc (4-cell) and 2.5 dpc (8-cell), 3 dpc (morula) and 3.5 dpc (blastocyst). 
3.2.3 Total mitochondrial quantification 
To analyze total mitochondrial pools, at least 40 spontaneously ovulated, hormone-
treated oocytes and ~20 1-cell, 2-cell, morula and blastocyst-stage embryos from control and 
hormone-treated females were stained with 0.250 µM Mitotracker® Green FM (Molecular 
Probes, Invitrogen) in M2 media under mineral oil for 30 minutes at 37°C and 5% CO2 in air.  
Following this, DNA was stained in M2 drops containing Hoechst 33342 (1:200 dilution) for 
15 minutes at 37°C and 5% CO2 in air.  For imaging, individual oocytes and embryos were 
immediately transferred to 4 µL M2 drops under mineral oil in glass bottom dishes (MatTek 
Corporation). The Olympus FluoViewTM FV1000 coupled to the IX81 Motorized Inverted 
System Microscope (IX2 series) confocal scanning microscope was used to obtain live cell 
images compiled of Z stacks of 4 µm slices. During image acquisition the microscope was 
kept warm at 37oC. To maintain consistent fluorescence intensity values between samples 
imaged on different days, acquisition parameters were identical for all oocytes (filter, 490 
HV; Gain, 1; Offset, 2%), and embryos (filter, 445 HV; Gain, 2; Offset 2%).  Determination 
of total Mitotracker green signal intensity was done using Volocity 6.3 Image Analysis 
Software (Perkin Elmer). For quantification, each oocyte or embryo was outlined to create a 
region of interest (ROI). The ROI for MII oocytes included all cytoplasm contained within 
the cortex and excluded the polar body, while the ROI for embryos included the area encased 
in the zona pellucida to maintain consistency between embryos. Mean total Mitotracker 
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fluorescence was calculated from the fluorescence intensity of all samples within a group and 
is represented in relative fluorescence units (RFU).  A minimum of 3 females were used for 
both oocyte and embryo collections, for all control and hormone treatment groups.  
3.2.4 Active mitochondrial quantification 
To analyze the active mitochondrial pools and the localization of active mitochondria, 
at least 40 spontaneously ovulated and hormone-treated oocytes were stained with 
Mitotracker® Red CMXRos (Molecular Probes, Invitrogen) at a final concentration of 
0.250 µM in M2 media under mineral oil for 30 minutes at 37°C and 5% CO2 in air.  
Subsequently, DNA was stained in M2 drops containing Hoechst 33342 (1:200 dilution) for 
15 minutes at 37°C and 5% CO2 in air.  For preimplantation embryos, a minimum of 20 
control and hormone-treated 1-cell, 2-cell, 4-cell, 8-cell, morula and blastocyst-stage 
embryos were stained using the same parameters as oocytes.  Individual oocytes and embryos 
were immediately transferred to 4 µL M2 drops under mineral oil in glass bottom dishes for 
imaging.  Confocal images were obtained using identical acquisition parameters for all 
Mitotracker red MII oocytes, 1-cell and 2-cell embryos (filter, 400 HV; Gain, 1; Offset, 2%) 
and Mitotracker red 4-cell, 8-cell, morula- and blastocyst-stage embryos (filter, 370 HV; 
Gain, 1; Offset, 2%).  Mean total Mitotracker red fluorescence was calculated as described 
above for Mitotracker green using Volocity. At least 3 females were used for both 
spontaneous and superovulated oocyte and embryo collections.  
3.2.5 Quantification of blastocyst cell number and blastocyst volume 
Cell counting for blastocysts embryos was performed using Hoechst staining and was 
done from the top to the bottom of each embryo Z-stack using images from the Olympus 
FluoViewTM FV1000 system (Market-Velker et al., 2012).  Blastocyst cavity volume was 
calculated using two perpendicular measurements of blastocyst cavity length (μm) obtained 
with Volocity software.  Then lengths were then averaged and halved to determine an 
average radius, and cavity volume was calculated using the formula for a sphere. 
3.2.6 Quantification of superoxide levels 
Superoxide accumulation in control and 10 IU blastocysts was determined by live cell 
immunofluorescence staining with 5 µM MitoSOX Red (Molecular Probes, Invitrogen) for 
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30 minutes at 37°C and 5% CO2 in air, followed by DNA detection via Hoechst 33342 (1:200 
dilution) staining for 15 minutes at 37°C and 5% CO2 in air. Following imaging as described 
above, mean total MitoSOX Red fluorescence was calculated. At least 3 females were used 
for both control and hormone-treated oocyte and embryo collections. 
3.2.7 Immunohistochemistry 
For immunohistochemistry analyses, control and hormone-treated embryos were 
flushed into warmed M2 medium, washed in 1X PBS and fixed in 4% PFA for 30 minutes.  
Following fixation, embryos were permeabilized for 40 minutes in 0.5% Triton-X-100 
(Sigma) in 1X PBS, blocked for 1 hour in 5% normal goat serum (NGS) (Jackson 
ImmunoResearch), and incubated with 1:50 anti-Tom20 FL-145 (Santa Cruz Biotechnology), 
1:100 CHDH (Proteintech), or 1:200 histone 3 lysine 9 dimethylation (H3K9me2) (Abcam) 
overnight at 4°C.  The next day, embryos were washed three times in antibody dilution buffer 
(ADB, 0.005% Triton-X-100 and 1% NGS in 1X PBS), incubated with appropriate 
secondary antibody in ADB (1:200) for 1 hour followed by Hoechst 33342 (1:200 dilution) 
staining for 20 minutes.  Embryos were then washed 3 times before imaging in 4 µL M2 
drops under mineral oil in glass bottom dishes.  Negative controls without primary antibody 
incubation were processed with experimental groups. 
3.2.8 Statistical analyses 
Significant differences in total mitochondrial distribution for MII oocytes and active 
mitochondrial distribution in MII oocytes, 1-cell and 2-cell embryos were analyzed using 
one-way ANOVA followed by the nonparametric Kolmogorov-Smirnov (KS) test to analyze 
differences between pairs.  The nonparametric KS test was used to analyze distribution 
differences between the control and treatment groups for total mitochondria in 1-cell and 2-
cell embryos and active mitochondria in 4-cell, 8-cell, morula and blastocyst embryos.  
Statistics for fluorescence intensity analyses for total mitochondria in MII oocytes and active 
mitochondria in MII oocytes, 1-cell and 2-cell embryos were performed using one-way 
ANOVA followed by Student’s t-test, while Student’s t-test was used to identify significance 
between control and hormone-treated 1-cell, 2-cell (total mitochondria, CHDH intensity) 4-
cell, 8-cell (active mitochondria), morula and blastocyst embryos (total and active 
mitochondria, CHDH and H3K9me2 [blastocysts]). All mean fluorescence intensity bar 
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graph values are presented as mean ± standard error of the mean (SEM).  A p-value of 
p<0.01 was considered to be statistically significant.  
3.3 Results 
3.3.1 Superovulation disrupted total and active mitochondrial pool 
and active mitochondrial distribution in MII ovulated oocytes 
Adequate mitochondrial numbers and mitochondrial activity are required for 
successful meiotic maturation (Yu et al., 2010). To investigate the effects of superovulation 
on the total mitochondrial pool in MII ovulated oocytes, live-cell immunofluorescence data 
was first obtained for 50 spontaneous, 57 6.25 IU superovulated and 62 10 IU superovulated 
oocytes using Mitotracker green and Hoechst 33342 staining.  Mitotracker green stains all 
mitochondria membranes irrespective of respiratory status and thus is a measure of the total 
mitochondrial pool.  Compared to control and the 6.25 IU groups, the total mitochondrial 
pool was significantly decreased in the 10 IU high hormone treatment group (Figure 3-1A).   
Since the high hormone dose disrupted the total mitochondrial pool in oocytes, this 
may result in a concomitant decrease in the pool of active mitochondria. I therefore assessed 
the active mitochondria pool in oocytes using Mitotracker red imaging in 48 spontaneously 
ovulated, 68 6.25 IU superovulated and 67 10 IU superovulated oocytes.   Mitotracker red is 
a dye that specifically stains mitochondria that are actively respiring through oxidative 
phosphorylation, since its accumulation is dependent on oxidation.  Compared to 
spontaneous controls, a significant decrease in the respiring mitochondrial pool was present 
at both 6.25 IU and 10 IU hormone dosages (Figure 3-1B). 
As mitochondria are dynamic organelles and translocate to different regions of the 
cytoplasm in oocytes and early embryos, I assessed the distribution of total mitochondria in 
spontaneous and superovulated oocytes.  Three distinct distribution patterns were observed, 
perinuclear, homogenous, and clustered aggregates, with the latter either to one side of the 
chromosomes or as clumps dispersed throughout the cytoplasm (Figure 3-1C).  With respect 
to total mitochondria, the majority of spontaneous, 6.25 IU, and 10 IU superovulated oocytes 
had perinuclear mitochondrial localization (86%, 77%, and 77% oocytes, respectively), with 
low percentages of oocytes exhibiting homogenous (2%, 5% and 8%, respectively) and 
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clustered aggregate (12%, 18% and 15%, respectively) patterns (Figure 3-1C). These 
distributions were not significantly different.  Of note is that within the clustered distribution 
category, oocytes possessed mitochondria that were clustered proximal to the DNA (75% 
spontaneous; 36% 6.25 IU; 50% 10 IU), distal to the DNA (12.5% spontaneous; 43% 
6.25 IU; 40% 10 IU), or in aggregates throughout the cytoplasm (12.5% spontaneous; 21% 
6.25 IU; 10% 10 IU) (Figure 3-1D).  These distributions were not significantly different, 
although 6.25 IU and 10 IU oocytes trended toward decreased proximal clustering. 
 Perinuclear translocation of active mitochondria during oogenesis is essential for 
oocyte competence (Calarco, 1995; Nagai et al., 2006; Van Blerkom, 1991; Yu et al., 2010). 
Therefore, I analyzed whether actively respiring mitochondria were correctly localized to the 
perinuclear region in spontaneous oocytes, and whether superovulation disrupted this 
organization (Figure 3-1E).  Similar to total mitochondrial distribution, perinuclear, 
homogenous, and clustered aggregate patterns were observed for active mitochondria.  
However, unlike total mitochondria, distribution of active mitochondria was predominantly 
perinuclear (92% oocytes; 4% homogenous; 4% clustered) in spontaneous oocytes, while 
6.25 IU and 10 IU hormone-treated oocytes had significantly decreased perinuclear 
localization (50%, 60%) and increased homogenous (26%, 22%) and clustered aggregate 
(24%, 18%) distributions, respectively (Figure 3-1E).  Within the clustered distribution 
category, oocytes had mitochondrial clusters proximal to the DNA (100% spontaneous; 62% 
6.25 IU; 58% 10 IU), distal to DNA (0% spontaneous; 38% 6.25 IU; 30% 10 IU), and in 
clustered aggregates throughout the cytoplasm (0% spontaneous; 0% 6.25 IU; 8% 10 IU) 
(Figure 3-1F).   These patterns were not significantly different, although 6.25 IU, and 10 IU 
superovulated oocytes seemed to exhibit decreased proximal clustering compared to controls. 
Overall, oocytes obtained after high-hormone treatment exhibited a significant 
decrease in both the total mitochondrial and active mitochondrial pools.  In contrast, the low 
hormone dose group exhibited a decreased pool of active mitochondria only.  Total 
mitochondria were correctly localized to the perinuclear region in spontaneous, 6.25 IU and 
10 IU oocytes.  However, active mitochondria were mislocalized as a result of both low and 
high hormone treatment, displaying increased homogenous and clustered aggregate patterns 
and decreased perinuclear accumulation. 
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Figure 3-1: Superovulation disrupts mitochondria in MII ovulated oocytes 
(A) The total mitochondrial pool, calculated from average total Mitotracker green 
fluorescence intensity in oocytes, was significantly decreased in the 10 IU hormone treatment 
group.  (B) The active mitochondrial pool, calculated using total Mitotracker red 
fluorescence intensity in oocytes, was significantly decreased in both 6.25 IU and 10 IU 
hormone treated groups.  (C) Distribution of total mitochondria in spontaneously ovulated 
(Spon), 6.25 IU and 10 IU superovulated oocytes was predominantly perinuclear, with a 
small percentage of oocytes displaying homogenous and clustered aggregate patterns. 
Quantification of distributions is represented as percentage of total oocytes analyzed. (D) 
With respect to the clustered total mitochondrial distribution, spontaneously ovulated oocytes 
primarily displayed mitochondrial clustering proximal to the DNA, while the 6.25 IU and 
10 IU superovulated oocytes exhibited mitochondrial clustering proximal to the DNA, distal 
to the DNA, or in clustered aggregates throughout the cytoplasm. (E) Distribution of active 
mitochondria in spontaneously ovulated oocytes was a perinuclear ring.  6.25 IU and 10 IU 
superovulated oocytes displayed perinuclear localization in addition to aberrant homogenous 
and clustered aggregate patterns. Quantification of distributions is depicted as percentage of 
total oocytes. (F) For clustered active mitochondrial distribution, spontaneously ovulated 
oocytes displayed mitochondrial clustering proximal to the DNA, while the 6.25 IU and 
10 IU superovulated oocytes exhibited mitochondrial clustering proximal to the DNA as well 
as distal to the DNA and/or in clustered aggregates throughout the cytoplasm.  
Representative images are shown.  Quantification of mitochondrial fluorescence intensity 
was calculated as the mean relative fluorescence units (RFU) in millions ± SEM for each 
oocyte group. Numbers in parentheses indicate total number of oocytes analyzed per group.  
Asterisks (*) indicate significant differences where p<0.01 determined by one-way ANOVA 
followed by nonparametric Kolmogorov-Smirnov test. DAPI DNA staining, blue (A, B) or 
magenta (C-F); Mitotracker green staining of total mitochondria, green (A); Mitotracker red 
staining of active mitochondria, red (B); white scale bar, 20 µm.  Pseudocolour imaging was 
applied to analyze mitochondrial distribution (C-F).  Pseudocolour scale is shown in panel C. 
132 
 
3.3.2 Total mitochondrial pool was stable throughout preimplantation 
development 
To determine whether a decreased total mitochondrial pool persisted in early 
cleavage-stage embryos following superovulation, control and 10 IU 1-cell and 2-cell 
embryos were stained with Mitotracker green and subjected to live-cell immunofluorescence.  
The 6.25 IU low hormone group was not analyzed, as no significant decrease was observed 
in oocytes, and since mitochondria DNA does not replicate post-ovulation and mitochondrial 
numbers are anticipated to decrease by approximately half with successive cell division 
(Larsson et al., 1998; Pikó and Chase, 1973; Pikó and Taylor, 1987). At the 1-cell and 2-cell 
stage, no significant difference in the total mitochondrial pool was detected in the control and 
10 IU treatment groups (Figure 3-2A, B). I next analyzed the distribution of total 
mitochondria within individual blastomeres of 1-cell and 2-cell embryos.  Both the control 
and 10 IU superovulated groups exhibited a homogenous distribution at the 1-cell stage 
(Figure 3-2C) and perinuclear distribution at the 2-cell stage (Figure 3-2D).  Since there was 
no change in total mitochondrial numbers at the 1-cell and 2-cell stages, I proceeded to 
analyze the total mitochondrial pool at the morula and blastocyst stages using Mitotracker 
green. No significant difference in the total mitochondrial pool was observed between morula 
(Figure 3-3A) and blastocysts (Figure 3-3B) in the control and 10 IU hormone-treated 
groups. Overall, 10 IU hormone-treated 1-cell, 2-cell, morula and blastocyst-stage embryos 
displayed similar total mitochondrial pools to their control counterparts. These results 
indicate that the total mitochondrial pool during preimplantation development is relatively 
stable following superovulation. 
3.3.3 Total mitochondria distribution is unchanged throughout 
preimplantation development 
Symmetrical mitochondrial distribution between blastomeres in early preimplantation 
embryos is important for competence (Van Blerkom et al., 2000).  A previous study indicated 
that human 1-cell to 8-cell preimplantation embryos with an uneven distribution of 
mitochondria were developmentally compromised (Van Blerkom et al., 2000).  To analyze 
whether superovulation alters the symmetrical distribution of mitochondria surrounding 
pronuclei in 1-cell embryos and between blastomeres in 2-cell embryos, embryos from 
control and 10 IU hormone-treated females were classified as either having symmetrical 
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(even) or asymmetrical (uneven) mitochondrial segregation.  For 1-cell pronuclear embryos, 
this was analyzed as the distribution of mitochondria surrounding the pronuclei.  The 
majority of 1-cell and 2-cell embryos in the both control and hormone-treated groups 
exhibited a symmetrical distribution of mitochondria surrounding pronuclei in 1-cell embryos 
(Figure 3-E) or between blastomeres of 2-cell embryos (Figure 3-2F), respectively, with no 
significant differences between groups (Figure 3-2E, F). Overall, mitochondrial localization 
was predominantly symmetrical in both control and hormone-treated 1-cell and 2-cell 
embryos.   
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Figure 3-2: Total mitochondrial pool and distribution in 1-cell and 2-cell embryos 
(A, B) Total mitochondrial pool quantification, calculated using Mitotracker green relative 
fluorescence units (RFU) (millions ± SEM), in 1-cell (A) and 2-cell (B) stage control (Ctrl) 
and 10 IU hormone-treated embryos.  (C, D) Representative pseudocolour conversion slices 
and quantification of the percent of total embryos showing a homogenous distribution of total 
mitochondria at the 1-cell stage (C) and a perinuclear distribution of total mitochondria at the 
2-cell stage (D). (E, F) Representative pseudocolour images and percentage of total embryos 
with a symmetrical (even segregation) or asymmetrical (uneven segregation) distribution of 
total mitochondria surrounding pronuclei at the 1-cell stage (E) and between blastomeres at 
the 2-cell stage (F) are shown.  DAPI DNA staining, blue (A, B) or magenta (C-F); 
Mitotracker green staining of total mitochondria, green (A, B); Mitotracker green staining, 
pseudocolour (C-F).  Pseudocolour scale is shown in panel C; numbers in brackets indicates 
the total number of embryos analyzed per Spon and 10 IU treatment groups; white scale bar 
is 20 µm. 
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Figure 3-3: Total mitochondrial pool in morula- and blastocyst-stage embryos 
Total mitochondrial pool quantification was measured as Mitotracker green relative 
fluorescence units (RFU) (millions ± SEM) in control (Ctrl) and 10 IU hormone-treated 
morula (A) and blastocysts (B).  Representative Z-stack images are shown.  DAPI DNA 
staining, blue; Mitotracker green staining of total mitochondria, green. Numbers in 
parentheses indicate total number of embryos analyzed per group; scale bar is 20 µm. 
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3.3.4 Superovulation affected mitochondrial activity but not 
mitochondrial organization at early cleavage stages  
In addition to total mitochondria pools, I next investigated if the active mitochondrial 
pool is perturbed in superovulated early cleavage embryos.  Compared to controls, the 
decreased active mitochondrial pool in superovulated oocytes persisted in 1-cell (Figure 3-
4A) and 2-cell (Figure 3-4B) embryos in the hormone groups. This effect was dose-
dependent.  However, no significant difference was seen in the active mitochondrial pool 
between 4-cell (Figure 3-4C) or 8-cell (Figure 3-4D) embryos in control and 10 IU groups.   
Since perinuclear accumulation of active mitochondria was disrupted in 
superovulated oocytes, I evaluated distribution of active mitochondria in cleavage embryos.  
Similar to perinuclear active mitochondria in control oocytes (91.6%; Figure 1-1E), the 
majority of 1-cell (100%; Figure 3-5A) and 2-cell (93.3%; Figure 3-5B) embryos in the 
untreated group maintained perinuclear distribution. Beginning at the 4-cell stage, active 
mitochondria move to a cortical arrangement in 4-cell (100%; Figure 3-5C) and 8-cell 
(81.5%; Figure 3-5D) embryos. Embryos in superovulated groups displayed a statistically 
similar perinuclear distribution to the controls at 1-cell (96.4% 6.25 IU, 82.9% 10 IU; Figure 
3-5A) and 2-cell (93.3% 6.25 IU, 85.7% 10 IU; Figure 3-5B) stages, and a primarily cortical 
distribution at the 4-cell (95.2% 10 IU, Figure 3-5C) and 8-cell (81.6% 10 IU, Figure 3-5D) 
stages. Thus, active mitochondrial distribution defects in superovulated oocytes were no 
longer evident in blastomeres of superovulated 1-cell, 2-cell, 4-cell and 8-cell embryos. 
Symmetrical distribution of mitochondria exists in competent early cleavage embryos 
(Van Blerkom et al., 2000). To determine if superovulation resulted in asymmetric 
distribution of mitochondria surrounding pronuclei of the 1-cell embryo and between 
blastomeres of cleavage stage embryos, embryos were classified as having symmetric or 
asymmetric distribution. The majority of 1-cell (81.8% control, 100% 6.25 IU, 94.3% 10 IU; 
Figure 3-6A), 2-cell (90% control, 93.3% 6.25 IU, 82.1% 10 IU; Figure 3-6B), and 4-cell 
(95.2% control, 90.5% 10 IU; Figure 3-6C) embryos in the control and hormone groups 
displayed a statistically similar symmetrical distribution of active mitochondria.  Although 
not statistically significant, compared to controls (92.6%, Figure 3-6D), the symmetrical 
distribution in 10 IU 8-cell embryos (73.7%) was slightly decreased.  
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Figure 3-4: Active mitochondrial pool in early cleavage stage embryos 
Active mitochondrial pool quantification in 1-cell (A), 2-cell (B), 4-cell (C) and 8-cell (D) 
early cleavage stage embryos. Representative Z-stack images are shown.  Quantification of 
active mitochondrial pool was calculated as the mean total Mitotracker red fluorescence units 
(RFU in millions ± SEM).  Numbers in parentheses indicate the total number of embryos 
analyzed.  DAPI DNA staining, blue; Mitotracker red staining of active mitochondria, red; 
scale bar, 20 µm; Ctrl, control. 
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Figure 3-5: Active mitochondrial distribution in early preimplantation embryos 
Representative pseudocolour conversion slices of embryos showing active mitochondria 
moving from a perinuclear distribution at the 1-cell (A) and 2-cell (B) stage to a cortical 
distribution at the 4-cell (C) and 8-cell (D) stages. This occurred in both control (Ctrl) and 
10 IU embryos.  Quantification of perinuclear (A, B) and cortical (C, D) staining is 
represented as the percentage of total embryos analyzed.  DAPI DNA staining, magenta; 
Mitotracker red staining, pseudocolour (scale in panel A).  Numbers in brackets indicate the 
total number of embryos analyzed per group and the scale bar is 20 µm. 
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Figure 3-6: Mitochondrial segregation between pronuclei and blastomeres in early 
preimplantation embryos 
Embryos at the 1-cell (A), 2-cell (B), 4-cell (C), and 8-cell (D) stage were classified as 
having symmetrical (Sym, even segregation) or asymmetrical (Asym, uneven segregation) 
distribution of active mitochondria between blastomeres.  Representative pseudocolour 
image slices of symmetrical and asymmetrical distributions are shown above each graph.   
Graphs display the percentage of control (Ctrl), 6.25 IU and 10 IU embryos displaying either 
distribution.  The pseudocolour scale is shown in panel B.  DAPI DNA staining, magenta; 
Mitotracker red staining of active mitochondria, pseudocolour; white bar, 20 µm.  
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Overall, the active mitochondrial pool was significantly reduced in a dose-dependent 
manner in superovulated 1-cell and 2-cell embryos, but this effect was not observed at 4-cell 
and 8-cell stages.  Furthermore, active mitochondria were correctly localized in control and 
hormone-stimulated 1-cell to 8-cell embryos, specifically to the perinuclear region at 1-cell 
and 2-cell stages, to the cortical region at 4-cell and 8-cell stages, and symmetrically around 
pronuclei and between blastomeres from 1-cell to 8-cell stages.  Thus, ovarian stimulation 
led to reduced active mitochondrial pools up to the 2-cell stage, after which there were no 
significant differences between control and hormone-stimulated early cleavage embryos. 
3.3.5 Superovulation perturbs mitochondria in morula and blastocyst-
stage embryos 
A previous study on human preimplantation embryos demonstrated asymmetrical 
mitochondrial distribution in developmentally competent late (12-16 cell) cleavage embryos 
(Van Blerkom et al., 2000). To determine the effects of superovulation on mitochondrial 
distribution between blastomeres in morula- and blastocyst-stage embryos, pseudocolour 
imaging was applied to Mitotracker green and Mitotracker red staining to allow 
characterization of mitochondrial intensity in individual blastomeres of an embryo.  
Blastomeres were classified as having low (primarily blue pseudocolour), medium (mostly 
green/yellow pseudocolour) or high (primarily red/white pseudocolour) amounts of 
mitochondria (i.e. Mitotracker red, 10 IU morula #84; 12 low; 4 medium; 10 high; Figure 3-
7A-J). Since a previous study identified increased levels of total mitochondria in 
trophectoderm compared to inner cell mass cells at the blastocyst stage (Houghton, 2006), I 
assessed inner and outer cells separately for total mitochondrial levels and active 
mitochondria levels. For total mitochondria distribution, in both control and 10 IU groups, 
inner blastomeres possessed low total mitochondria compared to outer blastomeres. 
Furthermore, no significant difference was observed in the percent of inner blastomeres with 
low levels of total mitochondria between control and 10 IU embryos. However, for outer 
blastomeres, compared to controls, blastomeres of embryos in the 10 IU group exhibited an 
increased percentage of blastomeres with low total mitochondria in both morula (control 
18.3%; 10 IU 31.9%, Figure 3-7K) and blastocysts (control 33.7%; 10 IU 50.2%, Figure 3-
7L).  Additionally in blastocysts, outer cells in the 10 IU embryo group had significantly 
decreased high total mitochondria (24.9% control, 8.8% 10 IU; Figure 3-7L). 
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Figure 3-7: Total mitochondrial distribution in morula- and blastocyst-stage embryos 
In morula- and blastocyst-stage preimplantation embryos, blastomeres were classified as 
having low (L, primarily blue pseudocolour), medium (M, mostly green/yellow 
pseudocolour) or high (H, primarily red/white pseudocolour) amounts of total mitochondria.  
Individual slices (A-J, example Mitotracker red 10 IU morula #84) of each embryo were 
analyzed, and each blastomere was followed throughout a subset of slices (see arrows for 
examples) to determine its classification.  (K) Early morula- and (L) blastocyst-stage 
embryos were divided into inner and outer cells for analysis. Representative morula (K) and 
blastocyst (L) are shown, with percentage of total blastomeres showing each distribution 
depicted in each graph.  DAPI DNA staining, magenta; (A-J) Mitotracker red staining of 
active mitochondria, pseudocolour; (K, L) Mitotracker green staining of total mitochondria, 
pseudocolour; white bar, 20 µm; Ctrl, control. Pseudocolour scale bar is shown under panel J. 
Asterisks indicate significant differences determined by Student’s T-test.  
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My assessment of mitochondrial activity with Mitotracker Red revealed that morula 
(Figure 3-8A) and blastocysts (Figure 3-8B) in the 10 IU group had a significant decrease in 
the active mitochondria pool compared to controls.  At the blastomere level, morula and 
blastocysts in both control and 10 IU groups had an asymmetrical distribution of active 
mitochondria between outer and inner blastomeres, with inner blastomeres primarily 
displaying low mitochondrial activity.  
For outer blastomeres, compared to the control group, embryos in the 10 IU group 
displayed a significantly decreased percentage of blastomeres with high mitochondrial 
activity in morula (control 50.9%; 10 IU 26.8%, Figure 3-8C) and blastocysts (control 
53.3%; 10 IU 21.1%, Figure 3-8D).  This coincided with a decreased percentage of 
blastomeres with low (morula control 19.5%; 10 IU 35.2%, Figure 3-8C; blastocysts control 
14.5%; 10 IU 34.0% Figure 3-8D) and medium (morula control 29.6%; 10 IU 37.9%, Fig. 
8C; blastocysts control 32.2%; 10 IU 44.8%, Figure 3-8D) amounts of active mitochondria in 
embryos obtained after hormone treatment.   
By comparison, inner blastomeres were indistinguishable between control and 10 IU 
morula-stage embryos (Figure 3-8C).  However, inner cells of blastocysts from the 10 IU 
group displayed a decreased percentage of blastomeres with low amounts of active 
mitochondria (control 96.6%, 10 IU 89.0%) and an increased percentage of blastomeres with 
medium amounts of active mitochondria (control 3.4%, 10 IU 10.3%, Figure 3-8D).   
On an individual embryo basis, few control morula (7%, Figure 3-9A) and blastocysts 
(4% Figure 3-9B) had less than 15% of outer blastomeres with high mitochondrial activity. 
By comparison, in the 10 IU group, approximately half of the morula (44%, Figure 3-9A) 
and blastocysts (56% Figure 3-9B) had less than 15% of blastomeres with high amounts of 
active mitochondria.  
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Figure 3-8: Active mitochondria intensity and distribution in morula and blastocysts 
Active mitochondrial pool quantification, calculated from total Mitotracker red fluorescence 
intensity, in morula- (A) and blastocyst-stage (B) control (Ctrl) and 10 IU hormone-treated 
embryos.  Representative Z-stack images are shown along with mean relative fluorescence 
units (RFU) in millions ± SEM for each group.  Active mitochondrial distribution in inner 
and outer blastomeres of morula (C) and blastocysts (D) depicted as percentage of 
blastomeres with low (L, primarily blue pseudocolour), medium (M, mostly green/yellow 
pseudocolour) or high (H, primarily red/white pseudocolour) amounts of active 
mitochondria. Representative slices are shown. DAPI DNA staining, magenta; Mitotracker 
red staining of active mitochondria, red (A, B) and pseudocolour (C, D); white bar, 20 µm; 
Ctrl, control. Pseudocolour scale bar is shown in panel D. Asterisks indicate significant 
differences.
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Figure 3-9: Active mitochondrial distribution patterns in individual morula and 
blastocysts 
Distribution of active mitochondria in individual (A) control morula, (B) hormone-stimulated 
morula, (C) control blastocysts and (D) hormone-stimulated blastocysts.  Data is arranged 
(left to right) in decreasing percentage of blastomeres with high (purple bars), then medium 
(green bars), then low (orange bars) percentage amounts of active mitochondria. The dotted 
black line represents where 15% of blastomeres within an embryo have high amounts of 
active mitochondria.  
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Since ATP is utilized by the Na+/K+-ATPase pump in trophectoderm cells, and this is 
required for successful cavitation and blastocyst formation (Madan et al., 2007), I assessed 
cell number (total, inner and outer) (Figure 3-10A) and blastocyst cavity volume (Figure 3-
10B) in control and 10 IU blastocysts.  Compared to controls, total cell numbers (Figure 3-
10C), outer cell numbers and inner cell numbers  (Figure 3-10D) were significantly increased 
in the 10 IU blastocyst group compared to controls, while blastocyst cavity volume was not 
significantly different (Figure 3-10E). 
Overall, late preimplantation embryos exhibited an asymmetrical distribution of both 
total and active mitochondria.  In comparison to control embryos, morula and blastocysts 
from the 10 IU hormone group exhibited an increase in the proportion of outer cells 
exhibiting low amounts of mitochondria, both total and active.  In addition, high total 
mitochondria in blastocysts and high active mitochondria in morula and blastocysts were 
significantly decreased in outer cells of embryos in the 10 IU hormone group.  The decrease 
in active mitochondria in outer cells of blastocysts was not associated with decreased 
blastocyst cell number or cavity volume. 
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Figure 3-10: Cell number and blastocyst cavity volume 
Merge of bright field and DAPI staining for (A) cell counts and (B) blastocyst cavity volume.  
(C) Total cell number and (D) outer and inner cell numbers and (E) blastocyst cavity volume 
in control and 10 IU blastocysts.  Asterisks indicate significant differences determined by 
Student’s t-test and numbers in parentheses indicate the number of embryos analyzed.  DAPI 
DNA staining, blue; white bar, 20 µm.  Representative embryos are shown with embryo 
number indicated on the top left of bright field images and cell number (A) and cavity 
volume (B) indicated at the bottom right.  Red line (1), horizontal cavity length; green line 
(2), vertical cavity length. 
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3.3.6 Superovulation does not alter TOM20 levels but increases 
superoxide accumulation 
To determine if mitochondrial function was affected following ovarian stimulation, 
levels of the mitochondrial import protein translocase of outer membrane 20 (TOM20) and 
oxidative stress was assessed. Nuclear-mitochondrial cross talk is vital for proper control of 
gene expression and mitochondrial function (Woodson and Chory, 2008).  Nuclear-encoded 
proteins are imported into the mitochondria to control its function in response to cellular 
demand (Jiang and Wang, 2012; Mootha et al., 2003).  TOM20 specifically targets the outer 
mitochondrial membrane and is responsible together with TOM22 to recognize and import 
cytosolic N-terminal mitochondrial preproteins (Baker et al., 2007; Perry et al., 2008).  Since 
import of nuclear-encoded cytosolic proteins is crucial for mitochondrial function, TOM20 
protein expression was analyzed by immunofluorescence in blastocysts from control and 
10 IU superovulated females.  No significant difference in TOM20 levels was observed 
between blastocysts in the control and 10 IU hormone groups (Figure 3-11A).  Furthermore, 
there was no difference in the distribution of TOM20 between inner (control 80.0%, 10 IU 
79.1%) and outer (control 73.2%, 10 IU 76.7%) blastomeres of these embryos, where the 
majority displayed medium levels of TOM20 immunofluorescence (Figure 3-11B). 
Mitochondrial dysfunction in aged oocytes has been attributed to increased oxidative 
stress causing oxidative damage (Chappel, 2013; Venkatesh et al., 2010).  To assess whether 
superovulation leads to increased oxidative stress, I analyzed the accumulation of superoxide, 
a reactive oxygen species (ROS) produced as a byproduct of mitochondrial respiration, using 
MitoSOX live-cell immunofluorescence. Oxidation of MitoSOX by superoxide produces red 
fluorescence.  Compared to controls, blastocysts in the 10 IU group displayed significantly 
increased superoxide intensity levels (Figure 3-11C).  To identify if accumulation of 
superoxide is more prevalent in inner or outer cells, pseudocolour imaging was applied and 
cells were quantified as having low, medium or high superoxide levels.  Control blastocysts 
exhibited low superoxide in both inner (100%) and outer (89.3%) cells (Figure 3-11D).  In 
contrast, while no significant difference in superoxide accumulation was observed between 
inner cells of control blastocysts versus the 10 IU hormone group (97.5% low, Figure 3-
11D), outer cells of the hormone group exhibited a significant increase in blastomeres with 
medium superoxide levels (37.1%), and decrease in cells with low superoxide levels (58.1%). 
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Figure 3-11: TOM20 and superoxide in control and 10 IU blastocysts 
(A) TOM20 protein levels in control (Ctrl) and 10 IU blastocysts.  Data were analyzed as 
relative fluorescence units (RFUs) ± SEM. DAPI, blue; TOM20 protein, red.  (B) Percentage 
of outer and inner blastomeres with low (L), medium (M) or high (H) amounts of TOM20 
immunofluorescence. (C) MitoSOX staining of superoxide levels in control (Ctrl) and 10 IU 
blastocysts.  Data were analyzed as RFUs ± SEM. (D) Percentage of outer and inner 
blastomeres with low (L), medium (M) or high (H) superoxide levels. Representative Z-
stacks (A, C) and slices (B, D) are shown. Number in parentheses indicate the total number 
of embryos analyzed.  DAPI DNA staining, blue; MitoSOX staining, red; pseudocolour L, 
primarily blue, pseudocolour M, mostly green/yellow; pseudocolour H, primarily red/white. 
The pseudocolour scale bar is shown in panel B and the white bars measure 20 µm.  
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3.3.7 CHDH protein levels  
Another function of mitochondria is to produce a proportion of the metabolites 
required for epigenetic control of nuclear gene expression.  For example, methylation groups, 
provided by the methyl donor S-adenosylmethionine (SAM), in the blastocyst are derived 
through two 1-carbon metabolic pathways (Ikeda et al., 2012); the folate cycle and the 
betaine-homocysteine methyltransferase (BHMT) pathway (Zhang et al., 2015).  The BHMT 
pathway requires the enzyme choline dehydrogenase (CHDH).  Choline dehydrogenase 
localizes to the inner mitochondrial membrane where it catalyzes the 2-step conversion of 
choline to betaine.  This specific pathway is active in mouse blastocysts (Anas et al., 2008; 
Lee et al., 2012).  Furthermore, Chdh deletion in mouse (Johnson et al., 2010) and a single 
nucleotide polymorphism in the human CHDH that decreases CHDH protein levels (Johnson 
et al., 2012) perturbs mitochondrial function in sperm and results in decreased sperm 
motility, indicating a role for CHDH in mitochondrial function. Thus, CHDH dysregulation 
has the potential to disrupt both mitochondrial function and DNA methylation. Since CHDH 
is a maternal effect protein, levels were analyzed in fertilized 1-cell embryos by CHDH 
protein immunofluorescence. There was a significant decrease in CHDH protein 
immunofluorescence, as measured by total RFUs, in 1-cell embryos derived from 10 IU 
hormone-treated females compared to controls (Figure 3-12A).  I next assessed the levels of 
CHDH and global H3K9me2, a repressive histone methylation mark, in control and 10 IU 
blastocysts.  In contrast to 1-cell embryos generated after ovarian stimulation, there was no 
longer a significant difference in CHDH protein levels (Figure 3-12B).  Furthermore, global 
levels of the repressive histone 3 lysine 9 dimethylation (H3K9me2) mark (Figure 3-12C) 
were unchanged between control and 10 IU blastocysts.  Additionally, there was no 
difference in the distribution of CHDH between inner (control 28.0% high, 62.4% medium; 
10 IU 26.0% high, 65.2% medium) and outer (control 71.8% high, 20.9%; 10 IU 71.2% high, 
24.2% medium) blastomeres of these embryos, where the majority displayed high or medium 
levels of CHDH immunofluorescence (Figure 3-12D). Having said this, a greater number of 
blastocysts, and more stages of preimplantation development, need to assessed for CHDH 
and H3K9me2 levels in control and hormone treated groups before this analysis is 
completed. 
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Figure 3-12: CHDH protein in 1-cells and blastocysts in the control and 10 IU groups 
(A) CHDH protein levels in 1-cell embryos in the control (Ctrl) and 10 IU groups. (B) 
CHDH protein levels in blastocysts in Ctrl and 10 IU groups. Data were analyzed as relative 
fluorescence units (RFUs) ± SEM. DAPI, blue; CHDH protein, red. (C) Global H3K9me2 
levels normalized to DAPI RFUs (quantified as total H3K9me2 RFU divided by total DAPI 
RFU) in blastocysts in the Ctrl and 10 IU groups. DAPI, blue; H3K9me2, green. (D) 
Percentage of outer and inner blastomeres with low (L), medium (M) or high (H) amounts of 
CHDH immunofluorescence. Representative Z-stacks (A, C) and slices (B, D) are shown. 
Number in parentheses indicates the number of embryos analyzed.  The pseudocolour scale 
bar is shown in panel D and white bars measure 20 µm. 
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3.4 Discussion 
My study is the first to report a detailed analysis of total and active mitochondrial 
pools, location, and distribution in control and hormone-treated oocytes and embryos 
throughout preimplantation development, specifically from the MII oocyte to the blastocyst 
stage (Figure 3-13).   I showed that high-hormone treatment led to a decrease in the total and 
active mitochondria pool in oocytes and abnormal accumulation of active mitochondria away 
from the perinuclear region.  Subsequently, the total mitochondrial pool was no longer 
affected by hormone administration in 1-cell, 2-cell, morula and blastocysts, although the 
active mitochondria pool was significantly decreased in a dose-dependent manner in 1-cell 
and 2-cell embryos.  This decrease was no longer present in 4-cell and 8-cell embryos in the 
10 IU group.  With respect to mitochondrial distribution, 1-cell and 2-cell embryos from both 
control and stimulated females displayed homogenous and perinuclear distribution patterns 
of total mitochondria, respectively.  Furthermore, all embryos, regardless of exogenous 
hormone administration, displayed perinuclear accumulation of active mitochondria at 1-cell 
and 2-cell stages and cortical distribution of active mitochondria at 4-cell and 8-cell stages.  
Finally, late preimplantation embryos exhibit an asymmetrical distribution of both total and 
active mitochondria.   In comparison to control embryos, morula and blastocysts in the 
hormone-treated group exhibited an increase in the proportion of outer cells with low 
amounts of both total and active mitochondria.  In addition, high total mitochondria in 
blastocysts and high active mitochondria in morula and blastocysts were significantly 
decreased in outer cells of embryos in the hormone-treated group.  This was accompanied by 
decreased active mitochondria in morula and blastocysts in the 10 IU hormone group, and 
increased superoxide in outer cells of 10 IU embryos.  Overall, these results indicate that 
10 IU hormone stimulation ultimately leads to blastocysts exhibiting abnormal mitochondrial 
dynamics in outer/TE cells. 
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Figure 3-13: Summary of hormone-induced disruption of mitochondrial dynamics 
The effects of hormone administration (10 IU) on the total mitochondrial pool (Total Mito, 
Mitotracker green), the active mitochondrial pool (Active Mito, Mitotracker red), distribution 
of total mitochondria (Total distribution, Mitotracker green), distribution of active 
mitochondria (Active distribution, Mitotracker red), superoxide levels (MitoSOX staining), 
TOM20 immunofluorescence (TOM20) and CHDH levels (CHDH) are summarized. 
Upwards arrow, increased in 10 IU hormone embryos; downwards arrow, decreased in 10 IU 
hormone-stimulated embryos; equal sign, no change between hormone and control groups; 
NA, not analyzed; P, perinuclear; H, homogenous; Cl, clustered; Co, cortical; Outer, outer 
cells of morula- and blastocyst-stage embryos 
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It is well documented that oocytes with decreased mitochondria and/or mitochondrial 
DNA molecules (Murakoshi et al., 2013; Pikó and Taylor, 1987; Reynier et al., 2001; Santos 
et al., 2006) or a decreased ability to produce ATP (i.e. mitochondrial activity) (Assou et al., 
2006; Ge et al., 2012; May-Panloup et al., 2005; Selesniemi et al., 2011; St John et al., 2010; 
Thouas et al., 2004; Yu et al., 2010) have reduced developmental competence.  Furthermore, 
domains of concentrated respiratory activity in oocytes, as previously observed in 
differentiated cells (Collins et al., 2002; Diaz et al., 1999),  permit local ATP supply and 
demand for spatially localized processes during oogenesis (Van Blerkom et al., 2002; Yu et 
al., 2010). Consistent with this, perinuclear accumulation of active mitochondria in mouse, 
human and porcine is essential for the high-energy consuming processes that occur during 
oogenesis, namely nuclear and meiotic maturation and polar body extrusion (Nagai et al., 
2006; Sun et al., 2001; Tokura et al., 1993; Van Blerkom, 1991; Van Blerkom and Runner, 
1984; Van Blerkom et al., 2000; Yu et al., 2010). In this study, I observed a dose-dependent 
effect of ovarian stimulation on mitochondria in resulting oocytes. In comparison to 
spontaneously ovulated oocytes, oocytes ovulated after low hormone dose administration had 
a decrease in the active mitochondrial pool, although the total mitochondrial pool was 
unchanged.  By comparison, high hormone-treated oocytes displayed a decrease in the total 
mitochondrial pool and as well as a decrease in the active mitochondrial pool. This indicates 
that a decrease in the total mitochondrial pool could lead to the diminished active 
mitochondrial pool in the 10 IU hormone group.   
 Active mitochondrial accumulation at the perinuclear region is required for oocyte 
maturation (Nagai et al., 2006; Sun et al., 2001; Tokura et al., 1993; Van Blerkom, 1991; 
Van Blerkom and Runner, 1984; Van Blerkom et al., 2000; Yu et al., 2010).  Although total 
mitochondria in superovulated oocytes maintained a perinuclear organization, the active 
mitochondria were mislocalized. Superovulated oocytes exhibited increased homogenous and 
clustered distributions and decreased perinuclear organization in comparison to their 
spontaneously ovulated counterparts.  Effects on the active mitochondria pool and 
distribution also occurred at the lower hormone dose.  
Overall, my results in oocytes indicate that superovulation leads to increased 
production of oocytes with mitochondrial defects, namely a decreased total mitochondrial 
pool, active mitochondrial pool, and active mitochondrial localization. These specific defects 
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have previously been shown to impede successful completion of the second meiotic division 
of oogenesis and subsequent development.  Future studies should confirm this data by 
analyzing the effect of superovulation on total mitochondrial DNA numbers, total 
mitochondrial numbers using transmission electron microscopy (TEM), and resulting ATP 
production. As mitochondria in the mouse and human oocyte are translocated by microtubule 
structures (Kan et al., 2011; Van Blerkom, 1991; Van Blerkom et al., 2000), it is possible that 
superovulation disrupts the microtubule network required for successful perinuclear 
translocation of active mitochondria. In fact, decreased mitochondrial generation of ATP has 
been shown to cause disassembly of meiotic spindles (Zhang et al., 2006). Furthermore, in 
mouse and human somatic cells, mitochondrial function and ROS levels/oxidative stress have 
been implicated in regulating microtubule dynamics (Shi et al., 2010; Wilson and González-
Billault, 2015). Thus, it is possible that superovulation induced mitochondrial dysfunction 
leads to failure to establish microtubule-dependent perinuclear accumulation of 
mitochondria.  Future research should investigate the effect of superovulation on cytoskeletal 
structures, particularly the microtubule network. 
The ability of superovulated oocytes with insufficient numbers of mitochondria to 
complete meiosis and undergo successful fertilization is compromised in both human 
(Reynier et al., 2001; Santos et al., 2006) and pig (Shourbagy et al., 2006). By extension 
generation of ATP is important for oocyte maturation and fertilization (Dumollard et al., 
2004; Yu et al., 2010; Zhang et al., 2006).  However, completion of meiosis and subsequent 
fertilization can occur over a wide range of ATP contents, while it is continued 
embryogenesis and implantation that is compromised in embryos from oocytes with low ATP 
contents (Van Blerkom et al., 1995).  Consistent with these studies, I have shown that 
superovulation leads to the disruption of the total mitochondrial pool in oocytes, although 
this was no longer evident in 1-cell and 2-cell embryos, which displayed a similar total 
mitochondrial pool compared to spontaneous counterparts. However, 1-cell and 2-cell 
preimplantation embryos continued to exhibit a decrease in the active mitochondrial pool 
compared to spontaneous counterparts, and this was dose-dependent. This decrease in the 
hormone-treated group was no longer evident in 4-cell and 8-cell embryos, suggesting that 2-
cell embryos with decreased mitochondrial activity may undergo a 2-cell block in 
development; a phenomenon that was originally observed in cultured embryos and certain 
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strains of mice (Biggers, 1998).  The 2-cell block depends on maternally inherited 
cytoplasmic factors (Biggers, 1998; Goddard and Pratt, 1983; Muggleton-Harris and Brown, 
1988; Zanoni et al., 2009) and is associated with lower ATP and mitochondrial membrane 
potential (Komatsu et al., 2014; Wang et al., 2009).  Two-cell embryos are particularly 
vulnerable as the mouse embryonic genome is activated at this stage and this process requires 
ATP (Bianchi and Sette, 2011; Bultman et al., 2006). Therefore, 2-cell embryos generated 
after ovarian stimulation with reduced mitochondrial activity may be energetically incapable 
of cleaving to the 4-cell stage.  Future studies should be directed towards analyzing 
mitochondrial dynamics using time-lapse microscopy to determine whether oocytes with 
decreased total mitochondria do not undergo successful fertilization, and whether 2-cell 
embryos with decreased mitochondrial activity are unable to divide to the 4-cell stage. 
Mouse and human 1-cell and 2-cell embryos display perinuclear accumulation of 
mitochondria (Tokura et al., 1993; Van Blerkom, 2000; Van Blerkom et al., 2000; Van 
Blerkom, 2009; Wilding et al., 2001; Zhao et al., 2009).  Furthermore, developmentally 
competent embryos exhibit an even distribution of mitochondria between blastomeres while 
those that arrest and lyse have an uneven segregation of mitochondria.  With regards to 
mitochondrial distribution in early cleavage embryos, regardless of ovarian stimulation, total 
mitochondria was homogenous in 1-cell embryos and perinuclear in 2-cell embryos, active 
mitochondria accumulated at the perinuclear region in 1-cell and 2-cell embryos, while 4-cell 
and 8-cell embryos exhibited cortical accumulation of active mitochondria.   Thus, it is 
possible that superovulated oocytes that did not establish perinuclear translocation of active 
mitochondria at the MII stage were unable to complete meiosis and be fertilized to create 
perinuclear 1-cell embryos.  In my study, the distribution of mitochondria around pronuclei 
and between blastomeres was mostly symmetrical in both control and hormone stimulated 
zygote to 8-cell embryos, indicating exogenous hormone administration does not lead to an 
increased frequency of asymmetrically distributed mitochondria. Overall, by 4-cell and 8-cell 
stages of preimplantation development, embryos generated spontaneously or by ovarian 
stimulation were indistinguishable with respect to active mitochondrial intensity and 
distribution. 
Adequate amounts of mitochondrial activity throughout preimplantation are required 
for successful development through to the blastocyst stage (Wakefield et al., 2011; Wilding 
160 
 
et al., 2001). As embryos progress to the morula and blastocyst stages, blastomeres no longer 
exhibit comparable mitochondrial distributions, with total and active mitochondria 
preferentially localizing to the outer cells (Houghton, 2006; Van Blerkom et al., 2000).  This 
is further supported by ATP production, oxygen consumption, and amino acid turnover that 
are significantly increased in blastocyst trophectoderm compared to inner cell mass cells 
(Houghton, 2006). Additionally, activity of the Na+/K+-ATPase, located on the basolateral 
surface of the trophectoderm cells accounts for 60% of the ATP used in human blastocysts 
(Houghton et al., 2003). Ultimately, the blastocysts requires ATP-dependent Na+/K+-ATPase 
to drive cavitation and blastocyst formation (Madan et al., 2007). In my study, I also 
observed a similar unequal mitochondrial distribution in morula and blastocysts in both the 
control and 10 IU hormone groups.  Here, superovulation led to significant alteration in the 
allocation of mitochondria in the outer blastomeres, with an increased percentage of 
blastomeres displaying low amounts of total and active mitochondria, and a decreased 
percentage of cells with high amounts of active mitochondria.  This decrease did not coincide 
with decreased number of cells in blastocysts obtained after hormone treatment, nor did it 
result in decreased embryo cavity volume, which would be suggestive of defective blastocyst 
cavitation.  Instead, while blastocysts produced after hormone treatment had increased cell 
numbers, they had similar embryo cavity volumes compared to controls.  The increased cell 
number could be due to a compensatory mechanism accounting for a lower mitochondrial 
activity in 10 IU hormone-stimulated embryos.  Future studies are required to investigate the 
effect of low mitochondria in outer blastomeres of hormone-treated embryos on downstream 
measurements such as successful blastocyst hatching, implantation and resulting pregnancy.  
Hyperstimulation has previously been shown to result in increased superoxide 
production in the mouse oocyte (Chao et al., 2005), and increased superoxide increases 
mitochondrial DNA mutations, which can ultimately affect oxidative phosphorylation and 
ATP generation (Jacobs et al., 2007; Keefe et al., 1995; Shamsi et al., 2013; Venkatesh et al., 
2010).  In this study, superovulation led to a significant increase in superoxide accumulation 
in blastocyst embryos, specifically in the outer blastomeres. Increased mitochondrial 
superoxide accumulation could result in decreased mitochondrial activity in outer embryonic 
cells. However, future studies will be required to determine the downstream consequences of 
this superoxide accumulation. Having said this, superovulation did not seem to impact 
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nuclear control over mitochondrial function, as measured by both intensity and localization 
of the mitochondrial import protein TOM20, which was unchanged between control and 
hormone groups.  
In addition to providing the oocyte and preimplantation embryo with the energy 
required for development, mitochondria also provide the cell with metabolites needed for 
epigenetic control of gene expression (Martinez-Pastor et al., 2013; Wallace and Fan, 2010).  
For example, methyl groups for the preimplantation embryo (generated from SAM) are 
produced in part via the betaine pathway, where choline is catalyzed to betaine in a 2-step 
process that involves CHDH (Anas et al., 2008; Ikeda et al., 2012; Lee et al., 2012).  This 
reaction occurs in the mitochondria. Therefore, I analyzed the effect of ovarian stimulation 
on CHDH protein levels.  My results indicate that the maternal supply of CHDH protein in 
fertilized 1-cell embryos is significantly decreased after exogenous hormone treatment 
compared to controls.  Consequently, this could affect the methyl pool available during 
preimplantation development.  By the blastocyst stage, this decrease no longer appeared to be 
present in the hormone-stimulated group, which showed similar levels of CHDH and the 
repressive histone methylation mark, H3K9me2, in comparison to controls.  Overall, future 
studies are required to determine the effect of ovarian stimulation on CHDH protein levels 
throughout preimplantation development, in addition to determining the consequences of 
decreased CHDH methylation present in 1-cell embryos and subsequent cleavage stage 
embryos with respect to both DNA and histone methylation. 
Current practices to increase success in the ART clinic have begun to target the 
mitochondria.  These include the controversial techniques of mitochondrial replacement 
therapy and AUGMENT.  My study confirms the importance of mitochondria in 
preimplantation development.  Additionally, it points to the greater need to understand the 
effects that all ARTs treatment modalities have on the mitochondria, as well as the basic 
science behind new technologies targeting mitochondria in animal models and clinical trials.  
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Chapter 4  
4 Discussion 
4.1 General overview 
Infertility has risen to 16% of Canadian couples, tripling since 1984 (5.4%) (Bushnik 
et al., 2012). Similar numbers exist in the United States, with infertility affecting more than 
10% of adult women (6.1 million) and 9% (4.7 million) of adult males, representing 10 to 
15% of couples (Chandra et al., 2013).  Due to rising rates of infertility, many couples are 
seeking medically assisted reproductive technologies (ARTs).  Thus, it is becoming 
increasingly important for researchers to investigate the effects of these techniques on the 
manipulated oocyte and preimplantation embryo.  
The developmental competence and health of the preimplantation embryo is 
dependent on successful completion of coordinated molecular processes that occur during 
early gamete and embryo development.  Two of these pathways include DNA methylation 
reprogramming (Macdonald and Mann, 2014) and mitochondrial dynamics (Van Blerkom, 
2011).  Here, I investigated (a) the effects of ARTs on imprinted DNA methylation in human 
preimplantation embryos, and (b) the effect of ovarian stimulation on mitochondrial 
dynamics in mouse oocytes and preimplantation embryos.  Although these pathways are 
distinct, based on my data, I propose that ARTs predispose trophectoderm cells of 
preimplantation embryos to aberrant imprinted methylation and mitochondrial defects. 
4.1.1 Human ART embryos display a high frequency of imprinted 
methylation errors 
Genomic imprinting disorders occur at an increased prevalence in the population of 
children conceived by ARTs (Okun and Sierra, 2014).  Thus, numerous animal models have 
investigated the impact of ARTs on imprint establishment in oocytes and maintenance in 
preimplantation embryos [reviewed in (Denomme and Mann, 2012)].   One benefit of using 
the mouse as a model is that it allows for controlled studies of the effects of individual ART 
procedures without issues of confounding infertility.  Major findings from mouse studies 
indicate that imprinted methylation is disrupted by superovulation (Hajj et al., 2011; Market-
Velker et al., 2010b), in vitro fertilization (IVF) (Fauque et al., 2010), in vitro embryo culture 
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(Li et al., 2005; Mann et al., 2004; Market-Velker et al., 2010a; 2012) and cryopreservation 
(Cheng et al., 2014).  Abnormal imprinted methylation occurs in 10-90% of ART 
preimplantation embryos (Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010b; 
2012).   
In contrast, due to the limited availability of and ethical issues associated with the use 
of human gametes and preimplantation embryos, very few studies have analyzed imprinted 
DNA methylation in the human, with the majority of studies utilizing human embryos not 
suitable for embryo transfer (Chen et al., 2010; Geuns et al., 2003; 2007; Ibala-Romdhane et 
al., 2011; Khoueiry et al., 2012; Shi et al., 2014).  To uncover the discrepancy between 
imprinted DNA methylation errors in mouse preimplantation embryos and human ART 
children, I evaluated individual, good to high quality, day 3 and blastocyst stage human 
preimplantation embryos for imprinted methylation at SNRPN, KCNQ1OT1 and H19.  I 
specifically analyzed these regions because they are associated with the three imprinting 
disorders showing increased prevalence (1 in 5,000 children) in the ART population (Okun 
and Sierra, 2014). The experimental design I used allowed for analysis of more than one gene 
per embryo in addition to comparing short and extended embryo culture. The human 
embryos used were subjected to the combined effect of multiple ARTs, namely ovarian 
stimulation, IVF/ICSI, in vitro embryo culture, and cryopreservation.  Importantly, these 
embryos were suitable for transfer but instead were donated for research after patients no 
longer needed embryos for their treatment. Overall, I observed a similar frequency of 
imprinted methylation errors in the donated human embryos to that observed in mouse 
(Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010b; 2012) and other studies 
of poor quality human preimplantation embryos (Chen et al., 2010; Geuns et al., 2003; 2007; 
Ibala-Romdhane et al., 2011; Khoueiry et al., 2012; Shi et al., 2014). Imprinted methylation 
in similar good to high-quality human preimplantation embryos has only been analyzed in 
two previous studies with small embryo numbers (14 blastocysts (Khoueiry et al., 2012), 5 
blastocysts (Ibala-Romdhane et al., 2011) compared to the 24 day 3 embryos and 29 
blastocysts analyzed here).  Therefore, my results are of clinical relevance as the embryos 
analyzed are representative of cleavage-stage and blastocyst-stage embryos that could be 
transferred to patients with the potential of future pregnancy.  Overall, these results indicate 
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that good quality, transferrable human ART preimplantation embryos possess a frequency of 
imprinted methylation errors similar to that previously reported in the mouse. 
Studies in the mouse permit controlled analysis of the effects of individual ARTs on 
resulting imprinted DNA methylation, without the confounding effects of inherent infertility. 
The results of these studies generally indicate that increasing the number of ART procedures 
exacerbates imprinting errors (de Waal et al., 2015; Fauque et al., 2007; Market-Velker et al., 
2010a; Rivera et al., 2008). However, discrepancy in the field exists with regards to whether 
it is the infertility treatment or inherent infertility itself that results in abnormal imprinted 
methylation (Doornbos et al., 2007; Ludwig et al., 2005; Strawn et al., 2010).  Notably, I 
identified two embryos possessing abnormal imprinted methylation that were generated using 
donor sperm due to male factor infertility. In these cases, inherent infertility is bypassed as 
embryos were generated with oocytes and sperm from a fertile man and woman. Although 
this is small subset of embryos, it provides support for ART-induced errors, presumably in 
the absence of inherent infertility. 
Taken together, I have identified similar imprinted DNA methylation abnormalities at 
the SNRPN, KCNQ1OT1 and H19 ICRs in human embryos to that observed in the mouse.  
Importantly, extending analyses to both day 3 cleavage and blastocyst stage embryos allowed 
me to conclude that continued culture to the blastocyst stage does not seem to pose greater 
risks for imprinting perturbations, although analyses during subsequent development would 
be required to confirm this result. 
4.1.2 Ovarian stimulation disrupts mitochondria in mouse oocytes 
and preimplantation embryos 
The vital role mitochondria have in establishing developmental competence of the 
oocyte and preimplantation embryo, and consequently IVF success, has fueled the design of 
new techniques aimed at improving or reconstituting the mitochondrial pool in oocytes and 
embryos in IVF clinics worldwide (Meldrum et al., 2016; Reinhardt et al., 2013; Wolf et al., 
2015; Woods and Tilly, 2015).  These techniques are experimental, and very few studies 
have been performed to examine their safety.  Additionally, the effects of standard ART 
protocols on mitochondria have not been fully discerned.  Here, I specifically demonstrated 
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that the most commonly used, indispensable treatment modality, ovarian stimulation, led to 
mitochondrial disruption in oocytes and preimplantation embryos.   
To extend my analysis of the effects of ARTs on the oocyte and preimplantation 
embryo, I analyzed the effects of ovarian stimulation on mitochondria in mouse oocytes and 
throughout preimplantation development.  Ovarian stimulation is implemented to increase 
the number of follicles recruited for ovulation during assisted reproduction.  The doses of 
exogenous hormones that accompany ovarian stimulation are administered during oogenesis, 
and coincide with the crucial time-points of drastic mitochondrial replication, biogenesis, 
respiration, and mitochondrial localization changes.  Consequently, this ART procedure has 
the potential to disrupt mitochondria in the mature, ovulated MII oocyte. I specifically 
identified that ovarian stimulation with exogenous hormones leads to a decrease in both total 
and active mitochondrial pools, and an increase in the percentage of ovulated oocytes 
displaying abnormal active mitochondrial localization.   These results are consistent with 
previous studies, which showed that ovarian stimulation disrupted mitochondrial DNA copy 
numbers and mitochondrial membrane potential in ovulated oocytes (Combelles and 
Albertini, 2003; Ge et al., 2012; Gibson et al., 2005).  
Analysis of embryos obtained after exogenous hormone treatment at later stages of 
preimplantation development indicated that mitochondrial perturbations caused by ovarian 
stimulation preferentially occurred in the outer trophectoderm cells.  In both morula and 
blastocyst-stage embryos, I reported a decrease in high amounts of active mitochondria in 
outer cells and a concomitant increase in the percentage of outer blastomeres inheriting low 
amounts of active mitochondria.  I also saw increased superoxide in outer cells of hormone-
stimulated embryos compared to controls.  Increased oxidative damage could increase 
mitochondrial DNA damage, consequently affecting respiration and ATP generation (Jacobs 
et al., 2007; Keefe et al., 1995; Shamsi et al., 2013; Venkatesh et al., 2010). However, this 
remains to be determined.   
Finally, I investigated the effects of hormone treatment on choline dehydrogenase 
(CHDH) levels.  CHDH links mitochondria to epigenetic regulation as it catalyzes the 
conversion of choline into betaine aldehyde at the inner mitochondrial membrane.  This 
substrate is required for production of s-adenosylmethionine (SAM), the cells methyl donor, 
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through the betaine pathway (Anas et al., 2008; Ikeda et al., 2012; Lee et al., 2012). I 
identified a significant decrease in CHDH levels in hormone stimulated 1-cell embryos 
compared to controls. However, this decrease no longer appeared to be present in hormone-
stimulated blastocysts compared to controls.  Furthermore, there appeared to be no difference 
in global levels of the repressive histone mark, histone 3 lysine 9 dimethylation (H3K9me2), 
in blastocysts in the 10 IU group compared to controls.  Thus, my results suggest that ovarian 
stimulation may lead to the disruption of mitochondrial control of epigenetic regulation in 
cleavage stage embryos, but this requires further investigation.  
 Overall, I have shown that ovarian stimulation alone, as an existing and indispensable 
ART procedure, leads to the disruption of mitochondria in the outer/trophectoderm cells of 
resultant morula- and blastocyst-stage embryos.  As respiration in the outer/trophectoderm 
cells is critical for blastocyst formation and hatching (Larsson et al., 1998; Madan et al., 
2007; Watson et al., 2004), future studies are required to investigate the downstream effects 
of this disruption. 
4.1.3 Contributions to the field of reproductive biology 
Overall, my work presented in this thesis advances the field of reproductive biology 
with the following novel findings: (a) ARTs disrupt imprinted methylation at the SNRPN, 
KCNQ1OT1 and H19 imprinting control regions (ICRs) in day 3 and blastocyst-stage, good 
to high quality, human embryos; (b) this occurs at a similar frequency to that observed in the 
mouse; (c) extended culture from the day 3 to blastocyst stage did not pose a greater risk for 
imprinting errors compared to short culture; (d) mitochondria were also disrupted by ARTs, 
specifically ovarian stimulation, resulting in decreased active mitochondrial pools, and 
mitochondrial localization defects as well as increased superoxide levels in the 
outer/trophectoderm cells of morula- and blastocyst-stage embryos; and (e) ovarian 
stimulation also leads to decreased CHDH protein levels in 1-cell embryos produced after 
hormone treatment; however, this decrease no longer appeared to be present in blastocyst-
stage embryos in the 10 IU group.  This research is relevant to the human clinic and 
demonstrates the need to establish a mechanistic basis for the validation of optimal 
techniques and procedures that will ensure the generation of healthy, viable embryos for 
infertile couples. 
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4.2 ARTs and the trophectoderm 
The results of my thesis suggest that the trophectoderm is a selective target of ART-
induced defects.  Specifically, in the first aim of this thesis, I demonstrated that human 
embryos produced through the use of multiple ARTs in the human IVF clinic exhibit a high 
frequency of abnormal imprinted DNA methylation.  However, disparity still exists with 
regards to the frequency of imprinting errors in human preimplantation embryos (6-89% 
embryos) (Chen et al., 2010; Geuns et al., 2003; 2007; Ibala-Romdhane et al., 2011; 
Khoueiry et al., 2012; Shi et al., 2014; White et al., 2015) compared to the frequencies of 
imprinting errors reported in ART children (~1 in 5,000 children) (Okun and Sierra, 2014).  
In the second aim of my thesis, I demonstrated that ovarian stimulation alone disrupted 
mitochondrial dynamics in mouse oocytes and preimplantation embryos. This resulted in a 
decreased amount of active mitochondria and increased superoxide production in 
outer/trophectoderm cells of blastocysts obtained after hormone stimulation.  Thus, ARTs 
affected two important components of early embryogenesis: imprinted DNA methylation 
maintenance and mitochondrial function. Hence, I hypothesize that the connection between 
these results is that ARTs-induced disruptions selectively occur within the trophectoderm. 
One explanation for the discrepancy between imprinting errors in human embryos 
compared to resulting children could be that blastomeres with aberrant imprinted methylation 
are preferentially relegated to the trophectoderm lineage.  In support of this, many studies in 
mouse have reported a selective loss of imprinted methylation and/or imprinted expression in 
the placenta compared to the embryo in midgestation mouse embryos following 
superovulation (Fortier et al., 2008; 2014) or preimplantation development in culture (de 
Waal et al., 2014; Khosla et al., 2001; Mann et al., 2004; Rivera et al., 2008).  A recent study 
in mouse found that ART procedures reduced fetal and placental growth at midgestation, 
reduced DNA methylation at H19, Kcnq1ot1 and Snrpn ICRs in the placenta, suppressed 
placental expression of paternally expressed imprinted genes that enhance fetal growth, and 
upregulated placental expression of maternally expressed imprinted genes that repress fetal 
growth (Li et al., 2016).  In humans, placentas from a group of successful IVF/ICSI 
pregnancies displayed abnormal H19/IGF2 expression compared to placentas from natural 
conceptions (Sakian et al., 2015; Turan et al., 2010). If imprinted methylation errors in 
human ART preimplantation embryos preferentially arise in the trophectoderm rather than 
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embryonic cells, this would explain the reduced frequency of imprinting disorders in the 
resulting child.   
A greater frequency of imprinted methylation errors in trophectoderm and placenta 
could lead to failed implantation or aberrant placental and fetal growth. The essential role of 
imprinted genes in placental function and fetal growth has been established in the mouse 
[reviewed in (Tunster et al., 2013)].  A correlation between imprinted gene expression in the 
placenta and resulting fetal growth was recently demonstrated in human, where increased or 
decreased placental expression of specific imprinted genes was correlated with large or small 
for gestational age infants (Kappil et al., 2015).  Thus, relegation of imprint abnormalities to 
the trophectoderm could account for the increased frequencies of IUGR, low birth weight, 
small for gestational age (Okun and Sierra, 2014) or large for gestational age (Hansen and 
Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014; Pinborg et al., 
2014; Sazonova et al., 2012; Wennerholm et al., 2013) in ART children.  Consistent with 
this, abnormal imprinted gene methylation or expression has been detected in IUGR 
(Gonzalez-Rodriguez et al., 2016; López-Abad et al., 2016; Madeleneau et al., 2015; 
McMinn et al., 2006) and low birth weight/ small for gestational age (Bouwland-Both et al., 
2013; Kanber et al., 2009) placentas compared to controls.  In my study, patients who 
donated their frozen embryos had received a fresh embryo transfer from the same cycle of 
which the donated frozen embryos were obtained.  Resulting information was available 
regarding live birth rate and pregnancy outcomes.  Consistent with growth restriction and 
overgrowth being associated with aberrant methylation or expression of imprinted genes, 
45% of newborns from patients in my study were outside clinically normal birth weight, with 
1 high (>4000g), 5 low (<2500g), 1 very low (<1500g) and 1 extremely low (<1000g).  This 
may suggest that the high frequency of imprinted DNA methylation errors in remaining day 3 
cleavage and blastocyst embryos could lead to a range of effects regarding placental 
development and growth. While risk of multiples increases the risk of low birth weight, it 
should be noted that one of the very low birth weight infants and one of the high birth weight 
infants were singletons, resulting in 2 out of 9 (22%) singletons under/above clinically 
normal birth weight. This increased risk of low birth weight (Helmerhorst et al., 2004; 
Jackson et al., 2004; Okun and Sierra, 2014; Reddy et al., 2007; Savage et al., 2011; Schieve 
et al., 2002; Sunderam et al., 2014; 2015; Wisborg et al., 2010) and large for gestational age 
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(Hansen and Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014; 
Pinborg et al., 2014; Sazonova et al., 2012; Wennerholm et al., 2013) in singletons of ART 
pregnancies has been previously reported. 
In addition to imprinted genes playing a role in placental function, mitochondrial 
studies also indicate a specific role for mitochondria in the trophectoderm.  Trophectoderm 
cells of blastocysts exhibit increased mitochondrial content, ATP production, oxygen 
consumption, and amino acid turnover compared to cells in the inner cell mass (Assou et al., 
2006; Houghton, 2006; Houghton et al., 2003; Thundathil et al., 2005).  Increased 
mitochondrial activity in the trophectoderm lineage is required to activate the Na+/K+ 
ATPase, which accounts for 60% of the ATP used in human blastocysts (Houghton et al., 
2003) and is required for cavity formation (Madan et al., 2007). I also observed in untreated, 
control embryos preferential total and active mitochondrial localization to trophectoderm 
cells in morula and blastocysts, indicating that this is a consistent process that normally 
occurs during preimplantation development. Ovarian stimulation led to a disruption in the 
mitochondria content of outer/trophectoderm cells, specifically resulting in decreased active 
mitochondrial pools and increased superoxide levels in outer/trophectoderm cells of morula 
and blastocysts. This indicates that the disruption was initiated when blastomeres adopted 
inner and outer cell identity, as outer morula cells will be specified to the trophectoderm 
lineage (Artus and Chazaud, 2014).   
Consistent with these observations, ART-induced mitochondrial defects have been 
demonstrated preferentially in the placental cell lineage (Thouas et al., 2006; Wakefield et 
al., 2011).  Specifically, embryos cultured in media containing low concentrations of a 
mitochondrial inhibitor had reduced placental but not fetal growth (Wakefield et al., 2011), 
while mitochondrial dysfunction in mouse oocytes lead to a decrease in trophectoderm cell 
number (Thouas et al., 2006).  Although the consequences of perturbed mitochondrial 
function in trophectoderm cells is unknown, like imprinted DNA methylation errors, 
mitochondrial disruption in the placenta has been implicated in growth restriction of the 
developing fetus.  Data from human IUGR placentas demonstrate a significant decrease in 
the expression of genes involved in mitochondrial function and oxidative phosphorylation, 
specifically affecting 3 out of 5 complexes of the respiratory chain (Madeleneau et al., 2015).  
Lower mitochondrial DNA content and higher placental superoxide dismutase activity, likely 
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to counteract oxidative damage, has also been observed in small for gestational age 
pregnancies (Díaz et al., 2014).  Finally in the mouse, mutation of a subunit of complex II of 
the respiratory chain induced ROS production and resulted in excessive apoptosis leading to 
low birth weight and growth retardation (Ishii et al., 2011). Overall, ART induced disruption 
of imprinted DNA methylation and mitochondria could be preferentially occurring in the 
outer/trophectoderm cells of the blastocyst embryo, and I propose this would lead to failed 
implantation or aberrant placental function and consequently, abnormal fetal growth. 
4.2.1 Potential link between ART-induced disruption of mitochondria 
and imprinted DNA methylation 
The role of mitochondria in epigenetic regulation is a recently emerging area of 
interest.  The relationship between mitochondria and chromatin arises through the metabolic 
products of energy consumption, as numerous intermediate epigenetic metabolites are 
produced by mitochondrial utilization of carbon sources to generate ATP (Castegna et al., 
2015; Martinez-Pastor et al., 2013; Wallace, 2010; Wallace and Fan, 2010) (Figure 4-1).  
First, histone acetylation and corresponding active chromatin depends on the availability of 
the acetyl-coA substrate.  In mammals, the majority of acetyl-coA is derived from the 
precursor citrate, which is produced solely by the mitochondria as a byproduct of the 
tricarboxylic acid (TCA) cycle and converted into acetyl-coA by the nuclear-encoded 
enzyme ATP-citrate lyase (ACL) (Martinez-Pastor et al., 2013; Wellen et al., 2009) (Figure 
4-1A).  The ACL-catalyzed generation of acetyl-coA from citrate is required for histone 
acetylation (Wellen et al., 2009).  In contrast to histone acetylation, histone deacetylation and 
corresponding repressive chromatin exhibits a metabolic influence through histone 
deacetylase (HDAC) activity and nicotinamide adenine dinucleotide (NAD+), another 
product of mitochondrial metabolism (Carafa et al., 2016; Martinez-Pastor et al., 2013) 
(Figure 4-1B).  DNA and histone methylation are also regulated by mitochondrial-produced 
metabolites (Martinez-Pastor et al., 2013).  During preimplantation development, two 1-
carbon metabolic pathways, the betaine pathway (Figure 1-4C) and the folate cycle (Figure 
4-1D), are required to produce methionine and ultimately S-adenosylmethionine (SAM) 
(Ikeda et al., 2012).  S-adenosylmethionine (SAM), the universal methyl donor for histone 
and DNA methylation, is produced from methionine by S-adenosylmethionine transferase 
(MAT) (Lu, 2000).  This reaction requires ATP, the product of mitochondrial respiration (Lu, 
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2000; Martinez-Pastor et al., 2013; Teperino et al., 2010) (Figure 4-1E). The reverse reaction, 
or removal of methyl groups from histone proteins, is catalyzed by histone demethylases 
(HDMs), which require two metabolites [flavin adenine dinucleotide (FAD+) (Anand and 
Marmorstein, 2007) and α-ketoglutarate (Tsukada et al., 2006)], that are produced during the 
TCA cycle (Martinez-Pastor et al., 2013; Teperino et al., 2010) (Figure 4-1F).  Finally, the 
end product of cellular respiration, ATP, is required as a substrate for histone 
phosphorylation in addition to powering ATP-dependent chromatin remodeling complexes 
(Runge et al., 2016). Thus, it is likely that fluctuations in mitochondrial respiration impact 
epigenetic dynamics. As the oocyte provides the preimplantation embryo with its only source 
of mitochondria during preimplantation development, and mitochondria provide the 
preimplantation embryo with its source of epigenetic metabolites, it is possible epigenetic 
control of imprint maintenance during preimplantation development is dependent on 
mitochondrial respiration. Overall, I would anticipate that decreased mitochondrial 
respiration, and consequently decreased ATP, would force blastomeres to allocate their 
metabolites to processes vital for immediate survival (i.e. DNA replication, transcription, cell 
division, and cavitation in blastocyst-stage embryos). This would have the net effect of 
reducing the metabolite pool required for proper epigenetic control of gene expression, for 
example, imprinted DNA methylation.   
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Figure 4-1: Mitochondria and epigenetics 
The relationship between mitochondria and nuclear epigenetic regulation is mediated through 
intermediate metabolites produced during mitochondrial respiration.  (A, pink arrows) 
Citrate, produced through the tricarboxylic acid cycle (TCA), is converted to acetyl-coA by 
ATP citrate lyase (ACL).  Histone acetyltransferases (HATs) catalyze the addition of acetyl 
groups (green square) to histones for formation of active chromatin.  (B, red arrow) Histone 
deacetylation requires histone deacetylases (HDACs) and nicotinamide adenine dinucleotide 
(NAD+), a metabolite from the TCA cycle, to remove acetyl groups. In preimplantation 
embryos, two 1-carbon metabolism pathways are involved in generation of methionine and 
ultimately S-adenosylmethionine (SAM), the universal methyl donor.  (C, blue arrows) In the 
first pathway, choline is converted into betaine aldehyde by the inner mitochondrial 
membrane enzyme choline dehydrogenase (CHDH, green circle).  Betaine aldehyde is 
subsequently converted into betaine in the mitochondrial matrix by betaine aldehyde 
dehydrogenase (BADH).  Betaine-homocysteine S-methyltransferase (BHMT) then converts 
betaine and homocysteine to dimethylglycine (DMG) and methionine, respectively.  (D, 
orange arrows) In the folate pathway, folic acid is reduced to tetrahydrofolate (THF), which 
is converted to methylene tetrahydrofolate (methylene THF) by serine 
hydroxymethyltransferase (SHMT).  Methylene tetrahydrofolate reductase  (MTHFR) 
catalyzes methylene THF conversion to methyl THF, and methionine synthase converts 
methyl THF and homocysteine to THF and methionine, respectively.  (E, purple arrows) 
Finally, methionine from both pathways is converted into S-adenosylmethionine (SAM) by 
S-adenosylmethionine transferase (MAT) and ATP.  SAM is the methyl donor for DNA 
methylation (white circle; unmethylated CpGs; black circles, methylated CpGs) and histone 
(i.e. H3K9me2) methylation (red square).  (F, yellow arrow) Demethylation by histone 
demethylases (HDMs) involves substrates flavin adenine dinucleotide (FAD+, utilized in the 
TCA cycle) and α-ketoglutarate, an intermediate in the TCA cycle.  
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A few studies have directly analyzed the effect of mitochondrial disruption on 
epigenetic control of nuclear gene expression.  Depletion of mitochondrial DNA resulted in 
significant DNA methylation changes at a number of genes (Smiraglia et al., 2008), in 
addition to decreasing the presence of multiple acetylation marks of histone H3, H2B and H4 
(Martínez-Reyes et al., 2016). A further relationship between mitochondria and epigenetics 
was demonstrated in Dnmt1o-deficient placentas (Himes et al., 2015). These placentas were 
characterized by swollen mitochondria with abnormal cristae, and exhibited metabolomic 
profiles indicative of mitochondrial dysfunction (Himes et al., 2015).  I hypothesized that 
ovarian stimulation-induced disruption of mitochondria consequently leads to aberrant 
epigenetic regulation.  Specifically, I demonstrated that CHDH, a mitochondrial membrane 
protein involved in production of SAM during preimplantation development (Ikeda et al., 
2012; Zhang et al., 2015), was significantly decreased in the 1-cell 10 IU hormone stimulated 
group.  By the blastocyst stage, there was no apparent difference in CHDH levels or the 
repressive histone 3 lysine 9 dimethylation (H3K9me2) mark in 10 IU blastocysts compared 
to controls.   Future studies are needed to investigate downstream effects of CHDH 
disruption in 1-cell and subsequent cleavage stage embryos, in addition to determining the 
effects of ARTs on other mitochondrial metabolites involved in epigenetic regulation. 
4.3 Translating results to the human ART clinic 
The results that I obtained in this thesis are relevant to the human ART clinic. Of 
particular relevance are the findings I obtained regarding imprinted methylation after 
extended culture to the blastocyst stage.  Specifically, I was the first to analyze imprinted 
methylation at two different stages of preimplantation development: the day 3 cleavage and 
the blastocyst stage.  Recently, there has been movement towards elective single embryo 
transfer (eSET) in ART to decrease the rate of multiple births (Maheshwari et al., 2011; Styer 
et al., 2016).  Furthermore, the advent of one free cycle of ART funding specifically in 
Ontario requires that a single embryo be transferred in patients ≤35 years of age (Motluk, 
2016).  Consequently, many fertility clinics will culture embryos from good prognosis 
patients to the blastocyst stage to help identify the best embryo for transfer based on rate of 
development and morphological grading (Blake et al., 2007; Gardner et al., 2000; Gleicher et 
al., 2015; Glujovsky et al., 2012; Ubaldi et al., 2015).  The data I obtained in this study 
support additional culture to the blastocyst stage.  Specifically, the presence of methylation 
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errors in both day 3 (76%) and blastocyst (50%) stage embryos indicated that methylation 
errors already exist in ~6 to 8-cell cleavage embryos, and extending culture to the blastocyst 
stage of development does not appear to pose an increased risk for imprinted methylation 
errors. 
Human fertility clinics implement supraphysiological exogenous hormone doses in 
addition to using multiple ART procedures to generate preimplantation embryos for transfer 
to mothers.  The overall live birth rate after ART is 25% per egg retrieval and 29% per 
embryo transfer in Canada (Human Assisted Reproduction 2014) and 39.4% per embryo 
transfer in the United States (Sunderam et al., 2015)].  Furthermore, the incidence of low 
birth weight (29.1% ART, 8% non-ART) and preterm birth (33.6% ART, 11.4% non-ART) 
is higher in the ART population than among all infants in the total birth population of the 
United States (Sunderam et al., 2015).  As the embryos analyzed in this study were 
transferrable but frozen for future cycles, the results here are applicable to the human clinic.  
The high frequency of imprinted DNA methylation abnormalities that I reported might 
provide one explanation for the birth rates between 25%-39% and increased incidences of 
fetal growth abnormalities in the ART population.  Mild stimulation and minimizing the 
number of ARTs used in human IVF could be beneficial, as additional studies in the mouse 
have also demonstrated dose-dependent effects of hormone-stimulation on imprinted DNA 
methylation (Market-Velker et al., 2010b) as well as confounding effects of multiple ARTs 
on imprinted DNA methylation errors (de Waal et al., 2015; Fauque et al., 2007; Market-
Velker et al., 2010a; Rivera et al., 2008).  The same is true for mitochondrial dynamics 
throughout human IVF.  My research along with others demonstrates that ARTs disrupt 
mitochondrial numbers, activity, membrane potential and distribution in the oocyte and 
preimplantation embryo (Acton et al., 2004; Amoushahi et al., 2013; Combelles and 
Albertini, 2003; Ge et al., 2012; Gibson et al., 2005; Lee et al., 2006; Lei et al., 2014; 
Manipalviratn et al., 2011; Wilding et al., 2001; Zander-Fox et al., 2013; Zhao et al., 2011a; 
2011b; 2009).  Minimizing the hormone dose and number of ART techniques may minimize 
effects to mitochondria during IVF.  Furthermore, with the recent advent of novel procedures 
in human ART designed to alter mitochondrial sources by nuclear transfer into donor oocytes 
(Reinhardt et al., 2013; Wolf et al., 2015) or injecting mitochondria from ovarian cortex cells 
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into the oocyte during ICSI (Woods and Tilly, 2015), it is important to continue studies on 
mitochondria with regards to both pre-existing and novel ART methods. 
4.4 Future directions 
4.4.1 ARTs and imprinted DNA methylation in human preimplantation 
embryos 
During preimplantation development in the mouse, recruitment of protein complexes 
to ICRs is required to ensure maintenance of DNA methylation when the remainder of the 
genome undergoes genome-wide DNA demethylation (Denomme and Mann, 2013).  These 
maternal effect protector proteins include DPPA3 (Nakamura et al., 2007; 2012), DNMT1o 
and DNMT1s (Cirio et al., 2008a; 2008b; Hirasawa et al., 2008), and ZFP57 (Li et al., 2008; 
Quenneville et al., 2011; Zuo et al., 2012).  As I reported similar disruptions to imprinted 
DNA methylation in the human preimplantation embryo to those reported in mouse, the next 
steps would be to determine the mechanism behind this disruption.  Specifically, I would 
assess the maternal factors that regulate imprinted methylation maintenance in donated 
human preimplantation embryos.  First, I would analyze whether DPPA3/DPPA3 mRNA and 
protein are present in donated human zygotes.  As DPPA3 transcript has been detected in 
human oocytes (Goto et al., 2002; Kobayashi et al., 2012; Yan et al., 2013), I expect that the 
role of this protein in protecting imprinted domains from active DNA demethylation from the 
1-cell to 2-cell stage is conserved.  Co-localization of DPPA3 and H3K9me2 (Nakamura et 
al., 2007; 2012) in human zygotes would be conducted by immunofluorescence to identify 
whether DPPA3 and H3K9me2 preferentially localize to the maternal pronucleus to protect 
imprinted domains from active DNA demethylation, and whether a subset of human embryos 
display mislocalization.  Mislocalization of DPPA3 and H3K9me2 in human zygotes would 
suggest that the imprinted methylation errors I observed in day 3 human preimplantation 
embryos originates at the first cleavage division.  Next, I would assess the DNMT1o/s mRNA 
and DNMT1o/s protein levels at all stages of preimplantation development in donated human 
embryos.  The presence of these mRNAs and proteins has been confirmed in human oocytes 
and preimplantation embryos (Huntriss et al., 2004; Okae et al., 2014; Petrussa et al., 2014). 
Therefore, I would specifically analyze nuclear localization of DNMT1o/s in early cleavage-
stage embryos and separately, in inner/outer cell nuclei of later-stage preimplantation 
embryos.  Finally, I would analyze the ZFP57 expression and ZFP57 protein levels in 
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donated human preimplantation embryos.  Although ZFP57 mRNA was not present in 
human oocytes (Okae et al., 2014), levels were detected in human morula (Yan et al., 2013). 
Additionally, the fact that mouse and human ZFP57 proteins are interchangeable in 
maintaining imprinted DNA methylation in mouse indicates conservation of this protein 
(Takikawa et al., 2013).  In mouse, ZFP57 is required for imprint maintenance at the 8-cell 
stage of preimplantation development (Denomme and Mann, 2013; Li et al., 2008; 
Quenneville et al., 2011). Therefore I would concentrate analyses of ZFP57 to later stages of 
preimplantation development.  Again, I would assess nuclear localization of ZFP57 
beginning at the 8-cell stage and separately in inner and outer nuclei of morula and 
blastocysts.  Overall, I would anticipate a disruption in DPPA3 and/or DNMT1o/s 
localization during early cleavage development to account for the aberrant imprinted DNA 
methylation I identified in day 3 embryos.  Furthermore, I would also expect to see 
preferential loss of DNMT1o/s and/or ZFP57 in the outer nuclei of donated human morula 
and blastocysts. 
4.4.2 ARTs and mitochondria 
My second aim was to analyze the effect of an indispensable ART treatment, ovarian 
stimulation, on mitochondrial pools, localization, and function during preimplantation 
development. I identified that ovarian stimulation led to decreased active mitochondrial pools 
and increased superoxide levels in the outer cells of morula and blastocyst-stage embryos.  
Mitochondrial activity in control and hormone-stimulated embryos was assessed at all stages 
of preimplantation development. However, embryos were recovered at distinct stages and not 
followed throughout the course of cleavage development.  Consequently, this analysis would 
benefit from time-lapse imaging of embryos and mitochondria throughout the course of 
preimplantation development, for multiple reasons.  Using this technique, mitochondrial 
dynamics could be linked to specific embryo characteristics such as failed fertilization and 
embryonic cleavage.  From my results, I hypothesized that hormone-stimulated oocytes with 
decreased total mitochondria pool cannot be fertilized to generate zygotes.  This hypothesis 
could be tested using time-lapse imaging.  Specifically, MitoTracker green-stained oocytes 
would be subjected to live-cell imaging, after which sperm would be injected using ICSI and 
successful fertilization of individual oocytes could be examined with time-lapse imaging. 
Next, I hypothesized that hormone-treated 2-cell embryos with decreased active 
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mitochondrial pool undergo a 2-cell block in development.  Using time-lapse microscopy, I 
would test this hypothesis by assessing the ability of hormone-stimulated 2-cell embryos with 
decreased mitochondrial activity to cleave to the 4-cell stage.  This finding would indicate 
that sufficient energy is required for 2-cell embryos to activate the embryonic genome and 
bypass a 2-cell block in development. The use of time-lapse during subsequent cleavage 
development will help to identify the segregation patterns of mitochondria in later-stage 
preimplantation embryos.  Specifically as 8-cell and morula-stage embryos divide, 
orientation of the plane of cleavage will determine whether a blastomere will give rise to an 
inner (inner cell mass) and outer (trophectoderm) cell (asymmetric cleavage), or two outer 
(trophectoderm) cells (symmetric cleavage) (Artus and Chazaud, 2014).  I would therefore 
use time-lapse imaging to analyze the segregation of mitochondria with respect to the 
orientation of division. In the hormone-treated groups, which exhibit a decrease in the 
percentage of outer blastomeres inheriting high mitochondria, I would expect to see an 
abnormal segregation of mitochondria during symmetric cleavage generating two outer cells.  
Specifically, I anticipate that distribution of mitochondria in this scenario will be reminiscent 
of asymmetric cleavage, where one cell inherits less mitochondria than the other. 
Investigation of the downstream consequences of abnormal mitochondrial dynamics 
in trophectoderm cells of blastocysts should also be assessed.  Specifically, I would assess 
whether blastocysts with abnormal mitochondria in trophectoderm cells are able to undergo 
blastocyst hatching and implantation.  To analyze whether hormone-stimulated embryos with 
aberrant mitochondria in the trophectoderm exhibit decreased hatching rates, control and 
10 IU blastocysts would be subjected to live-cell Mitotracker red imaging and subsequently 
cultured until hatching is complete or embryos degenerate.  To analyze post-implantation 
development of blastocysts, control and hormone-stimulated embryos would be subjected to 
live-cell Mitotracker red imaging then transferred to pseudopregnant females.  Specifically, 
recipient females would randomly receive embryos with abnormal mitochondria in one 
uterine horn and control embryos in the other.  Implantation rates will be calculated as the 
number of implantation sites compared to the number of embryos transferred, and this will be 
compared for uterine horns containing embryos with abnormal mitochondria versus control 
embryos along with fetal and placental analysis.  
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Recent experimental infertility treatments have been aimed at replacing existing 
oocyte mitochondria in an attempt to bypass inheritance of mitochondrial disease or enhance 
IVF success (Chappel, 2013; Reinhardt et al., 2013; Wolf et al., 2015; Woods and Tilly, 
2015).  These techniques are already implemented in human IVF with little supporting 
research performed to assess their safety.  The need for investigation of these techniques has 
been acknowledged by few research groups, and a recent study examining replacement of 
mitochondria through nuclear transfer between a donor and recipient oocyte found that 
mitochondrial heteroplasmy leads to reversion to the disease phenotype (Yamada et al., 
2016). This further emphasizes the need to carefully analyze these treatments.  Since I have 
shown that ovarian stimulation alone leads to mitochondrial disruption, it is essential that 
these new techniques be scrutinized. To study the effects of mitochondrial replacement 
therapy, AUGMENT and CoQ10 administration on mitochondrial dynamics, I would first 
use time-lapse imaging to assess the activity and distribution of mitochondria throughout 
preimplantation development after each treatment.  This would be completed using a mouse 
model.  Specifically, oocytes generated using each treatment will be fertilized and cultured to 
the blastocyst stage while being subjected to time-lapse Mitotracker red imaging. Treatment 
groups would be compared to spontaneously obtained zygotes cultured to the blastocyst stage 
and subjected to Mitotracker time-lapse imaging.  Additionally with respect to AUGMENT, I 
would assess mitochondrial morphology in injected oocytes and throughout preimplantation 
development using transmission electron microscopy to assess whether mitochondria are 
structurally underdeveloped and elongate to mature forms first in trophectoderm cells of 
blastocysts (Motta et al., 2000; Pikó and Chase, 1973; Van Blerkom et al., 1973).  If I find 
that this is not the case, it will mean that mitochondria injected during AUGMENT are not 
morphologically equivalent to mitochondria in a mature oocyte. 
4.4.3 Establishing a connection between the effects ARTs on 
mitochondria and imprinted DNA methylation 
Together, the results presented in my thesis suggest that ARTs might affect processes 
specifically in the trophectoderm. This is supported by the discrepancy between the high 
frequency of imprinted methylation errors in human preimplantation embryos and low 
penetrance of imprinting disorders in resultant ART children; mitochondrial abnormalities in 
the trophectoderm of hormone-stimulated blastocysts; and the seeming role of imprinted 
187 
 
gene regulation and mitochondria respiration in placental insufficiency. Overall, I propose 
that decreased mitochondrial activity in trophectoderm cells of blastocysts derived from 
hormone-treated females causes abnormal imprinted DNA methylation.  I hypothesize that 
this would be due to decreased availability of metabolites/epigenetic molecules produced as 
products of mitochondrial respiration. In support of this, I identified decreased CHDH 
protein levels in 1-cell embryos in the hormone-stimulated group. This decrease no longer 
appeared to be present in blastocysts in the hormone-stimulated group and did not correspond 
with diminished global H3K9me2 levels in blastocysts. Therefore, to further test the effect of 
ovarian stimulation on mitochondrial control of epigenetic regulation, I would analyze 
CHDH protein levels throughout all stages of preimplantation development to determine 
whether embryonic genome activation at the 2-cell stage compensates for the decreased 
maternally-derived CHDH in 1-cell embryos.  Additionally, rather than analyzing the effect 
of ovarian stimulation on global methylation levels as I did using H3K9me2 
immunofluorescence analyses, I would analyze the effect of ovarian stimulation-induced 
mitochondrial disruption on gene-specific DNA methylation. Specifically, blastocysts in the 
control and 10 IU treated group would be subjected to live-cell Mitotracker red imaging and 
then trophectoderm and inner cell mass would be isolated separately to single 
trophectoderm/epiblast cells, which would be subjected to the bisulfite mutagenesis and 
sequencing assay.  Imprinted methylation would be tested at the Snrpn, Kcnq1ot1 and H19 
imprinted domains for both maternal and paternal alleles in hormone-stimulated embryos 
with normal mitochondria, hormone-stimulated embryos with abnormal mitochondria, and 
control untreated embryos.  Abnormal imprinted methylation in trophectoderm but not 
epiblast samples would indicate that imprinted methylation errors predominantly occur in the 
trophectoderm lineage. Furthermore, if this occurs in the group of embryos with abnormal 
mitochondria, a correlation between decreased mitochondrial activity and imprinted 
methylation errors in the trophectoderm can be made. 
If the above results indicate a linkage between mitochondria and imprinted DNA 
methylation in the trophectoderm, I would assess postimplantation development of normal 
and affected embryos.  Embryos with normal and aberrant mitochondria will be transferred to 
separate uterine horns of recipient females.   Downstream postimplantation development 
would be then be assessed separately for fetal and placental parameters as previously 
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described (Wakefield et al., 2011). Additionally, imprinted DNA methylation and expression 
would be assessed.  Overall, I would anticipate that embryos obtained after hormone 
stimulation with decreased mitochondrial activity in trophectoderm cells display decreased 
fetal and placental weights and abnormal imprinted regulation compared to controls.  This 
would mean that ART-induced effects occurring in the trophectoderm disrupt both 
mitochondria and imprinted DNA methylation, ultimately resulting in abnormal growth of 
the embryo through placental insufficiencies. 
4.5 Conclusions 
The use of assisted reproductive technologies has rapidly increased since the first 
human success story in 1978 (Steptoe and Edwards, 1978).  The treatment modalities used by 
infertile couples to conceive their own biological child are continually growing in number.  It 
is therefore imperative that research be conducted to assess any negative consequences of 
these techniques on the oocyte, preimplantation embryo, and resulting children. Work in this 
thesis has specifically provided insight on the effects of ARTs on two critical components of 
successful development: imprinted DNA methylation maintenance and mitochondrial 
dynamics.  Specifically, I have shown that imprinted DNA methylation is disrupted in human 
preimplantation embryos, and ovarian stimulation alone leads to perturbations in 
mitochondrial dynamics in mouse oocytes and embryos.  These two affected pathways may 
converge, and future studies are required to delineate whether these effects are (1) specific to 
the trophectoderm cell lineage, and (2) whether ART-induced mitochondrial dysfunction 
alters epigenetic signatures such as imprinted DNA methylation. 
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